Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Bladder Cancer, January 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 1467 articles:
HTML format


 

Single Articles

  1. PAVLOV VN, Urmantsev MF, Yudina YB, Bakeev MP, et al
    [A place of robot-assisted cystectomy in treatment of muscle-invasive bladder cancer].
    Urologiia. 2021;:141-144.
    Abstract     Related articles   

  2. PEMOV A, Wegman-Ostrosky T, Kim J, Koutros S, et al
    Identification of Genetic Risk Factors for Familial Urinary Bladder Cancer: An Exome Sequencing Study.
    JCO Precis Oncol. 2021;5.
    Abstract     Related articles   

  3. FU M, Klose C, Sparks A, Whalen M, et al
    Impact of Variant Histology on Occult Nodal Metastasis after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Review of the National Cancer Database.
    Clin Genitourin Cancer. 2021 Dec 1. pii: S1558-7673(21)00226.
    Abstract     Related articles   

  4. REN W, Hu J, Li H, Chen J, et al
    miR-616-5p Promotes Invasion and Migration of Bladder Cancer via Downregulating NR2C2 Expression.
    Front Oncol. 2021;11:762946.
    Abstract     Related articles   

  5. TANABE S, Sugino S, Niiya K, Ichida K, et al
    A Case of Incidental Detection of Asymptomatic Bladder Cancer by Transvaginal Ultrasound.
    Cureus. 2021;13:e20451.
    Abstract     Related articles   

  6. TANG W, Niu H, Yang Y, Li H, et al
    Efficacy and safety of transurethral resection of bladder tumor for superficial bladder cancer.
    Am J Transl Res. 2021;13:12860-12867.
    Abstract     Related articles   

  7. MA X, Wen Y, Wang Y, Zhang M, et al
    Linc00662 plays an oncogenic role in bladder cancer by sponging miR-199a-5p.
    Am J Transl Res. 2021;13:12673-12683.
    Abstract     Related articles   

  8. FABIANO E, Riou O, Pointreau Y, Perichon N, et al
    Role of radiotherapy in the management of bladder cancer: Recommendations of the French society for radiation oncology.
    Cancer Radiother. 2021 Dec 23. pii: S1278-3218(21)00295.
    Abstract     Related articles   

  9. ZHANG X, Ma X, Wang Q, Kong Z, et al
    EZH2 targeting to improve the sensitivity of acquired radio-resistance bladder cancer cells.
    Transl Oncol. 2021;16:101316.
    Abstract     Related articles   

  10. HAN C, Wang Z, Chen S, Li L, et al
    Erratum to "Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-kappaB Axis".
    Oxid Med Cell Longev. 2021;2021:9857803.
    Abstract     Related articles   

  11. ADAMCZYK P, Kadlubowski M, Poblocki P, Adamowicz J, et al
    Age and risk of major complications in patients undergoing radical cystectomy for muscle invasive bladder cancer.
    Wideochir Inne Tech Maloinwazyjne. 2021;16:722-727.
    Abstract     Related articles   

  12. LU M, Zhan H, Liu B, Li D, et al
    N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer.
    EPMA J. 2021;12:589-604.
    Abstract     Related articles   

  13. FLETCHER SA, Bivalacqua TJ, Brawley OW, Kates M, et al
    Race, ethnicity, and gender reporting in North American clinical trials for BCG-unresponsive non-muscle invasive bladder cancer.
    Urol Oncol. 2021 Dec 20. pii: S1078-1439(21)00514.
    Abstract     Related articles   

  14. LIU T, Jiang G
    A systematic review and meta-analysis of neoadjuvant chemotherapy for bladder cancer between ddMVAC and GC regimen.
    Urol Oncol. 2021 Dec 20. pii: S1078-1439(21)00515.
    Abstract     Related articles   

  15. LEMINSKI A, Kaczmarek K, Bancarz A, Zakrzewska A, et al
    Educational and Psychological Support Combined with Minimally Invasive Surgical Technique Reduces Perioperative Depression and Anxiety in Patients with Bladder Cancer Undergoing Radical Cystectomy.
    Int J Environ Res Public Health. 2021;18.
    Abstract     Related articles   

  16. NEDJADI T, Albarakati N, Benabdelkamel H, Masood A, et al
    Proteomic Profiling of Plasma-Derived Biomarkers in Patients with Bladder Cancer: A Step towards Clinical Translation.
    Life (Basel). 2021;11.
    Abstract     Related articles   

  17. D'ALOIA A, Arrigoni E, Costa B, Berruti G, et al
    RalGPS2 Interacts with Akt and PDK1 Promoting Tunneling Nanotubes Formation in Bladder Cancer and Kidney Cells Microenvironment.
    Cancers (Basel). 2021;13.
    Abstract     Related articles   

  18. THAM SM, Rahmat JN, Chiong E, Wu Q, et al
    Intravesical High Dose BCG Tokyo and Low Dose BCG Tokyo with GMCSF+IFN alpha Induce Systemic Immunity in a Murine Orthotopic Bladder Cancer Model.
    Biomedicines. 2021;9.
    Abstract     Related articles   

  19. CONSTANTIN T, Pavalean M, Bucur S, Constantin MM, et al
    Animal Models in Bladder Cancer.
    Biomedicines. 2021;9.
    Abstract     Related articles   

  20. RANA V, Parama D, Khatoon E, Girisa S, et al
    Reiterating the Emergence of Noncoding RNAs as Regulators of the Critical Hallmarks of Gall Bladder Cancer.
    Biomolecules. 2021;11.
    Abstract     Related articles   

  21. YAMASHITA S, Iwahashi Y, Miyai H, Matsumura N, et al
    Usefulness of Preoperative High Systemic Immune-Inflammation Index as a Prognostic Biomarker in Patients Who Undergo Radical Cystectomy for Bladder Cancer: Multicenter Analysis.
    Diagnostics (Basel). 2021;11.
    Abstract     Related articles   

  22. LAUKHTINA E, Schuettfort VM, D'Andrea D, Pradere B, et al
    Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
    Mol Carcinog. 2022;61:5-18.
    Abstract     Related articles   

  23. NA L, Wang Z, Bai Y, Sun Y, et al
    WNT7B represses epithelial-mesenchymal transition and stem-like properties in bladder urothelial carcinoma.
    Biochim Biophys Acta Mol Basis Dis. 2022;1868:166271.
    Abstract     Related articles   

  24. SHEU ZL, Huang CP, Chang CH, Chen CH, et al
    Tumor distribution affects bladder recurrence but not survival outcome of multifocal upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Sci Rep. 2021;11:19059.
    Abstract     Related articles   

  25. GHASEMI H, Mousavibahar SH, Hashemnia M, Karimi J, et al
    Transitional cell carcinoma matrix stiffness regulates the osteopontin and YAP expression in recurrent patients.
    Mol Biol Rep. 2021;48:4253-4262.
    Abstract     Related articles   

  26. MINERVINI A, Di Maida F, Tasso G, Mari A, et al
    Robot assisted radical cystectomy with Florence robotic intracorporeal neobladder (FloRIN): Analysis of survival and functional outcomes after first 100 consecutive patients upon accomplishment of phase 3 IDEAL framework.
    Eur J Surg Oncol. 2021;47:2651-2657.
    Abstract     Related articles   

  27. MICHEL KF, Spaulding A, Jemal A, Yabroff KR, et al
    Associations of Medicaid Expansion With Insurance Coverage, Stage at Diagnosis, and Treatment Among Patients With Genitourinary Malignant Neoplasms.
    JAMA Netw Open. 2021;4:e217051.
    Abstract     Related articles   

  28. LOPEZ-BELTRAN A, Cimadamore A, Montironi R, Cheng L, et al
    Molecular pathology of urothelial carcinoma.
    Hum Pathol. 2021;113:67-83.
    Abstract     Related articles   

  29. ZANCHETTIN C, Zanella L, Zoffoli G, Venturini A, et al
    Ultra-rapid regrowth of urothelial cardiac metastasis after debulking surgery.
    Cardiovasc Pathol. 2021;53:107334.
    Abstract     Related articles   

  30. WANG Y, Ju L, Guo Z, Qian K, et al
    Pedigree analysis of a POLD1 germline mutation in urothelial carcinoma shows a close association between different mutation burdens and overall survival.
    Cell Mol Immunol. 2021;18:767-769.
    Abstract     Related articles   

  31. KATAYAMA S, Schuettfort VM, Pradere B, Mori K, et al
    Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer.
    J Cancer Res Clin Oncol. 2022 Jan 8. pii: 10.1007/s00432-021-03887.
    Abstract     Related articles   

  32. TSE RT, Zhao H, Wong CY, Kong AW, et al
    In vitro assessment of intra-operative and post-operative environment in reducing bladder cancer recurrence.
    Sci Rep. 2022;12:22.
    Abstract     Related articles   

  33. BOUCHELOUCHE K
    PET/CT in Bladder Cancer: An Update.
    Semin Nucl Med. 2022 Jan 4. pii: S0001-2998(21)00105.
    Abstract     Related articles   

  34. YU XY, Ma CQ, Sheng YH
    circRNA CRIM1 regulates the migration and invasion of bladder cancer by targeting miR182/Foxo3a axis.
    Clin Transl Oncol. 2022 Jan 7. pii: 10.1007/s12094-021-02768.
    Abstract     Related articles   

  35. MASTRI M, Ramakrishnan S, Shah SD, Karasik E, et al
    Patient derived models of bladder cancer enrich the signal of the tumor cell transcriptome facilitating the analysis of the tumor cell compartment.
    Am J Clin Exp Urol. 2021;9:416-434.
    Abstract     Related articles   

  36. DAVIS L, Isali I, Prunty M, Calaway A, et al
    Female Sexual Function Following Radical Cystectomy in Bladder Cancer.
    Sex Med Rev. 2022 Jan 3. pii: S2050-0521(21)00090.
    Abstract     Related articles   

  37. LI P, Li L, Li Z, Wang S, et al
    Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway.
    Cancer Cell Int. 2022;22:7.
    Abstract     Related articles   

  38. ALAM SM, Chollet-Hinton L, Thompson J, Holzbeierlein JM, et al
    Effect of prior radiation on stage, differentiation, and survival in bladder cancer.
    World J Urol. 2022 Jan 6. pii: 10.1007/s00345-021-03901.
    Abstract     Related articles   

  39. CHEN K, Xing J, Yu W, Xia Y, et al
    Identification and Validation of Hub Genes Associated with Bladder Cancer by Integrated Bioinformatics and Experimental Assays.
    Front Oncol. 2021;11:782981.
    Abstract     Related articles   

  40. LIU X, Xu A, Huang J, Shen H, et al
    Effective prediction model for preventing postoperative deep vein thrombosis during bladder cancer treatment.
    J Int Med Res. 2022;50:3000605211067688.
    Abstract     Related articles   

  41. MA J, Vaishnani DK, Lin R, Lyu J, et al
    Artificial intelligence in bladder cancer: current trends and future possibilities.
    Chin Med J (Engl). 2022 Jan 4. pii: 00029330-900000000-98223.
    Abstract     Related articles   

  42. OKUNEYE K, Bergman D, Bloodworth JC, Pearson AT, et al
    A validated mathematical model of FGFR3-mediated tumor growth reveals pathways to harness the benefits of combination targeted therapy and immunotherapy in bladder cancer.
    Comput Syst Oncol. 2021;1.
    Abstract     Related articles   

  43. WAN P, Chen Z, Huang M, Jiang H, et al
    miR-200a-3p facilitates bladder cancer cell proliferation by targeting the A20 gene.
    Transl Androl Urol. 2021;10:4262-4274.
    Abstract     Related articles   

  44. TENG X, Liu Y, Wang L, Wang G, et al
    Lidocaine exerts anticancer activity in bladder cancer by targeting isoprenylcysteine carboxylmethyltransferase (ICMT).
    Transl Androl Urol. 2021;10:4219-4230.
    Abstract     Related articles   

  45. CHEN C, Huang Z, Huang P, Li K, et al
    Urogenital Microbiota:Potentially Important Determinant of PD-L1 Expression in Male Patients with Non-muscle Invasive Bladder Cancer.
    BMC Microbiol. 2022;22:7.
    Abstract     Related articles   

  46. FATTAHI MJ, Haghshenas MR, Ghaderi A
    Immunometabolism in bladder cancer microenvironment.
    Endocr Metab Immune Disord Drug Targets. 2022 Jan 4. pii: EMIDDT-EPUB-119930.
    Abstract     Related articles   

  47. REIS LO, Dal Col LSB, Capibaribe DM, de Mendonca GB, et al
    Presence and predominance of histological grade 3 define cT1HG bladder cancer prognostic groups.
    Investig Clin Urol. 2022;63:21-26.
    Abstract     Related articles   

  48. LEE S, Oh YT, Kim HM, Jung DC, et al
    Imaging Patterns of Bacillus Calmette-Guerin-Related Granulomatous Prostatitis Based on Multiparametric MRI.
    Korean J Radiol. 2022;23:60-67.
    Abstract     Related articles   

  49. FAVARO WJ, Socca EAR, Bockelmann PK, Reis IB, et al
    Impact of intravesical instillation of a novel biological response modifier (P-MAPA) on progress of non-muscle invasive bladder cancer treatment in a rat model.
    Med Oncol. 2022;39:24.
    Abstract     Related articles   

  50. LIU Q
    The emerging roles of exosomal long non-coding RNAs in bladder cancer.
    J Cell Mol Med. 2022 Jan 3. doi: 10.1111/jcmm.17152.
    Abstract     Related articles   

  51. DA Z, Huo Z, Luo HH, Liao RQ, et al
    [Clinicopathological Analysis of Brain Metastatic Carcinoma in Tibet].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2021;43:869-874.
    Abstract     Related articles   

  52. ZHUANG J, Hao J, Bu F, Yin H, et al
    MicroRNA-582-5p regulates cell invasion in bladder cancer through targeting Forkhead Box G1.
    Pathol Res Pract. 2021;230:153752.
    Abstract     Related articles   

  53. YACOUBA A, Alou MT, Lagier JC, Dubourg G, et al
    Urinary microbiota and bladder cancer: A systematic review and a focus on uropathogens.
    Semin Cancer Biol. 2021 Dec 31. pii: S1044-579X(21)00303.
    Abstract     Related articles   

  54. GHASSEMI H, Hashemnia M, Mousavibahar SH, Mahmoodzadeh Hosseini H, et al
    Positive Association of Matrix Proteins Alteration with TAZ and The Progression of High-Grade Bladder Cancer.
    Cell J. 2021;23:742-749.
    Abstract     Related articles   

  55. HEMISSI I, Boussetta S, Dallali H, Hellal F, et al
    Correction to: Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort.
    Mol Biol Rep. 2022 Jan 2. pii: 10.1007/s11033-021-07052.
    Abstract     Related articles   

  56. HUANG Z, Liu J, Yang J, Yan Y, et al
    PDE4B Induces Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Is Transcriptionally Suppressed by CBX7.
    Front Cell Dev Biol. 2021;9:783050.
    Abstract     Related articles   

  57. SZYMANKIEWICZ M, Kamecki K, Jarzynka S, Koryszewska-Baginska A, et al
    Case Report: Echinocandin-Resistance Candida glabrata FKS Mutants From Patient Following Radical Cystoprostatectomy Due to Muscle-Invasive Bladder Cancer.
    Front Oncol. 2021;11:794235.
    Abstract     Related articles   

  58. XU Y, Chen D, Shen L, Huang X, et al
    Identification and Mechanism of the PD-1/PD-L1 Genomic Signature SORL1 as Protective Factor in Bladder Cancer.
    Front Genet. 2021;12:736158.
    Abstract     Related articles   

  59. LIU Z, Qi T, Li X, Yao Y, et al
    A Novel TGF-beta Risk Score Predicts the Clinical Outcomes and Tumour Microenvironment Phenotypes in Bladder Cancer.
    Front Immunol. 2021;12:791924.
    Abstract     Related articles   

  60. LI B, Xiao Q, Shan L, Song Y, et al
    NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway.
    Cell Cycle. 2022 Jan 2:1-12. doi: 10.1080/15384101.2021.2021050.
    Abstract     Related articles   

  61. NAUMAN M, Hasan AS, Sultan G, Kumar P, et al
    Inflammatory myofibroblastic tumour of genitourinary system.
    J Pak Med Assoc. 2021;71:2467-2469.
    Abstract     Related articles   

  62. RAVINDRANATHAN D, Alhalabi O, Rafei H, Shah AY, et al
    Landscape of Immunotherapy in Genitourinary Malignancies.
    Adv Exp Med Biol. 2021;1342:143-192.
    Abstract     Related articles   

  63. ISHIYAMA Y, Kondo T, Tachibana H, Ishihara H, et al
    Association Between Anesthetic Technique and Survival After Radical Nephroureterectomy: A Propensity Score-matching Study.
    In Vivo. 2022;36:458-464.
    Abstract     Related articles   

  64. XIANG P, Du Z, Hao Y, Guan D, et al
    Impact of Androgen Suppression Therapy on the Risk and Prognosis of Bladder Cancer: A Systematic Review and Meta-Analysis.
    Front Oncol. 2021;11:784627.
    Abstract     Related articles   

  65. TALWAR HS, Panwar VK, Mittal A, Ghorai RP, et al
    Successful management of a high-output urinary fistula following radical cystectomy and ileal conduit: a conservative approach.
    BMJ Case Rep. 2021;14.
    Abstract     Related articles   

  66. SCHULE J, Kraus F, Veil C, Kunkel S, et al
    Multi-Physical Tissue Modeling of a Human Urinary Bladder.
    Annu Int Conf IEEE Eng Med Biol Soc. 2021;2021:4297-4302.
    Abstract     Related articles   

  67. YANAGISAWA T, Mori K, Katayama S, Mostafaei H, et al
    Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis.
    Int J Clin Oncol. 2022;27:59-71.
    Abstract     Related articles   

  68. ISOBE T, Naiki T, Sugiyama Y, Naiki-Ito A, et al
    Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis.
    Int J Clin Oncol. 2022;27:165-174.
    Abstract     Related articles   

  69. SHIMIZU R, Honda M, Teraoka S, Yumioka T, et al
    Sarcopenia is associated with survival in patients with urothelial carcinoma treated with systemic chemotherapy.
    Int J Clin Oncol. 2022;27:175-183.
    Abstract     Related articles   

  70. SHIGIHARA K, Shimonohara N, Stanley BJ
    Outcome of a dog with urinary bladder osteosarcoma treated with a total cystectomy and ureterocutaneostomy.
    Can Vet J. 2021;62:1089-1094.
    Abstract     Related articles   

  71. LI X, Wei Z, Yu H, Xu Y, et al
    Secretory autophagy-induced bladder tumour-derived extracellular vesicle secretion promotes angiogenesis by activating the TPX2-mediated phosphorylation of the AURKA-PI3K-AKT axis.
    Cancer Lett. 2021;523:10-28.
    Abstract     Related articles   

  72. GAO H, Chen J, Li G, Cui X, et al
    Pediatric laparoscopic partial cystectomy for the treatment of benign bladder tumors and urachal cysts.
    BMC Urol. 2021;21:128.
    Abstract     Related articles   

  73. OSHINA T, Taguchi S, Miyakawa J, Akiyama Y, et al
    Clinicopathological features and oncological outcomes of urothelial carcinoma involving the ureterovesical junction.
    Jpn J Clin Oncol. 2022;52:65-72.
    Abstract     Related articles   

  74. DURANTE J, Manassero F, Fidecicchi T, Tognarelli A, et al
    Autologous fascial slings remain viable at long-term follow-up: a post cystectomy case report.
    BMC Urol. 2021;21:122.
    Abstract     Related articles   

  75. HO SR, Lee YC, Ittmann MM, Lin FT, et al
    RNF144A deficiency promotes PD-L1 protein stabilization and carcinogen-induced bladder tumorigenesis.
    Cancer Lett. 2021;520:344-360.
    Abstract     Related articles   

  76. MIYASAKA Y, Kawamura H, Sato H, Kubo N, et al
    Carbon ion radiotherapy for prostate cancer with bladder invasion.
    BMC Urol. 2021;21:106.
    Abstract     Related articles   

  77. TU X, Zhang N, Zhuang X, Chen S, et al
    Incidental diagnosis of nonfunctional bladder paraganglioma: a case report and literature review.
    BMC Urol. 2021;21:98.
    Abstract     Related articles   

  78. PRUITT SL, Gerber DE, Zhu H, Heitjan DF, et al
    Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer.
    Cancer Med. 2021;10:4752-4767.
    Abstract     Related articles   

  79. SHIMOHAMA S, Oki K, Narita H, Mashima K, et al
    Trousseau's Syndrome Presenting as Multiple Cerebral Infarctions Caused by Mucin-producing Bladder Micropapillary Urothelial Cancer.
    Intern Med. 2022;61:97-101.
    Abstract     Related articles   

  80. MOHANTY SK, Mishra SK, Tiwari A, Sharma S, et al
    Reappraisal of HER2 Amplification in High-Grade Urothelial Carcinoma Based on 2018 ASCO/CAP Clinical Practice Guidelines.
    Am J Clin Pathol. 2021;156:1130-1141.
    Abstract     Related articles   

  81. STERN ES, Siddiqui MT
    Nuclear hypochromasia: Shedding light on the "lightness" of high-grade urothelial carcinoma.
    Diagn Cytopathol. 2021;49:1032-1035.
    Abstract     Related articles   

  82. TODENHOFER T, Gibb EA, Seiler R, Kamyabi A, et al
    Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinoma.
    Urol Oncol. 2021;39:498.
    Abstract     Related articles   

  83. BELLAMRI M, Brandt K, Brown CV, Wu MT, et al
    Cytotoxicity and genotoxicity of the carcinogen aristolochic acid I (AA-I) in human bladder RT4 cells.
    Arch Toxicol. 2021;95:2189-2199.
    Abstract     Related articles   

  84. LAUKHTINA E, Pradere B, Mori K, Schuettfort VM, et al
    Prognostic blood-based biomarkers in patients treated with neoadjuvant chemotherapy for urothelial carcinoma of the bladder: A systematic review.
    Urol Oncol. 2021;39:471-479.
    Abstract     Related articles   

  85. GOTO T, Miyamoto H
    The Role of Estrogen Receptors in Urothelial Cancer.
    Front Endocrinol (Lausanne). 2021;12:643870.
    Abstract     Related articles   

  86. NAYYAR R, Saini S, Sharma A, Kurra S, et al
    Systemic dissemination of tumor cells during transurethral resection in patients with bladder tumor and its clinical relevance: A follow up study.
    Urol Oncol. 2021;39:497.
    Abstract     Related articles   

  87. KERROUMI S, Neuzillet Y, Soorojebally Y, Radulescu C, et al
    The impact of carcinoma in situ in ureteral margins during radical cystectomy: A case-controlled study.
    Urol Oncol. 2021;39:497.
    Abstract     Related articles   

  88. DIAMANTOPOULOS LN, Sekar RR, Holt SK, Khaki AR, et al
    Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomy.
    Urol Oncol. 2021;39:496.
    Abstract     Related articles   

  89. SWAMI U, Grivas P, Pal SK, Agarwal N, et al
    Utilization of systemic therapy for treatment of advanced urothelial carcinoma: Lessons from real world experience.
    Cancer Treat Res Commun. 2021;27:100325.
    Abstract     Related articles   

  90. SU X, Lu X, Bazai SK, Comperat E, et al
    Comprehensive integrative profiling of upper tract urothelial carcinomas.
    Genome Biol. 2021;22:7.
    Abstract     Related articles   

  91. CHEN CH, Grollman AP, Huang CY, Shun CT, et al
    Additive Effects of Arsenic and Aristolochic Acid in Chemical Carcinogenesis of Upper Urinary Tract Urothelium.
    Cancer Epidemiol Biomarkers Prev. 2021;30:317-325.
    Abstract     Related articles   

  92. ASSADI A, Alzubaidi A, Lesmana H, Brennan RC, et al
    Pure Bladder Malignant Rhabdoid Tumor Successfully Treated With Partial Cystectomy, Radiation, and Chemotherapy: A Case Report and Review of the Literature.
    J Pediatr Hematol Oncol. 2021;43:e1214-e1216.
    Abstract     Related articles   

  93. LIPETSKAIA L, Lee TG, Li D, Meyer H, et al
    Pelvic Floor Organ Prolapse After Radical Cystectomy in Patients With Uroepithelial Carcinoma.
    Female Pelvic Med Reconstr Surg. 2021;27:e501-e504.
    Abstract     Related articles   

  94. QIU Y, Gao Y, Chen C, Xie M, et al
    Deciphering the influence of urinary microbiota on FoxP3+ regulatory T cell infiltration and prognosis in Chinese patients with non-muscle-invasive bladder cancer.
    Hum Cell. 2022 Jan 15. pii: 10.1007/s13577-021-00659.
    Abstract     Related articles   

  95. MAO M, Yang L, Hu J, Liu B, et al
    Oncogenic E3 ubiquitin ligase NEDD4 binds to KLF8 and regulates the microRNA-132/NRF2 axis in bladder cancer.
    Exp Mol Med. 2022 Jan 14. pii: 10.1038/s12276-021-00663.
    Abstract     Related articles   

  96. YAMASHITA S, Mashima N, Higuchi M, Matsumura N, et al
    Modified 5-Item Frailty Index Score as Prognostic Marker After Radical Cystectomy in Bladder Cancer.
    Clin Genitourin Cancer. 2021 Dec 27. pii: S1558-7673(21)00250.
    Abstract     Related articles   

  97. QIU F, Liu Q, Xia Y, Jin H, et al
    Circ_0000658 knockdown inhibits epithelial-mesenchymal transition in bladder cancer via miR-498-induced HMGA2 downregulation.
    J Exp Clin Cancer Res. 2022;41:22.
    Abstract     Related articles   

  98. DING H, Huang Y, Shi J, Wang L, et al
    Correction to: Attenuated expression of SNF5 facilitates progression of bladder cancer via STAT3 activation.
    Cancer Cell Int. 2022;22:20.
    Abstract     Related articles   

  99. PENG G, Guan J, Leng P, Peng L, et al
    Circular RNA circ_0000515 adsorbs miR-542-3p to accelerate bladder cancer progression via up-regulating ILK expression.
    Aging (Albany NY). 2022;14.
    Abstract     Related articles   

  100. HAMADA K, Yoshimura K, Oshinomi K, Hirasawa Y, et al
    A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case report.
    Medicine (Baltimore). 2022;101:e28339.
    Abstract     Related articles   

  101. WEN Z, Huang G, Lai Y, Xiao L, et al
    Diagnostic panel of serum miR-125b-5p, miR-182-5p, and miR-200c-3p as non-invasive biomarkers for urothelial bladder cancer.
    Clin Transl Oncol. 2022 Jan 14. pii: 10.1007/s12094-021-02741.
    Abstract     Related articles   

  102. HURST CD, Cheng G, Platt FM, Castro MAA, et al
    Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.
    Cell Rep Med. 2021;2:100472.
    Abstract     Related articles   

  103. BILIM V, Hoshi S
    Prostatic urethra recurrence after transurethral resection of bladder tumor (TURBT) for non-muscle-invasive bladder cancer (NMIBC).
    Clin Case Rep. 2022;10:e05256.
    Abstract     Related articles   

  104. ZHU K, Deng W, Deng H, Liu X, et al
    Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer.
    PPAR Res. 2021;2021:7056506.
    Abstract     Related articles   

  105. YU EY, Stern MC, Jiang X, Tang L, et al
    Family history and risk of bladder cancer: an analysis accounting for first- and second-degree relatives.
    Cancer Prev Res (Phila). 2022 Jan 13. pii: 1940-6207.CAPR-21-0490.
    Abstract     Related articles   


  106. Correction: Bladder cancer incidence among workers exposed to o-toluidine, aniline and nitrobenzene at a rubber chemical manufacturing plant.
    Occup Environ Med. 2022;79:e1.
    Abstract     Related articles   

  107. LIA T, Shao Y, Regmi P, Li X, et al
    Development and validation of Pyroptosisrelated lncRNAs prediction model for bladder cancer.
    Biosci Rep. 2022 Jan 13. pii: 230650. doi: 10.1042/BSR20212253.
    Abstract     Related articles   

  108. SCHMIDT B, Velaer KN, Thomas IC, Ganesan C, et al
    Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer.
    Eur Urol Open Sci. 2022;35:29-36.
    Abstract     Related articles   

  109. HORIBE Y, Nakata W, Tsujimura G, Tsujimoto Y, et al
    A case of long-term complete remission of locally advanced T4 bladder cancer treated with pembrolizumab.
    Urol Case Rep. 2021;41:101959.
    Abstract     Related articles   

  110. KONG N, Chen X, Feng J, Duan T, et al
    Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1.
    Acta Pharm Sin B. 2021;11:4045-4054.
    Abstract     Related articles   

  111. YU J, Mao W, Sun S, Hu Q, et al
    Characterization of an Autophagy-Immune Related Genes Score Signature and Prognostic Model and its Correlation with Immune Response for Bladder Cancer.
    Cancer Manag Res. 2022;14:67-88.
    Abstract     Related articles   

  112. MOHSENZADEGAN M, Razmi M, Vafaei S, Abolhasani M, et al
    Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer.
    Sci Rep. 2022;12:599.
    Abstract     Related articles   

  113. SHAH AA, Sun Z, Eom KY, Grajales V, et al
    Treatment disparities in muscle-invasive bladder cancer: Evidence from a large statewide cancer registry.
    Urol Oncol. 2022 Jan 9. pii: S1078-1439(21)00552.
    Abstract     Related articles   

  114. ZHAO H, Wu W, Li X, Chen W, et al
    Long noncoding RNA UCA1 promotes glutamine-driven anaplerosis of bladder cancer by interacting with hnRNP I/L to upregulate GPT2 expression.
    Transl Oncol. 2022;17:101340.
    Abstract     Related articles   

  115. XU J, Wei L, Liu H, Lei Y, et al
    CD274 (PD-L1) Methylation is an Independent Predictor for Bladder Cancer Patients' Survival.
    Cancer Invest. 2022 Jan 12:1-11. doi: 10.1080/07357907.2022.2028805.
    Abstract     Related articles   

  116. LIEDBERG F, Hagberg O, Baseckas G, Brandstedt J, et al
    Anorectal dysfunction after radical cystectomy for bladder cancer.
    Scand J Urol. 2022 Jan 12:1-7. doi: 10.1080/21681805.2021.2025423.
    Abstract     Related articles   

  117. HAJJAR M, Rezazadeh A, Naja F, Kardoust Parizi M, et al
    Association of Recommended and Non-Recommended Food Score and Risk of Bladder Cancer: A Case-Control Study.
    Nutr Cancer. 2022 Jan 12:1-8. doi: 10.1080/01635581.2021.2004172.
    Abstract     Related articles   

  118. DIANATINASAB M, Forozani E, Akbari A, Azmi N, et al
    Dietary patterns and risk of bladder cancer: a systematic review and meta-analysis.
    BMC Public Health. 2022;22:73.
    Abstract     Related articles   

  119. LIU H, Zhang M, Jin H, Tao K, et al
    Fe(III)-Doped Polyaminopyrrole Nanoparticle for Imaging-Guided Photothermal Therapy of Bladder Cancer.
    ACS Biomater Sci Eng. 2022 Jan 11. doi: 10.1021/acsbiomaterials.1c01217.
    Abstract     Related articles   

  120. YIN H, Zhang C, Wei Z, He W, et al
    EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation.
    Cell Death Dis. 2022;13:39.
    Abstract     Related articles   

  121. DYUGAY IA, Lukyanov DK, Turchaninova MA, Serebrovskaya EO, et al
    Accounting for B-cell behavior and sampling bias predicts anti-PD-L1 response in bladder cancer.
    Cancer Immunol Res. 2022 Jan 10. pii: 2326-6066.CIR-21-0489.
    Abstract     Related articles   

  122. RENTSCH CA, Thalmann GN, Lucca I, Kwiatkowski M, et al
    A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guerin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14.
    Eur Urol Oncol. 2022 Jan 7. pii: S2588-9311(21)00222.
    Abstract     Related articles   

  123. RACIOPPI M
    Advances in Management of Bladder Cancer.
    J Clin Med. 2021;11.
    Abstract     Related articles   

  124. WRONSKI P, Wronski S, Kurant M, Malinowski B, et al
    Curcumin May Prevent Basement Membrane Disassembly by Matrix Metalloproteinases and Progression of the Bladder Cancer.
    Nutrients. 2021;14.
    Abstract     Related articles   

  125. JIMENEZ-GUERRERO R, Belmonte-Fernandez A, Flores ML, Gonzalez-Moreno M, et al
    Wnt/beta-Catenin Signaling Contributes to Paclitaxel Resistance in Bladder Cancer Cells with Cancer Stem Cell-Like Properties.
    Int J Mol Sci. 2021;23.
    Abstract     Related articles   

  126. JAGUSIAK A, Gosiewski T, Romaniszyn D, Lasota M, et al
    Antibacterial Therapy by Ag(+) Ions Complexed with Titan Yellow/Congo Red and Albumin during Anticancer Therapy of Urinary Bladder Cancer.
    Int J Mol Sci. 2021;23.
    Abstract     Related articles   

  127. VAN HATTUM JW, de Ruiter BM, Oddens JR, Hulshof MCCM, et al
    Bladder-Sparing Chemoradiotherapy Combined with Immune Checkpoint Inhibition for Locally Advanced Urothelial Bladder Cancer-A Review.
    Cancers (Basel). 2021;14.
    Abstract     Related articles   

  128. MAZZA C, Gaydou V, Eymard JC, Birembaut P, et al
    Identification of Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer by Fourier-Transform Infrared Micro-Imaging.
    Cancers (Basel). 2021;14.
    Abstract     Related articles   

  129. YANG X, Wei X, Yi C, Yang Y, et al
    Long Noncoding RNA HAND2-AS1 Suppresses Cell Proliferation, Migration, and Invasion of Bladder Cancer via miR-17-5p/KLF9 Axis.
    DNA Cell Biol. 2022 Jan 10. doi: 10.1089/dna.2021.0637.
    Abstract     Related articles   

  130. CHEN WH, Yu KJ, Jhou JW, Pang HH, et al
    Glucose/Glutathione Co-triggered Tumor Hypoxia Relief and Chemodynamic Therapy to Enhance Photothermal Therapy in Bladder Cancer.
    ACS Appl Bio Mater. 2021;4:7485-7496.
    Abstract     Related articles   

  131. CHEN D, Ye Y, Guo S, Yao K, et al
    Progress in the Research and Targeted Therapy of ErbB/HER Receptors in Urothelial Bladder Cancer.
    Front Mol Biosci. 2021;8:800945.
    Abstract     Related articles   

  132. ZHANG F, Feng D, Wang X, Gu Y, et al
    An Unfolded Protein Response Related Signature Could Robustly Predict Survival Outcomes and Closely Correlate With Response to Immunotherapy and Chemotherapy in Bladder Cancer.
    Front Mol Biosci. 2021;8:780329.
    Abstract     Related articles   

  133. LIU J, Wang J, Wu M, Zhang W, et al
    Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer.
    Front Med (Lausanne). 2021;8:757432.
    Abstract     Related articles   

  134. ZHENG X, Liao X, Nie L, Lin T, et al
    LCK and CD3E Orchestrate the Tumor Microenvironment and Promote Immunotherapy Response and Survival of Muscle-Invasive Bladder Cancer Patients.
    Front Cell Dev Biol. 2021;9:748280.
    Abstract     Related articles   

  135. WANG J, Peng X, Li R, Liu K, et al
    Evaluation of Serum miR-17-92 Cluster as Noninvasive Biomarkers for Bladder Cancer Diagnosis.
    Front Oncol. 2021;11:795837.
    Abstract     Related articles   

  136. TAN S, Fu L, Dong Q
    AATF is Overexpressed in Human Bladder Cancer and Regulates Chemo-Sensitivity Through Survivin.
    Onco Targets Ther. 2021;14:5493-5505.
    Abstract     Related articles   

  137. SANTOS HJSP, Matheus LHG, Silva A, Dalmazzo SV, et al
    Indoleamine 2,3-Dioxygenase-1 Expression is Changed During Bladder Cancer Cell Invasion.
    Int J Tryptophan Res. 2022;15:11786469211065612.
    Abstract     Related articles   

  138. JIN S, Zeng H, Liu Z, Jin K, et al
    Stromal Tumor-Associated Macrophage Infiltration Predicts Poor Clinical Outcomes in Muscle-Invasive Bladder Cancer Patients.
    Ann Surg Oncol. 2022 Jan 9. pii: 10.1245/s10434-021-11155.
    Abstract     Related articles   

  139. SUN Y, Guan Z, Sheng Q, Duan W, et al
    N-myristoyltransferase-1 deficiency blocks myristoylation of LAMTOR1 and inhibits bladder cancer progression.
    Cancer Lett. 2022;529:126-138.
    Abstract     Related articles   

  140. CROCETTO F, Barone B, Ferro M, Busetto GM, et al
    Liquid biopsy in bladder cancer: State of the art and future perspectives.
    Crit Rev Oncol Hematol. 2022;170:103577.
    Abstract     Related articles   

  141. WILKINS A, Hall E, Lewis R, Gribble H, et al
    RE-ARMing the Immune Response to Bladder Cancer with Radiotherapy.
    Clin Oncol (R Coll Radiol). 2022 Jan 5. pii: S0936-6555(21)00518.
    Abstract     Related articles   

  142. FUJIZUKA Y, Suzuki K, Sawada T, Suto Y, et al
    [Malignant Central Nervous System Lymphoma after Radical Total Cystectomy : A Diagnostic Challenge].
    Hinyokika Kiyo. 2021;67:539-542.
    Abstract     Related articles   

  143. SUZUKI R, Kohei N, Kiyozuka K
    [A Case of Advanced Bladder Carcinoma Treated by Third-Line Gemcitabine and Paclitaxel Chemotherapy].
    Hinyokika Kiyo. 2021;67:533-537.
    Abstract     Related articles   

  144. COHEN S, Gal J, Freifeld Y, Khoury S, et al
    Nutritional Status Impairment Due to Neoadjuvant Chemotherapy Predicts Post-Radical Cystectomy Complications.
    Nutrients. 2021;13.
    Abstract     Related articles   

  145. HAGHSHENAS MR, Hosseini SR, Fattahi MJ, Malekzadeh M, et al
    Elevated IL-37 Serum Levels in Patients with Transitional Cell Carcinoma of Bladder.
    Iran J Immunol. 2021;18:346-353.
    Abstract     Related articles   

  146. XU G, Li J, Yu L
    miR-19a-3p Promotes Tumor-Relevant Behaviors in Bladder Urothelial Carcinoma via Targeting THBS1.
    Comput Math Methods Med. 2021;2021:2710231.
    Abstract     Related articles   

  147. TAPAK L, Kosorok MR, Sadeghifar M, Hamidi O, et al
    Regularized Weighted Nonparametric Likelihood Approach for High-Dimension Sparse Subdistribution Hazards Model for Competing Risk Data.
    Comput Math Methods Med. 2021;2021:5169052.
    Abstract     Related articles   

  148. KHRIGUIAN J, Patrocinio H, Andonian S, Aprikian A, et al
    Stereotactic Ablative Radiation Therapy for the Treatment of Upper Urinary Tract Urothelial Carcinoma.
    Pract Radiat Oncol. 2022;12:e34-e39.
    Abstract     Related articles   

  149. SINGH PK, Bhatt MLB, Singh P, Rath SK, et al
    Frequent expression of a novel cancer testis antigen, protein kinase human monopolar spindle 1 (hMps1/TTK) in human urinary bladder transitional cell carcinoma.
    Drug Discov Ther. 2021;15:204-209.
    Abstract     Related articles   

  150. CHEN TJ, Dehghanian SZ, Chan TC, He HL, et al
    High G protein subunit beta 4 protein level is correlated to poor prognosis of urothelial carcinoma.
    Med Mol Morphol. 2021;54:356-367.
    Abstract     Related articles   

  151. KAPETANAKIS V, Prawitz T, Schlichting M, Ishak KJ, et al
    How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments.
    Value Health. 2021;24:1137-1144.
    Abstract     Related articles   

  152. GALSKY MD, Balar AV, Black PC, Campbell MT, et al
    Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer.
    J Immunother Cancer. 2021;9.
    Abstract     Related articles   

  153. ANAMI T, Komohara Y, Miura Y, Yamanaka K, et al
    High T-cell infiltration in tumor tissue and younger age predict the response to pembrolizumab in recurrent urothelial cancer.
    Med Mol Morphol. 2021;54:316-323.
    Abstract     Related articles   

  154. WU B, Jiang X, Huang Y, Ying X, et al
    Integrated analysis of mRNA-m(6)A-protein profiles reveals novel insights into the mechanisms for cadmium-induced urothelial transformation.
    Biomarkers. 2021;26:499-507.
    Abstract     Related articles   

  155. TAN WS, Kelly JD
    Is delay to radical cystectomy following BCG failure oncologically safe?
    Nat Rev Urol. 2021;18:323-324.
    Abstract     Related articles   

  156. TODENHOFER T, Maas M, Ketz M, Kossack N, et al
    Retrospective German claims data study on initial treatment of bladder carcinoma (BCa) by transurethral bladder resection (TURB): a comparative analysis of costs using standard white light- (WL-) vs. blue light- (BL-) TURB.
    World J Urol. 2021;39:2953-2960.
    Abstract     Related articles   

  157. SANCHEZ DJ, Missiaen R, Skuli N, Steger DJ, et al
    Cell-Intrinsic Tumorigenic Functions of PPARgamma in Bladder Urothelial Carcinoma.
    Mol Cancer Res. 2021;19:598-611.
    Abstract     Related articles   

  158. BERRIDGE C, Kailavasan M, Athanasiadis G, Gkentzis A, et al
    Endoscopic surgical simulation using low-fidelity and virtual reality transurethral resection simulators in urology simulation boot camp course: trainees feedback assessment study.
    World J Urol. 2021;39:3103-3107.
    Abstract     Related articles   

  159. SURCEL C, Mirvald C, Tsaur I, Borgmann H, et al
    Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer.
    World J Urol. 2021;39:2483-2490.
    Abstract     Related articles   

  160. RODLER S, Buchner A, Ledderose ST, Eismann L, et al
    Prognostic value of pretreatment inflammatory markers in variant histologies of the bladder: is inflammation linked to survival after radical cystectomy?
    World J Urol. 2021;39:2537-2543.
    Abstract     Related articles   

  161. MITRA S, Purkait S, Das MK
    Unilateral axillary lymph node metastasis from small cell neuroendocrine carcinoma of the urinary bladder.
    Cytopathology. 2021;32:371-373.
    Abstract     Related articles   

  162. HACEK J, Brisuda A, Babjuk M, Zamecnik J, et al
    Expression of cancer stem cells markers in urinary bladder urothelial carcinoma and its precursor lesions.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021;165:316-321.
    Abstract     Related articles   

  163. FREUDENBURG E, Shan Y, Martinez A, Srinivasan A, et al
    Geographic distribution of racial differences in mortality in muscle-invasive bladder cancer patients: an opportunity for improvement.
    Cancer Causes Control. 2022 Jan 20. pii: 10.1007/s10552-022-01553.
    Abstract     Related articles   

  164. AMINOLTEJARI K, Kulkarni G, Mason R
    Practice-changing publications: Muscle-invasive bladder cancer.
    Can Urol Assoc J. 2021 Aug 26. pii: cuaj.7733. doi: 10.5489/cuaj.7733.
    Abstract     Related articles   

  165. SHIH HJ, Lin KH, Wen YC, Fan YC, et al
    Increased risk of bladder cancer in young adult men with hyperlipidemia: A population-based cohort study.
    Medicine (Baltimore). 2021;100:e28125.
    Abstract     Related articles   

  166. MENG X, Hu H, Wang Y, Feng C, et al
    Accuracy and Challenges in the Vesical Imaging-Reporting and Data System for Staging Bladder Cancer.
    J Magn Reson Imaging. 2022 Jan 20. doi: 10.1002/jmri.28064.
    Abstract     Related articles   

  167. ZHANG Z, Zhao H, Zhou G, Han R, et al
    Circ_0002623 promotes bladder cancer progression by regulating the miR-1276/SMAD2 axis.
    Cancer Sci. 2022 Jan 20. doi: 10.1111/cas.15274.
    Abstract     Related articles   

  168. XUAN L, Hu JH, Bi R, Liu SQ, et al
    Andrographolide Inhibits Proliferation and Promotes Apoptosis in Bladder Cancer Cells by Interfering with NF-kappaB and PI3K/AKT Signaling In Vitro and In Vivo.
    Chin J Integr Med. 2022 Jan 19. pii: 10.1007/s11655-022-3464.
    Abstract     Related articles   

  169. MUSAT MG, Kwon CS, Masters E, Sikirica S, et al
    Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR).
    Clinicoecon Outcomes Res. 2022;14:35-48.
    Abstract     Related articles   

  170. MATSUI Y
    [. The Development Status of the Novel Therapeutic Strategies against Non-Muscle Invasive Bladder Cancer -The Introduction of On-Going or Completed Clinical Trials].
    Gan To Kagaku Ryoho. 2022;49:39-42.
    Abstract     Related articles   

  171. MIYAKE M
    [. Clinical Evidence and Biological Mechanism of BCG Failure in Patients with Non-Muscle Invasive Bladder Cancer].
    Gan To Kagaku Ryoho. 2022;49:33-38.
    Abstract     Related articles   

  172. FUKUHARA H, Inoue K
    [. Diagnosis and Therapy for Non-Muscle Invasive Bladder Cancer Using Photodynamic Technique].
    Gan To Kagaku Ryoho. 2022;49:29-32.
    Abstract     Related articles   

  173. NISHIYAMA H
    [Urological Cancer Non-Muscle Invasive Bladder Cancer- Update of Diagnosis and Treatment].
    Gan To Kagaku Ryoho. 2022;49:28.
    Abstract     Related articles   

  174. KALAYARASAN R, Narayanan S, James M
    Robotic fluorescence-guided anatomical segment IVb and V liver resection with radical lymphadenectomy for gall bladder cancer.
    J Minim Access Surg. 2022 Jan 6. pii: 335071. doi: 10.4103.
    Abstract     Related articles   

  175. GABRIELSON AT, Daniels MJ, Rowe J, Alam R, et al
    Residual CIS after neoadjuvant chemotherapy and radical cystectomy for muscle invasive bladder cancer: Implications for neoadjuvant trials.
    Urol Oncol. 2022 Jan 16. pii: S1078-1439(21)00536.
    Abstract     Related articles   

  176. ZHANG Z, Liang Z, Li D, Wang L, et al
    Development of a CAFs-related gene signature to predict survival and drug response in bladder cancer.
    Hum Cell. 2022 Jan 19. pii: 10.1007/s13577-022-00673.
    Abstract     Related articles   

  177. YU Y, Zeng H, Jin K, You R, et al
    Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer.
    Cancer Immunol Immunother. 2022 Jan 18. pii: 10.1007/s00262-022-03153.
    Abstract     Related articles   

  178. NISHIMURA K, Nishio K, Hirosuna K, Komura K, et al
    Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer.
    J Immunother Cancer. 2022;10.
    Abstract     Related articles   

  179. VENKAT S, Lewicki PJ, Khan AI, Gaffney C, et al
    Sociodemographic Disparities in Access to Chemotherapy for Bladder Cancer.
    Clin Genitourin Cancer. 2021 Dec 24. pii: S1558-7673(21)00248.
    Abstract     Related articles   

  180. ISALI I, McClellan P, Calaway A, Prunty M, et al
    Gene network profiling in muscle-invasive bladder cancer: A systematic review and meta-analysis.
    Urol Oncol. 2022 Jan 15. pii: S1078-1439(21)00484.
    Abstract     Related articles   

  181. YANG C, Wu S, Mou Z, Zhou Q, et al
    Exosome derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironment through modulating reactive oxygen species equilibrium via GLS1 mediated glutamine metabolism alteration.
    Mol Ther. 2022 Jan 13. pii: S1525-0016(22)00022.
    Abstract     Related articles   

  182. LEONI C, Paradiso FV, Foschi N, Tedesco M, et al
    Prevalence of bladder cancer in Costello syndrome: new insights to drive clinical decision-making.
    Clin Genet. 2022 Jan 17. doi: 10.1111/cge.14111.
    Abstract     Related articles   

  183. GUERRERO-RAMOS F, Gonzalez-Padilla DA, Gonzalez-Diaz A, de la Rosa-Kehrmann F, et al
    Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial.
    World J Urol. 2022 Jan 17. pii: 10.1007/s00345-022-03928.
    Abstract     Related articles   

  184. THOMAS PB, Perera MPJ, Alinezhad S, Joshi A, et al
    Culture of Bladder Cancer Organoids as Precision Medicine Tools.
    J Vis Exp. 2021;.
    Abstract     Related articles   

  185. ADEYELU TT, Moya-Garcia AA, Orengo C
    Exploiting protein family and protein network data to identify novel drug targets for bladder cancer.
    Oncotarget. 2022;13:105-117.
    Abstract     Related articles   

  186. BAN D, Lu W, Lu Z, Li B, et al
    Effects of radical cystectomy combined with GC chemotherapy in the treatment of invasive bladder cancer and its influence on the incidence of adverse reactions.
    Am J Transl Res. 2021;13:13845-13853.
    Abstract     Related articles   

  187. XU Y, Lou J, Gao Z, Zhan M, et al
    Computed Tomography Image Features under Deep Learning Algorithm Applied in Staging Diagnosis of Bladder Cancer and Detection on Ceramide Glycosylation.
    Comput Math Methods Med. 2022;2022:7979523.
    Abstract     Related articles   

  188. SINGH PK, Bhatt MLB, Singh P, Rath SK, et al
    CASC5 is a potential cancer-testis gene in human urinary bladder transitional cell carcinoma.
    Drug Discov Ther. 2021;15:331-336.
    Abstract     Related articles   

  189. MUHLBAUER J, Klotz D, Buttner S, Stein R, et al
    Bladder cancer in patients with neurogenic bladder disorder: a comparative study of different etiologies.
    World J Urol. 2022 Jan 15. pii: 10.1007/s00345-021-03922.
    Abstract     Related articles   

  190. WANG SC, Yu CY, Wu YC, Chang YC, et al
    Chidamide and mitomycin C exert synergistic cytotoxic effects against bladder cancer cells in vitro and suppress tumor growth in a rat bladder cancer model.
    Cancer Lett. 2022;530:8-15.
    Abstract     Related articles   

  191. OSWALD D, Pallauf M, Herrmann TRW, Netsch C, et al
    [Transurethral resection of bladder tumors (TURBT)].
    Urologe A. 2022;61:71-82.
    Abstract     Related articles   

  192. LAUKHTINA E, Sari Motlagh R, Mori K, Katayama S, et al
    Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes.
    Crit Rev Oncol Hematol. 2022;169:103570.
    Abstract     Related articles   

  193. KOLLI RT, Xu Z, Panduri V, Taylor JA, et al
    Differential Gene Expression in Bladder Tumors from Workers Occupationally Exposed to Arylamines.
    Biomed Res Int. 2021;2021:2624433.
    Abstract     Related articles   

  194. MORRISS S, Zargar H, Dias BH
    Management of the Distal Ureter During Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Comprehensive Review of Literature.
    Urol J. 2021;18:585-599.
    Abstract     Related articles   

  195. ALSYOUF M, Djaladat H, Daneshmand S
    An emerging role for immuno-nutrition in patients undergoing radical cystectomy.
    Nat Rev Urol. 2022;19:1-2.
    Abstract     Related articles   

  196. AGARWAL PK, Sfakianos JP, Feldman A, Tagawa ST, et al
    A 25-year perspective on advances in an understanding of the biology, evaluation, treatment and future directions/challenges of urothelial cancer.
    Urol Oncol. 2021;39:528-547.
    Abstract     Related articles   

  197. FELDMAN AS, Lokeshwar V, Lin DW
    A 25-year perspective on evaluation and understanding of biomarkers in urologic cancers.
    Urol Oncol. 2021;39:602-617.
    Abstract     Related articles   

  198. TAYEH GA, Alkassis M, Semaan A, Khalil N, et al
    Neoadjuvant PARPi for urothelial carcinoma: between lifeline and desperation.
    Future Oncol. 2021;17:3281-3283.
    Abstract     Related articles   

  199. BASIRI A, Soltani MH, Shakhssalim N, Shemshaki HR, et al
    Single Umbilical Stoma for Bilateral Ureterostomy after Radical Cystectomy.
    Urol J. 2021;18:646-651.
    Abstract     Related articles   

  200. OGUNBONA OB, Matoso A, Cheng L, Shen S, et al
    Metastatic urothelial carcinoma to the brain, spinal cord and spine: A contemporary multi-institutional clinicopathologic analysis of 24 cases.
    Pathol Res Pract. 2021;224:153537.
    Abstract     Related articles   

  201. VARELA DOS SANTOS M, Pacheco J, Barroca H
    Guar cells in urine cytology: Two case reports and literature review.
    Cytopathology. 2021;32:671-673.
    Abstract     Related articles   

  202. TREGUNNA R
    Combination treatment in advanced urothelial carcinoma.
    Nat Rev Urol. 2021;18:383.
    Abstract     Related articles   

  203. FUKUOKAYA W, Kimura T, Yanagisawa T, Kimura S, et al
    Clinical benefit of continuing pembrolizumab treatment beyond progression in patients with metastatic urothelial carcinoma.
    Cancer Immunol Immunother. 2022;71:229-236.
    Abstract     Related articles   

  204. OKUDA C, Kyotake A, Nakamura A, Itoh T, et al
    Quantitative cytomorphological comparison of SurePath and ThinPrep liquid-based cytology using high-grade urothelial carcinoma cells.
    Cytopathology. 2021;32:654-659.
    Abstract     Related articles   

  205. ABDULLGAFFAR B, Hotait H
    The value of intercluster single cell streaks, triplet signet ring cells, and a two-cell population in urine small cell neuroendocrine carcinoma.
    Cytopathology. 2021;32:700-704.
    Abstract     Related articles   

  206. ZEUSCHNER P, Vollmer SG, Linxweiler J, Wagenpfeil G, et al
    Robot-assisted versus open radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: A retrospective cohort study across ten years.
    Surg Oncol. 2021;38:101607.
    Abstract     Related articles   

  207. GIERTH M, Breyer J, Zeman F, Fritsche HM, et al
    The HELENA study: Hexvix((R))-TURB vs. white-light TURB followed by intravesical adjuvant chemotherapy-a prospective randomized controlled open-label multicenter non-inferiority study.
    World J Urol. 2021;39:3799-3805.
    Abstract     Related articles   

  208. UYSAL D, Egen L, Grilli M, Wessels F, et al
    Impact of perioperative blood transfusions on oncologic outcomes after radical cystectomy: A systematic review and meta-analysis of comparative studies.
    Surg Oncol. 2021;38:101592.
    Abstract     Related articles   

  209. XIAO CX, Zhang W, Lin BX
    The Effect of Action Research on Neobladder Function Training in Patients with Orthotopic Ileal Neobladders: A Prospective Cohort Study.
    Urol J. 2021;18:525-529.
    Abstract     Related articles   

  210. WU YR, Lee YC, Li WM, Hsu WC, et al
    High Transaldolase 1 expression predicts poor survival of patients with upper tract urothelial carcinoma.
    Pathol Int. 2021;71:463-470.
    Abstract     Related articles   

  211. XU H, Genega EM, Zhuang L, Zhou M, et al
    High-grade Urothelial Carcinoma with Malignant Melanocytic Differentiation.
    Int J Surg Pathol. 2021;29:794-797.
    Abstract     Related articles   

  212. MARIAPPAN P
    Attention to detail and a permissive set-up: crucial for an effective TURBT.
    Nat Rev Urol. 2021;18:253-254.
    Abstract     Related articles   

  213. BANSAL P, Dwivedi DK, Hatwal D, Sharma P, et al
    Erdafitinib as a Novel and Advanced Treatment Strategy of Metastatic Urothelial Carcinoma.
    Anticancer Agents Med Chem. 2021;21:2478-2486.
    Abstract     Related articles   

  214. WU J, Chen S, Wu X, Mao W, et al
    Trends of incidence and prognosis of upper tract urothelial carcinoma.
    Bosn J Basic Med Sci. 2021;21:607-619.
    Abstract     Related articles   

  215. EL-GEDAMY M, El-Khayat Z, Abol-Enein H, El-Said A, et al
    Rs-1884444 G/T variant in IL-23 receptor is likely to modify risk of bladder urothelial carcinoma by regulating IL-23/IL-17 inflammatory pathway.
    Cytokine. 2021;138:155355.
    Abstract     Related articles   

  216. BRUNELLI M, Tafuri A, Cima L, Cerruto MA, et al
    MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma.
    J Clin Pathol. 2022;75:39-44.
    Abstract     Related articles   

  217. TAMBARO R, Napoli MD, Pisano C, Cecere SC, et al
    From clinical trials to clinical use of checkpoint inhibitors for patients with metastatic urothelial cancer.
    Immunotherapy. 2021;13:67-77.
    Abstract     Related articles   

  218. POSIELSKI N MD, Koenig H MPH, Ho O PhD, Porter C MD, et al
    Use of Neoadjuvant Chemotherapy in Elderly Patients With Muscle-Invasive Bladder Cancer: A Population-Based Study, 2006-2017.
    Oncology (Williston Park). 2022;36:21-33.
    Abstract     Related articles   

  219. GONG J
    Cisplatin Neoadjuvant Chemotherapy in an Aging Population With Muscle-Invasive Bladder Cancer.
    Oncology (Williston Park). 2022;36:30-31.
    Abstract     Related articles   

  220. ZARGAR P, Koochakkhani S, Hassanzadeh M, Ashouri Taziani Y, et al
    Downregulation of topoisomerase 1 and 2 with acriflavine sensitizes bladder cancer cells to cisplatin-based chemotherapy.
    Mol Biol Rep. 2022 Jan 28. pii: 10.1007/s11033-021-07087.
    Abstract     Related articles   

  221. LIU Q
    Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer.
    Front Genet. 2022;12:825109.
    Abstract     Related articles   

  222. LEE YC, Tsai KW, Liao JB, Kuo WT, et al
    High expression of tight junction protein 1 as a predictive biomarker for bladder cancer grade and staging.
    Sci Rep. 2022;12:1496.
    Abstract     Related articles   

  223. KOKOROVIC A, Ory J, Saad F
    Emerging treatment options for bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer.
    Curr Opin Support Palliat Care. 2022;16:48-53.
    Abstract     Related articles   

  224. WEI W, Rong Y, Sanhe L, Chunxiu Y, et al
    Single-cell sequencing and its applications in bladder cancer.
    Expert Rev Mol Med. 2022;24:e6.
    Abstract     Related articles   

  225. YU X, Wu T, Liao B, Du Z, et al
    Anticancer potential of corilagin on T24 and TSGH 8301 bladder cancer cells via the activation of apoptosis by the suppression of NF-kappaB-induced P13K/Akt signaling pathway.
    Environ Toxicol. 2022 Jan 27. doi: 10.1002/tox.23472.
    Abstract     Related articles   

  226. BALASUBRAMANIAN A, Gunjur A, Weickhardt A, Papa N, et al
    Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage.
    World J Urol. 2022 Jan 27. pii: 10.1007/s00345-021-03908.
    Abstract     Related articles   

  227. KOSTYEV F, Bondar O, Chystiakov R, Lysenko V, et al
    The impact of different adjuvant intravesical therapy methods on tumor biology in patients with high-risk non-muscle-invasive bladder cancer.
    Cent European J Urol. 2021;74:496-502.
    Abstract     Related articles   


  228. Erratum: The Usefulness of the Modified Frailty Index for Muscle-Invasive Bladder Cancer Patients Treated with Radical Cystectomy: Erratum.
    Curr Urol. 2021;15:253.
    Abstract     Related articles   


  229. Erratum: In vivo photobleaching kinetics and epithelial biodistribution of hexylaminolevulinate-induced protoporphyrin IX in rat bladder cancer: Erratum.
    Curr Urol. 2021;15:246.
    Abstract     Related articles   

  230. WU G, Liang H, Nan H, Shao Z, et al
    One-Step In Situ Self-Assembly of Biodegradable Films for Long-Term Intravesical Bladder Cancer Therapy.
    ACS Appl Bio Mater. 2022 Jan 26. doi: 10.1021/acsabm.1c01186.
    Abstract     Related articles   

  231. MOCHIZUKI Y, Tsuchiya M, Oyama J, Wada A, et al
    Left supraclavicular (Virchow's) node metastasis detected before primary infradiaphragmatic tumor: a case series.
    J Med Case Rep. 2022;16:33.
    Abstract     Related articles   

  232. STERNSCHUSS M, Sarfaty M
    [ANTIBODY-DRUG CONJUGATES - A NOVEL APPROACH FOR THE TREATMENT OF METASTATIC UROTHELIAL CARCINOMA].
    Harefuah. 2022;161:49-54.
    Abstract     Related articles   

  233. WU Y, Zhang Z, Liu Y, Shi G, et al
    The Application Effect of Traditional Chinese Medicine Nursing on General Anesthesia Combined with Epidural Anesthesia and Electric Resection for the Treatment of Bladder Cancer and Its Influence on Tumor Markers.
    Evid Based Complement Alternat Med. 2022;2022:7178711.
    Abstract     Related articles   

  234. SYMEONIDIS A, Tsikopoulos I, Symeonidis EN, Tsifountoudis I, et al
    More than meets the eye: A case of synchronous ipsilateral clear cell renal cell carcinoma and urothelial carcinoma of the pelvicalyceal system and literature review.
    Acta Biomed. 2022;92:e2021380.
    Abstract     Related articles   

  235. CHIANG CH, Chiang CH, Chiang CH
    Re: Ekaterina Laukhtina, Sung Ryul Shim, Keiichiro Mori, et al. Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis. Eur Urol Oncol 2021;4:927-42: Considerations for
    Eur Urol Oncol. 2022 Jan 21. pii: S2588-9311(22)00002.
    Abstract     Related articles   

  236. DOWNES MR, Lajkosz K, Kuk C, Gao B, et al
    The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes.
    Pathology. 2022 Jan 21. pii: S0031-3025(21)00545.
    Abstract     Related articles   

  237. RISTIC PETROVIC A, Stokanovic D, Stojnev S, Potic Floranovic M, et al
    The Association between NOTCH3 expression and the clinical outcome in the urothelial bladder cancer patients.
    Bosn J Basic Med Sci. 2022 Jan 24. doi: 10.17305/bjbms.2021.6767.
    Abstract     Related articles   

  238. YANG R, Zhu D, Howard LE, De Hoedt A, et al
    Context-Based Identification of Muscle Invasion Status in Patients With Bladder Cancer Using Natural Language Processing.
    JCO Clin Cancer Inform. 2022;6:e2100097.
    Abstract     Related articles   

  239. JIN S, Zeng H, Liu Z, Jin K, et al
    ASO Visual Abstract: Stromal Tumor-Associated Macrophage Infiltration Predicts Poor Clinical Outcomes in Muscle-Invasive Bladder Cancer Patients.
    Ann Surg Oncol. 2022 Jan 24. pii: 10.1245/s10434-021-11262.
    Abstract     Related articles   

  240. SZYMANSKA B, Sawicka E, Jurkowska K, Matuszewski M, et al
    The relationship between interleukin-13 and angiogenin in patients with bladder cancer.
    J Physiol Pharmacol. 2021;72.
    Abstract     Related articles   

  241. KOTHA NV, Kumar A, Nelson TJ, Qiao EM, et al
    Treatment Discontinuation in Patients With Muscle-Invasive Bladder Cancer Undergoing Chemoradiation.
    Adv Radiat Oncol. 2021;7:100836.
    Abstract     Related articles   

  242. XIE C, Yuan X, Chen SH, Liu ZY, et al
    Successful response to camrelizumab in metastatic bladder cancer: A case report.
    World J Clin Cases. 2022;10:254-259.
    Abstract     Related articles   

  243. ZENG S, Ying Y, Yu X, Wang L, et al
    Impact of previous, simultaneous or intravesical recurrence bladder cancer on prognosis of upper tract urothelial carcinoma after nephroureterectomy: a large population-based study.
    Transl Androl Urol. 2021;10:4365-4375.
    Abstract     Related articles   

  244. ZHANG Z, Li Q, Li A, Wang F, et al
    Identifying a hypoxia related score to predict the prognosis of bladder cancer: a study with The Cancer Genome Atlas (TCGA) database.
    Transl Androl Urol. 2021;10:4353-4364.
    Abstract     Related articles   

  245. WANG H, Zuo Y, Ding M, Ke C, et al
    Erratum: LASS2 inhibits growth and invasion of bladder cancer by regulating ATPase activity.
    Oncol Lett. 2022;23:69.
    Abstract     Related articles   

  246. WU K, Zeng J, Shi X, Xie J, et al
    Targeting TIGIT Inhibits Bladder Cancer Metastasis Through Suppressing IL-32.
    Front Pharmacol. 2022;12:801493.
    Abstract     Related articles   

  247. ANWAR I, Pandith AA, Wani MS, Mir H, et al
    Analysis of MNS16A VNTR polymorphic sequence variations of the TERT gene and associated risk for development of bladder cancer.
    Curr Urol. 2021;15:225-230.
    Abstract     Related articles   

  248. ERAY A, Erkek-Ozhan S
    Classification of bladder cancer cell lines according to regulon activity.
    Turk J Biol. 2021;45:656-666.
    Abstract     Related articles   

  249. VAN HAUEN MB, Maibom SL, Thind PO, Martin Poulsen A, et al
    Risk of recurrence and long-term mortality following radical cystectomy for bladder cancer.
    Scand J Urol. 2022 Jan 24:1-6. doi: 10.1080/21681805.2022.2028897.
    Abstract     Related articles   

  250. ZHANG Z, Wang C, Liu T, Tang Z, et al
    miRNA-182-5p promotes human bladder cancer proliferation and migration through the FOXF2/SHH axis.
    Neoplasma. 2022 Jan 25. pii: 210903N1266. doi: 10.4149/neo_2021_210903N1266.
    Abstract     Related articles   

  251. WIECZOREK E, Jablonowski Z, Lesicka M, Jablonska E, et al
    Genetic contributions of MHC class I antigen processing and presentation pathway to bladder cancer risk and recurrence.
    Neoplasma. 2022 Jan 25. pii: 210805N1113. doi: 10.4149/neo_2021_210805N1113.
    Abstract     Related articles   

  252. SZUCS E, Lukacs N, Budai A, Seres E, et al
    Actinomycosis mimicking urachal cancer
    Orv Hetil. 2022;163:157-160.
    Abstract     Related articles   

  253. BORHANI S, Borhani R, Kajdacsy-Balla A
    Artificial intelligence: A promising frontier in bladder cancer diagnosis and outcome prediction.
    Crit Rev Oncol Hematol. 2022 Jan 19:103601.
    Abstract     Related articles   

  254. MARTINS-LIMA C, Miranda-Goncalves V, Lobo J, Constancio V, et al
    Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression.
    Cell Oncol (Dordr). 2022 Jan 22. pii: 10.1007/s13402-021-00657.
    Abstract     Related articles   

  255. ZHANG G, Wu Z, Zhang X, Xu L, et al
    CT-based radiomics to predict muscle invasion in bladder cancer.
    Eur Radiol. 2022 Jan 22. pii: 10.1007/s00330-021-08426.
    Abstract     Related articles   

  256. WU Z, Xia C, Zhang C, Tang D, et al
    Adeno-associated virus-delivered alpha synuclein inhibits bladder cancer growth via the p53/p21 signaling pathway.
    Cancer Gene Ther. 2022 Jan 21. pii: 10.1038/s41417-022-00425.
    Abstract     Related articles   

  257. ARAFA A, Ewis A, Eshak E
    Chronic exposure to nitrate in drinking water and the risk of bladder cancer: a meta-analysis of epidemiological evidence.
    Public Health. 2022;203:123-129.
    Abstract     Related articles   

  258. LIU D, Wang S, Wang J
    The effect of CT high-resolution imaging diagnosis based on deep residual network on the pathology of bladder cancer classification and staging.
    Comput Methods Programs Biomed. 2022;215:106635.
    Abstract     Related articles   

  259. LAUKHTINA E, Shim SR, Mori K, D'Andrea D, et al
    Corrigendum to "Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis" [Eur Urol Oncol 2021;4:927-42].
    Eur Urol Oncol. 2022 Jan 19. pii: S2588-9311(22)00004.
    Abstract     Related articles   

  260. CHEN JQ, Salas LA, Wiencke JK, Koestler DC, et al
    Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes.
    Clin Epigenetics. 2022;14:14.
    Abstract     Related articles   

  261. KHATAMI A, Salavatiha Z, Razizadeh MH
    Bladder cancer and human papillomavirus association: a systematic review and meta-analysis.
    Infect Agent Cancer. 2022;17:3.
    Abstract     Related articles   

  262. CHOI SY, Ha MS, Chi BH, Kim JW, et al
    Neoadjuvant versus adjuvant chemotherapy in bladder cancer: a nationwide cohort study.
    J Cancer Res Clin Oncol. 2022 Jan 21. pii: 10.1007/s00432-022-03926.
    Abstract     Related articles   

  263. XIA W, Zhang S, Duan H, Wang C, et al
    The combination therapy of Everolimus and anti-PD-1 improves the antitumor effect by regulating CD8(+) T cells in bladder cancer.
    Med Oncol. 2022;39:37.
    Abstract     Related articles   

  264. CHEN W, Wang W, Zhang J, Liao G, et al
    Qici Sanling Decoction Suppresses Glutamine Consumption and Bladder Cancer Cell Growth through Inhibiting c-Myc Expression.
    J Oncol. 2022;2022:7985468.
    Abstract     Related articles   

  265. WEN L, Zhong G, Ren M
    Increased risk of secondary bladder cancer after radiation therapy for endometrial cancer.
    Sci Rep. 2022;12:1032.
    Abstract     Related articles   

  266. XIAO L, Xu C, Lin P, Mu L, et al
    Novel dihydroartemisinin derivative Mito-DHA5 induces apoptosis associated with mitochondrial pathway in bladder cancer cells.
    BMC Pharmacol Toxicol. 2022;23:10.
    Abstract     Related articles   

  267. RUTZ J, Maxeiner S, Juengel E, Chun FK, et al
    Olive Mill Wastewater Inhibits Growth and Proliferation of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro by Down-Regulating the Akt/mTOR-Signaling Pathway.
    Nutrients. 2022;14.
    Abstract     Related articles   

  268. MANTICA G, Chierigo F, Malinaric R, Smelzo S, et al
    Intravesical Therapy for Non-Muscle-Invasive Bladder Cancer: What Is the Real Impact of Squamous Cell Carcinoma Variant on Oncological Outcomes?
    Medicina (Kaunas). 2022;58.
    Abstract     Related articles   

  269. TSAI IJ, Shen WC, Lee CL, Wang HD, et al
    Machine Learning in Prediction of Bladder Cancer on Clinical Laboratory Data.
    Diagnostics (Basel). 2022;12.
    Abstract     Related articles   

  270. MURAKAMI K, Pagano I, Furuya H, Daskivich T, et al
    Clinical Utility of Oncuria, a Multiplexed Liquid Biopsy for the Non-Invasive Detection of Bladder Cancer-A Pilot Study.
    Diagnostics (Basel). 2022;12.
    Abstract     Related articles   

  271. RUBIO C, Avendano-Ortiz J, Ruiz-Palomares R, Karaivanova V, et al
    Toward Tumor Fight and Tumor Microenvironment Remodeling: PBA Induces Cell Cycle Arrest and Reduces Tumor Hybrid Cells' Pluripotency in Bladder Cancer.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  272. CONSTANTIN T, Pavalean M, Bucur S, Constantin MM, et al
    Retraction: Constantin et al. Animal Models in Bladder Cancer. Biomedicines 2021, 9, 1762.
    Biomedicines. 2022;10.
    Abstract     Related articles   

  273. ASANO A, Nishikimi T, Morikami H, Ohashi T, et al
    [A PRIMARY BLADDER ALVEOLAR SOFT PART SARCOMA: A CASE REPORT].
    Nihon Hinyokika Gakkai Zasshi. 2021;112:45-48.
    Abstract     Related articles   

  274. TABEI T, Iwai T, Noguchi G, Horiguchi A, et al
    [ARTIFICIAL URINARY SPHINCTER IMPLANTATION AFTER ILEAL NEOBLADDER RECONSTRUCTION: A CASE REPORT].
    Nihon Hinyokika Gakkai Zasshi. 2021;112:34-37.
    Abstract     Related articles   

  275. SCHLARBAUM JP, Fenyk J, Miller D, O'Neill LB, et al
    Paraneoplastic Signs in Bladder Transitional Cell Carcinoma: An Unusual Presentation.
    Cutis. 2021;108:E29-E32.
    Abstract     Related articles   

  276. AFIFY H, Ghoneum A, Almousa S, Abdulfattah AY, et al
    Metabolomic credentialing of murine carcinogen-induced urothelial cancer.
    Sci Rep. 2021;11:22085.
    Abstract     Related articles   

  277. DUBOIS J, Sczakiel G
    The human TRAM1 locus expresses circular RNAs.
    Sci Rep. 2021;11:22114.
    Abstract     Related articles   

  278. ZHENG S, Carugo D, Mosayyebi A, Turney B, et al
    Fluid mechanical modeling of the upper urinary tract.
    WIREs Mech Dis. 2021;13:e1523.
    Abstract     Related articles   

  279. KAWASHIMA A, Yamamoto Y, Sato M, Nakata W, et al
    FAN score comprising fibrosis-4 index, albumin-bilirubin score and neutrophil-lymphocyte ratio is a prognostic marker of urothelial carcinoma patients treated with pembrolizumab.
    Sci Rep. 2021;11:21199.
    Abstract     Related articles   

  280. YANG WS
    Automated urine sediment analyzers underestimate the severity of hematuria in glomerular diseases.
    Sci Rep. 2021;11:20981.
    Abstract     Related articles   

  281. LIU Q, Gong H, Zhu H, Yuan C, et al
    Contrast-Enhanced Ultrasound in the Bladder: Critical Features to Differentiate Occupied Lesions.
    Comput Math Methods Med. 2021;2021:1047948.
    Abstract     Related articles   

  282. BRUNETTI B, Foglia A, Savini F, Dondi F, et al
    Inverted urothelial papilloma in a cat.
    Vet Pathol. 2022;59:138-142.
    Abstract     Related articles   

  283. HE W, Jin L, Lin FF, Qi XL, et al
    Cavernous lymphangioma of the urinary bladder in an adult woman: an additional case report of a rare lesion and literature review.
    BMC Urol. 2021;21:145.
    Abstract     Related articles   

  284. INANAGA S, Igase M, Sakai Y, Tanabe M, et al
    Mismatch repair deficiency in canine neoplasms.
    Vet Pathol. 2021;58:1058-1063.
    Abstract     Related articles   

  285. SHUKLA SK, Chandra S, Chauhan N, Sarpal R, et al
    Expression of CD10 in urothelial carcinoma of the bladder and its correlation with histopathological grade, pathological stage, and survival of patients.
    J Cancer Res Ther. 2021;17:887-892.
    Abstract     Related articles   

  286. XIE Y, Olkhov-Mitsel E, Alminawi S, Slodkowska E, et al
    Development of a multiplex immuno-oncology biomarker and digital pathology workflow for assessment of urothelial carcinoma.
    Pathol Res Pract. 2021;226:153607.
    Abstract     Related articles   

  287. FENG Z, Vuky J
    Combination Therapy With Immune Checkpoint Inhibitors in Urothelial Carcinoma: Current Data and Future Outlook.
    Oncology (Williston Park). 2021;35:410-420.
    Abstract     Related articles   

  288. FENNER A
    Using ctDNA to guide immunotherapy for urothelial cancer.
    Nat Rev Urol. 2021;18:443.
    Abstract     Related articles   

  289. CHILDS DS, Quevedo JF, Costello BA, Pagliaro LC, et al
    Chemoimmunotherapy after progression on single-agent pembrolizumab for metastatic urothelial carcinoma: a case series.
    Anticancer Drugs. 2021;32:986-990.
    Abstract     Related articles   

  290. SEKER NS, Tekin E, Ozen A, Can C, et al
    Prognostic significance of tumor budding in muscle invasive urothelial carcinomas of the urinary bladder.
    Ann Diagn Pathol. 2021;54:151786.
    Abstract     Related articles   

  291. ZHANG X, Chen Y, Yan D, Han J, et al
    TERT Gene rs2736100 and rs2736098 Polymorphisms are Associated with Increased Cancer Risk: A Meta-Analysis.
    Biochem Genet. 2022;60:241-266.
    Abstract     Related articles   

  292. FENNER A
    Adjuvant nivolumab improves survival after radical cystectomy.
    Nat Rev Urol. 2021;18:444.
    Abstract     Related articles   

  293. CHOI E, Waldbillig F, Jeong M, Li D, et al
    Soft Urinary Bladder Phantom for Endoscopic Training.
    Ann Biomed Eng. 2021;49:2412-2420.
    Abstract     Related articles   

  294. CHANDLER JB, Colunga M, Celli R, Lithgow MY, et al
    Applicability of the Paris System for veterans: high rates of undiagnosed low-grade urothelial neoplasia.
    J Am Soc Cytopathol. 2021;10:357-365.
    Abstract     Related articles   

  295. CHENG L, Lopez-Beltran A, Wang M, Montironi R, et al
    Telomerase reverse transcriptase (TERT) promoter mutations in primary adenocarcinoma of bladder and urothelial carcinoma with glandular differentiation: pathogenesis and diagnostic implications.
    Mod Pathol. 2021;34:1384-1391.
    Abstract     Related articles   

  296. MCALONEY CA, Evans SJM, Hokamp JA, Wellman ML, et al
    Comparison of pathologist review protocols for cytologic detection of prostatic and urothelial carcinomas in canines: A bi-institutional retrospective study of 298 cases.
    Vet Comp Oncol. 2021;19:374-380.
    Abstract     Related articles   

  297. SEN A, Kaul A, Kaul R
    Estrogen receptors in human bladder cells regulate innate cytokine responses to differentially modulate uropathogenic E. coli colonization.
    Immunobiology. 2021;226:152020.
    Abstract     Related articles   

  298. WOO S, Ghafoor S, Becker AS, Hricak H, et al
    Prognostic Utility of MRI Features in Intradiverticular Bladder Tumor.
    Acad Radiol. 2022;29:219-228.
    Abstract     Related articles   

  299. SBIZZERA M, Descotes F, Arber T, Neuville P, et al
    Bladder cancer detection in patients with neurogenic bladder: are cystoscopy and cytology effective, and are biomarkers pertinent as future diagnostic tools? A scoping review.
    World J Urol. 2022 Feb 4. pii: 10.1007/s00345-022-03943.
    Abstract     Related articles   

  300. DEB AA, Agag A, Naushad N, Krishnamoorthy R, et al
    Chemoresection by mitomycin C compared to transurethral resection of bladder tumor in patients with recurrent nonmuscle-invasive bladder cancer: A systematic review and meta-analysis.
    Turk J Urol. 2021;47:260-269.
    Abstract     Related articles   

  301. YANG Y, Yan X, Li J, Liu C, et al
    CD47-targeted optical molecular imaging and near-infrared photoimmunotherapy in the detection and treatment of bladder cancer.
    Mol Ther Oncolytics. 2022;24:319-330.
    Abstract     Related articles   

  302. ZHOU Q, Zhang Z, Ang X, Zhang H, et al
    A nomogram combined with radiomics features, albuminuria, and metabolic syndrome to predict the risk of myometrial invasion of bladder cancer.
    Transl Cancer Res. 2021;10:3177-3191.
    Abstract     Related articles   

  303. LU JL, Xia QD, Liu CQ, Sun JX, et al
    Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guerin for Ta and T1 bladder cancer: a systematic review and meta-analysis.
    Transl Cancer Res. 2021;10:2849-2858.
    Abstract     Related articles   

  304. FENG D, Song P, Yang Y, Wei W, et al
    Is metabolic syndrome associated with high tumor grade and stage of bladder cancer: a systematic review and meta-analysis.
    Transl Cancer Res. 2021;10:2188-2198.
    Abstract     Related articles   

  305. LI X, Wu Y, Yuan Y
    Gene network screening of bladder cancer via modular analysis.
    Transl Cancer Res. 2021;10:1043-1052.
    Abstract     Related articles   

  306. ONG K, Dyer J, Wilson M, Hayne D, et al
    Urethral fistula and perineal collection during intravesical treatment for non-muscle invasive bladder cancer - A rare complication.
    Urol Case Rep. 2022;42:102003.
    Abstract     Related articles   

  307. LI ZJ, Wang DY, Liu ZH
    Clinical Efficacy and Quality of Life Assessment of Partial Cystectomy and Plasmakinetic Transurethral Resection of Tumor in Bladder Cancer Patients.
    Cancer Manag Res. 2022;14:389-398.
    Abstract     Related articles   

  308. ZHU RJ, Zhou J, Liang PQ, Xiang XX, et al
    Accuracy of cytokeratin 19 fragment in the diagnosis of bladder cancer.
    Biomark Med. 2022 Feb 3. doi: 10.2217/bmm-2021-0754.
    Abstract     Related articles   

  309. ALGHAFEES MA, Alqahtani MA, Musalli ZF, Alasker A, et al
    Bladder cancer in Saudi Arabia: a registry-based nationwide descriptive epidemiological and survival analysis.
    Ann Saudi Med. 2022;42:17-28.
    Abstract     Related articles   

  310. MALIK K, Raja A, Ravishankar LS, Narayanaswamy K, et al
    Intravesical Bacillus Calmette-Guerin (BCG) Therapy for Non-muscle Invasive Bladder Cancers: Long-term Results of a Modified Schedule.
    Indian J Surg Oncol. 2021;12:796-801.
    Abstract     Related articles   

  311. ATHER MH
    What after BCG Fails in Non-muscle Invasive Bladder Cancer?
    J Coll Physicians Surg Pak. 2022;32:139-140.
    Abstract     Related articles   

  312. OMURA M, Kikuchi E, Shigeta K, Ogihara K, et al
    Potential therapeutic effects of adjuvant chemotherapy after neoadjuvant chemotherapy for locally advanced muscle-invasive bladder cancer.
    Jpn J Clin Oncol. 2022 Feb 1. pii: 6518269. doi: 10.1093.
    Abstract     Related articles   

  313. MARTINI A, Lonati C, Montorsi F, Briganti A, et al
    The Role of Prior Bladder Cancer on Recurrence in Patients Treated with Radical Nephroureterectomy.
    Clin Genitourin Cancer. 2021 Dec 11. pii: S1558-7673(21)00236.
    Abstract     Related articles   

  314. LUO Y, He Z, Liu W, Zhou F, et al
    DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis.
    Oxid Med Cell Longev. 2022;2022:3369858.
    Abstract     Related articles   

  315. BERTOLASO P, Brouste V, Cazeau AL, de Clermont-Gallerande H, et al
    Impact of (18) FDG- PET CT in the Management of Muscle Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2022 Jan 14. pii: S1558-7673(22)00020.
    Abstract     Related articles   

  316. ZHANG LH, Zhang WY, Xiong JM, Duan XM, et al
    Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.
    Chin J Nat Med. 2022;20:43-53.
    Abstract     Related articles   

  317. CHEN H, Hong Y, Yu B, Ruiqian L, et al
    Retrospective analysis of bladder cancer morphology and depth of invasion under cystoscopy.
    BMC Urol. 2022;22:12.
    Abstract     Related articles   

  318. KOOL R, Yanev I, Hijal T, Vanhuyse M, et al
    Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Canadian cost-effectiveness analysis.
    Can Urol Assoc J. 2022 Jan 27. pii: cuaj.7430. doi: 10.5489/cuaj.7430.
    Abstract     Related articles   

  319. BHINDI B, Kool R, Kulkarni GS, Siemens DR, et al
    Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer - Abridged version.
    Can Urol Assoc J. 2021;15:230-239.
    Abstract     Related articles   

  320. KOOL R, Marcq G, Shinde-Jadhav S, Mansure JJ, et al
    Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy.
    Eur Urol Open Sci. 2021;36:26-33.
    Abstract     Related articles   

  321. WU JH, Sun KN, Chen ZH, He YJ, et al
    Exosome-Mediated miR-4792 Transfer Promotes Bladder Cancer Cell Proliferation via Enhanced FOXC1/c-Myc Signaling and Warburg Effect.
    J Oncol. 2022;2022:5680353.
    Abstract     Related articles   

  322. SELL V, Ettala O, Perez IM, Jarvinen R, et al
    Awareness of Smoking as a Risk Factor in Bladder Cancer: Results from the Prospective FinnBladder 9 Trial.
    Eur Urol Focus. 2022 Jan 27. pii: S2405-4569(22)00035.
    Abstract     Related articles   

  323. KIDA N, Morishima T, Tsubakihara Y, Miyashiro I, et al
    Stage at Diagnosis and Prognosis of Colorectal, Stomach, Lung, Liver, Kidney, and Bladder Cancers in Dialysis Patients: A Multicenter Retrospective Study Using Cancer Registry Data and Administrative Data.
    Nephron. 2022 Jan 28:1-10. doi: 10.1159/000521603.
    Abstract     Related articles   

  324. KANMALAR M, Abdul Sani SF, Kamri NINB, Said NABM, et al
    Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review.
    Cell Mol Biol Lett. 2022;27:9.
    Abstract     Related articles   

  325. BOTHIG R, Rosenbaum C, Bohme H, Kowald B, et al
    Special surgical aspects of radical cystectomy in spinal cord injury patients with bladder cancer.
    World J Urol. 2022 Jan 29. pii: 10.1007/s00345-022-03939.
    Abstract     Related articles   

  326. MAMDOUH S, Khorshed F, Hammad G, Elesaily K, et al
    Molecular Detection of Genetic Susceptibility to Bladder Cancer in Egyptian Patients.
    Asian Pac J Cancer Prev. 2022;23:221-232.
    Abstract     Related articles   

  327. TANG F, Li Z, Lai Y, Lu Z, et al
    A 7-gene signature predicts the prognosis of patients with bladder cancer.
    BMC Urol. 2022;22:8.
    Abstract     Related articles   

  328. SHIGA M, Nishiyama H
    [. Current Understanding of Mechanism of BCG Failure, and the Status of Drug Development Using BCG Cell Wall Components].
    Gan To Kagaku Ryoho. 2022;49:43-46.
    Abstract     Related articles   

  329. ALLAMEH F, Sangian A, Razaghi M, Razzaghi Z, et al
    Comparison of various types of lasers and transurethral resection in the treatment of bladder tumors: a systematic review and meta-analysis.
    Lasers Med Sci. 2022;37:95-101.
    Abstract     Related articles   

  330. PALACKA P, Gvozdjakova A, Rausova Z, Kucharska J, et al
    Platelet Mitochondrial Bioenergetics Reprogramming in Patients with Urothelial Carcinoma.
    Int J Mol Sci. 2021;23.
    Abstract     Related articles   

  331. BELL CJ, Potts KG, Hitt MM, Pink D, et al
    Novel colchicine derivative CR42-24 demonstrates potent anti-tumor activity in urothelial carcinoma.
    Cancer Lett. 2022;526:168-179.
    Abstract     Related articles   

  332. OU L, Luo J, Wei Z, Zheng A, et al
    Urachal tuberculosis with invasion of the bladder wall: A case report and literature review.
    Actas Urol Esp (Engl Ed). 2022;46:1-3.
    Abstract     Related articles   

  333. KAWADA T
    Sex difference in survival in patients with radical cystectomy.
    Urol Oncol. 2022;40:67.
    Abstract     Related articles   

  334. WESTERDAHL JS, Grant J, Sontheimer R, Zussman J, et al
    Darier disease, radiation therapy, and herpesvirus -- an unfortunate triad.
    Dermatol Online J. 2021;27.
    Abstract     Related articles   

  335. PARMAR KM, Thummala Y, Kumar S, Singh P, et al
    Utility of FDG-PET CT scan to detect an incidental rare recurrence of carcinoma urinary bladder following radical cystectomy.
    BMJ Case Rep. 2021;14.
    Abstract     Related articles   

  336. MADHUMITHA B, Joseph LD, Archana B, Chandru T, et al
    Urothelial carcinoma with divergent differentiation in a horseshoe kidney.
    Indian J Pathol Microbiol. 2021;64:866-867.
    Abstract     Related articles   

  337. KRISHNAMURTHY S, Menon M, Parameswaran A, Sivaraman A, et al
    A case of solitary fibrous tumor of urinary bladder.
    Indian J Pathol Microbiol. 2021;64:847-849.
    Abstract     Related articles   

  338. YAO X, Liu H, Xu H
    The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis.
    Biomed Res Int. 2021;2021:5311828.
    Abstract     Related articles   

  339. MOLLICA V, Rizzo A, Massari F
    Re: Thomas Powles, Tibor Csoszi, Mustafa Ozguroglu, et al. Pembrolizumab Alone or Combined with Chemotherapy Versus Chemotherapy as First-line Therapy for Advanced Urothelial Carcinoma (KEYNOTE-361): A Randomised, Open-label, Phase 3 Trial. Lancet Onc
    Eur Urol Oncol. 2021;4:854.
    Abstract     Related articles   

  340. LI F, Wang Y, Xie K, Fang Y, et al
    The efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in treating advanced urothelial cancer: a meta-analysis of clinical trials.
    Aging (Albany NY). 2021;13:20468-20480.
    Abstract     Related articles   

  341. BURATIN A, Gaffo E, Dal Molin A, Bortoluzzi S, et al
    CircIMPACT: An R Package to Explore Circular RNA Impact on Gene Expression and Pathways.
    Genes (Basel). 2021;12.
    Abstract     Related articles   

  342. REDDY AG, Sparks AD, Darwish C, Whalen MJ, et al
    Oncologic Outcomes for Robotic Vs. Open Radical Cystectomy Among Locally Advanced and Node-Positive Patients: Analysis of The National Cancer Database.
    Clin Genitourin Cancer. 2021;19:547-553.
    Abstract     Related articles   

  343. FENG C, Wang Y, Dan G, Zhong Z, et al
    Evaluation of a fractional-order calculus diffusion model and bi-parametric VI-RADS for staging and grading bladder urothelial carcinoma.
    Eur Radiol. 2022;32:890-900.
    Abstract     Related articles   

  344. KHALIFE N, Chahine C, Kordahi M, Felefly T, et al
    Urothelial carcinoma in the era of immune checkpoint inhibitors.
    Immunotherapy. 2021;13:953-964.
    Abstract     Related articles   

  345. LAUKHTINA E, Mori K, Mostafaei H, Merseburger AS, et al
    Adverse events of the second-line treatment for patients with locally advanced or metastatic urothelial carcinoma of the bladder: network meta-analysis.
    Immunotherapy. 2021;13:917-929.
    Abstract     Related articles   

  346. WONG JL, Rosenberg JE
    Targeting nectin-4 by antibody-drug conjugates for the treatment of urothelial carcinoma.
    Expert Opin Biol Ther. 2021;21:863-873.
    Abstract     Related articles   

  347. JAIN RK, Skelton Iv WP, Pond GR, Naqvi M, et al
    Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma.
    Clin Genitourin Cancer. 2021;19:540-546.
    Abstract     Related articles   

  348. RIZZO A, Mollica V, Massari F
    Re: Thomas Powles, Jonathan E. Rosenberg, Guru P. Sonpavde, et al. Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma. N Engl J Med 2021;384:1125-35.
    Eur Urol Oncol. 2021;4:670.
    Abstract     Related articles   

  349. HOFFMAN-CENSITS JH, Lombardo KA, Parimi V, Kamanda S, et al
    Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes.
    Appl Immunohistochem Mol Morphol. 2021;29:619-625.
    Abstract     Related articles   

  350. PATEL SY, Trona N, Alford B, Laborde JM, et al
    Preoperative immunonutrition and carbohydrate loading associated with improved bowel function after radical cystectomy.
    Nutr Clin Pract. 2022;37:176-182.
    Abstract     Related articles   

  351. BOREA R, Damassi A, Rebuzzi SE, Banna GL, et al
    Immunotherapy retreatment: case report, review of the literature and proposal for the definition of different scenarios.
    Immunotherapy. 2021;13:645-652.
    Abstract     Related articles   

  352. SZABADOS B, Prendergast A, Jackson-Spence F, Choy J, et al
    Immune Checkpoint Inhibitors in Front-line Therapy for Urothelial Cancer.
    Eur Urol Oncol. 2021;4:943-947.
    Abstract     Related articles   

  353. KHAKI AR, Li A, Diamantopoulos LN, Miller NJ, et al
    A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.
    Eur Urol Oncol. 2021;4:464-472.
    Abstract     Related articles   

  354. MAAS M, Stuhler V, Walz S, Stenzl A, et al
    Enfortumab vedotin - next game-changer in urothelial cancer.
    Expert Opin Biol Ther. 2021;21:801-809.
    Abstract     Related articles   

  355. COLLA RUVOLO C, Nocera L, Stolzenbach LF, Wenzel M, et al
    Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma.
    Eur Urol Oncol. 2021;4:792-801.
    Abstract     Related articles   

  356. RAVI P, McGregor BA
    Antibody-drug conjugates for the treatment of urothelial carcinoma.
    Expert Opin Biol Ther. 2021;21:915-922.
    Abstract     Related articles   

  357. BROOKS N, Nagaraju S, Matulay J, Han XY, et al
    Bacillus Calmette-Guerin Retains Clinically Relevant Viability for up to 72 Hours After Reconstitution: Potential Implications for Clinical Practice in Times of Shortage.
    Eur Urol Oncol. 2021;4:826-828.
    Abstract     Related articles   

  358. SHARIAT S, Gontero P, Catto JWF
    How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?
    Eur Urol Oncol. 2021;4:663-669.
    Abstract     Related articles   

  359. BURGER M, Kamat AM, McConkey D
    Does Variant Histology Change Management of Non-muscle-invasive Bladder Cancer?
    Eur Urol Oncol. 2021;4:510-514.
    Abstract     Related articles   

  360. STENZL A, McConkey D, Bellmunt J
    Does it matter whether a T1 high-grade tumor is molecularly classified?
    Eur Urol Oncol. 2021;4:837-842.
    Abstract     Related articles   

  361. LAM JM, Liu WK, Powles T, Tang YZ, et al
    Single-centre Experience of Patients with Metastatic Urothelial Cancer Treated with Chemotherapy Following Immune Checkpoint Inhibition.
    Eur Urol Oncol. 2021;4:659-662.
    Abstract     Related articles   

  362. TAMAI M, Tatarano S, Okamura S, Fukumoto W, et al
    microRNA-99a-5p induces cellular senescence in gemcitabine-resistant bladder cancer by targeting SMARCD1.
    Mol Oncol. 2022 Feb 11. doi: 10.1002/1878-0261.13192.
    Abstract     Related articles   

  363. LIU J, Zhang Z, Zhang W, Meng L, et al
    Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer.
    Front Cell Dev Biol. 2022;10:791630.
    Abstract     Related articles   

  364. PAGLIARULO F, Cheng PF, Brugger L, van Dijk N, et al
    Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer.
    Front Immunol. 2022;12:793992.
    Abstract     Related articles   

  365. TOMIDA R, Miyake M, Minato R, Sawada Y, et al
    Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guerin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data.
    Int J Clin Oncol. 2022 Feb 10. pii: 10.1007/s10147-022-02127.
    Abstract     Related articles   

  366. AFFERI L, Lonati C, Montorsi F, Briganti A, et al
    Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer.
    World J Urol. 2022 Feb 10. pii: 10.1007/s00345-022-03948.
    Abstract     Related articles   

  367. CHEN K, Zhu S, Yu W, Xia Y, et al
    Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer.
    Front Oncol. 2022;12:774307.
    Abstract     Related articles   

  368. PENG S, Ma S, Yang F, Xu C, et al
    Prognostic value and underlying mechanism of autophagy-related genes in bladder cancer.
    Sci Rep. 2022;12:2219.
    Abstract     Related articles   

  369. MICHEL F, Cancrini F, Cancel-Tassin G, Game X, et al
    A study of the immunohistochemical profile of bladder cancer in neuro-urological patients by the French Association of Urology.
    World J Urol. 2022 Feb 9. pii: 10.1007/s00345-022-03942.
    Abstract     Related articles   

  370. SCHIERZ JH, McLeod A, Ali F
    Rare osteoarticular complications on [18F]FDG-PET/CT - following intravesical BCG immunotherapy for bladder cancer.
    Nucl Med Rev Cent East Eur. 2022;25:68-69.
    Abstract     Related articles   

  371. NERLI RB, Ghagane SC, Rangrez SS, Chandra S, et al
    Author Reply Re: Nerli RB, Ghagane SC, Rangrez S, Chandra S, Thakur ML, Gomella L. Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors. Indian J Urol 2021;37:345-9.
    Indian J Urol. 2022;38:78-79.
    Abstract     Related articles   

  372. PATTNAIK SS
    Re: Nerli RB, Ghagane SC, Rangrez S, Chandra S, Thakur ML, Gomella L. Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors. Indian J Urol 2021;37:345-9.
    Indian J Urol. 2022;38:77-78.
    Abstract     Related articles   

  373. WETTSTEIN MS, Baxter NN, Sutradhar R, Mamdani M, et al
    Uptake of re-resection in T1 bladder cancer: An interrupted population-based time series analysis among different groups of surgeons.
    Urol Oncol. 2022 Feb 5. pii: S1078-1439(21)00553.
    Abstract     Related articles   

  374. OKAMOTO T, Yamamoto K, Kanomata N
    Metastatic Rectal Linitis Plastic From Bladder Cancer.
    Am J Gastroenterol. 2021;116:2324.
    Abstract     Related articles   

  375. MOHSENZADEGAN M, Razmi M, Vafaei S, Abolhasani M, et al
    Publisher Correction: Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer.
    Sci Rep. 2022;12:2330.
    Abstract     Related articles   

  376. AL-ZUBAIDI M, McCombie S, Swarbrick N, Hayne D, et al
    Unique case of IgG4-related disease of the renal pelvis involving the inferior vena cava masquerading as locally advanced urothelial cancer.
    BMJ Case Rep. 2022;15.
    Abstract     Related articles   

  377. SHI ZD, Hao L, Han XX, Wu ZX, et al
    Targeting HNRNPU to overcome cisplatin resistance in bladder cancer.
    Mol Cancer. 2022;21:37.
    Abstract     Related articles   

  378. BOOT IWA, Wesselius A, Yu EYW, Brinkman M, et al
    Dietary B group vitamin intake and the bladder cancer risk: a pooled analysis of prospective cohort studies.
    Eur J Nutr. 2022 Feb 7. pii: 10.1007/s00394-022-02805.
    Abstract     Related articles   

  379. PRESS RH, Shelton JW, Zhang C, Dang Q, et al
    Bone Marrow Suppression during Postoperative Radiation for Bladder Cancer and Comparative Benefit of Proton Therapy-Phase 2 Trial Secondary Analysis.
    Int J Part Ther. 2021;8:1-10.
    Abstract     Related articles   

  380. ZHANG S, Wang Q, Li W, Chen J, et al
    MIR100HG Regulates CALD1 Gene Expression by Targeting miR-142-5p to Affect the Progression of Bladder Cancer Cells in vitro, as Revealed by Transcriptome Sequencing.
    Front Mol Biosci. 2022;8:793493.
    Abstract     Related articles   

  381. LU X, Jiang H, Wang D, Wang Y, et al
    Early Warning Models to Predict the 90-Day Urinary Tract Infection Risk After Radical Cystectomy and Urinary Diversion for Patients With Bladder Cancer.
    Front Surg. 2022;8:782029.
    Abstract     Related articles   

  382. SONG Y, Du Y, Qin C, Liang H, et al
    Gemcitabine-Resistant Biomarkers in Bladder Cancer are Associated with Tumor-Immune Microenvironment.
    Front Cell Dev Biol. 2022;9:809620.
    Abstract     Related articles   

  383. HU J, Zheng Z, Zheng J, Xie W, et al
    A Model for Identifying Optimal Patients for Primary Tumor Resection in Patients With Metastatic Bladder Cancer.
    Front Oncol. 2022;11:809664.
    Abstract     Related articles   

  384. WANG DQ, Shuai J, Zheng H, Guo ZQ, et al
    Can Routine Blood and Urine Parameters Reveal Clues to Detect Bladder Cancer? A Case-Control Study.
    Front Oncol. 2022;11:796975.
    Abstract     Related articles   

  385. ZHANG Y, Lin Y, Lv D, Wu X, et al
    Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer.
    PeerJ. 2022;10:e12843.
    Abstract     Related articles   

  386. XU C, Zhou G, Sun Z, Zhang Z, et al
    miR-148a-3p inhibits the proliferation and migration of bladder cancer via regulating the expression of ROCK-1.
    PeerJ. 2022;10:e12724.
    Abstract     Related articles   

  387. ZHANG C, Wang YQ, Jin G, Wu S, et al
    Erratum: Selection of reference genes for gene expression studies in human bladder cancer using SYBR-Green quantitative polymerase chain reaction.
    Oncol Lett. 2022;23:85.
    Abstract     Related articles   

  388. HUANG L, Zhang X, Li F, Wang X, et al
    MicroRNA-143-3p/TBX3 Axis Represses Malignant Cell Behaviors in Bladder Cancer.
    Comput Math Methods Med. 2022;2022:2880087.
    Abstract     Related articles   

  389. ZHU K, Liu X, Deng W, Wang G, et al
    Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer.
    Hereditas. 2022;159:13.
    Abstract     Related articles   

  390. BANGASH M, Faruqui N, Muhammad AU, Uddin Z, et al
    Leiomyoma Urinary Bladder, Mimicking Urothelial Cancer.
    J Ayub Med Coll Abbottabad. 2021;33:685-689.
    Abstract     Related articles   

  391. JORDAN SR, Geiger CL, Fischer SM, Kessler ER, et al
    Care planning priorities of older patients with advanced bladder cancer.
    J Geriatr Oncol. 2022 Feb 2. pii: S1879-4068(22)00011.
    Abstract     Related articles   

  392. YU C, Zhang Y, Wang N, Wei W, et al
    Treatment of bladder cancer by geoinspired synthetic chrysotile nanocarrier-delivered circPRMT5 siRNA.
    Biomater Res. 2022;26:6.
    Abstract     Related articles   

  393. HENTSCHEL AE, Beijert IJ, Bosschieter J, Kauer PC, et al
    Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation.
    Clin Epigenetics. 2022;14:19.
    Abstract     Related articles   

  394. ASGHARIAZAR V, Kadkhodayi M, Mansoori B, Mohammadi A, et al
    Restoration of miR-143 reduces migration and proliferation of bladder cancer cells by regulating signaling pathways involved in EMT.
    Mol Cell Probes. 2022;61:101794.
    Abstract     Related articles   

  395. MOSCHINI M, Gandaglia G, Deho F, Salonia A, et al
    Bladder cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up.
    Ann Oncol. 2022 Feb 1. pii: S0923-7534(22)00102.
    Abstract     Related articles   

  396. TOMITA Y, Yamamoto Y, Tsuchiya N, Kanayama H, et al
    Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis.
    Int J Clin Oncol. 2022;27:383-395.
    Abstract     Related articles   

  397. PINARD CJ, Hocker SE, Poon AC, Inkol JM, et al
    Evaluation of PD-1 and PD-L1 expression in canine urothelial carcinoma cell lines.
    Vet Immunol Immunopathol. 2022;243:110367.
    Abstract     Related articles   

  398. SCHNEIDER AK, Teuschler T, Wolko S
    [Care after radical cystectomy].
    Urologe A. 2022;61:83-86.
    Abstract     Related articles   

  399. ZENGIN ZB, Chehrazi-Raffle A, Salgia NJ, Muddasani R, et al
    Targeted therapies: Expanding the role of FGFR3 inhibition in urothelial carcinoma.
    Urol Oncol. 2022;40:25-36.
    Abstract     Related articles   

  400. LI L, Na R, Mi T, Cheng H, et al
    Medical Image Diagnostic Value of Computed Tomography for Bladder Tumors.
    Comput Math Methods Med. 2021;2021:3781028.
    Abstract     Related articles   

  401. LI S, Liu X, Chen X
    Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.
    BMC Urol. 2021;21:162.
    Abstract     Related articles   

  402. TUO Z, Zhang Y, Wang J, Zhou H, et al
    Three-port approach vs standard laparoscopic radical cystectomy with an ileal conduit: a single-centre retrospective study.
    BMC Urol. 2021;21:159.
    Abstract     Related articles   

  403. TURNER LD, Trinh CH, Hubball RA, Orritt KM, et al
    From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor.
    J Med Chem. 2022;65:1481-1504.
    Abstract     Related articles   

  404. INOUE K, Fukuhara H, Yamamoto S, Karashima T, et al
    Current status of photodynamic technology for urothelial cancer.
    Cancer Sci. 2022;113:392-398.
    Abstract     Related articles   

  405. CACCIAMANI GE, Matulewicz RS, Kumar R, Teoh JY, et al
    Fighting the 'tobacco epidemic' - A call to action to identify Targeted Intervention Points (TIPs) for better counseling patients with urothelial cancer.
    Urol Oncol. 2021;39:793-796.
    Abstract     Related articles   

  406. GRUNEWALD CM, Niegisch G
    [Circulating tumor DNA (ctDNA) in urothelial carcinoma-the long-desired biomarker?]
    Urologe A. 2021;60:1466-1467.
    Abstract     Related articles   

  407. BETANCOURT RL, Samulski DT
    Endometrial adenocarcinoma presenting in a voided urine cytology specimen: Case report.
    Diagn Cytopathol. 2021 Aug 19. doi: 10.1002/dc.24838.
    Abstract     Related articles   

  408. DURSUN F, Mackay A, Guzman JCA, Wenker E, et al
    Utilization and outcomes of metastasectomy for patients with metastatic urothelial cancer: An analysis of the national cancer database.
    Urol Oncol. 2022;40:61.
    Abstract     Related articles   

  409. SOOD A, Keeley J, Palma-Zamora I, Novara G, et al
    High-intensity local treatment of clinical node-positive urothelial carcinoma of the bladder alongside systemic chemotherapy improves overall survival.
    Urol Oncol. 2022;40:62.
    Abstract     Related articles   

  410. LI CF, Chan TC, Pan CT, Vejvisithsakul PP, et al
    EMP2 induces cytostasis and apoptosis via the TGFbeta/SMAD/SP1 axis and recruitment of P2RX7 in urinary bladder urothelial carcinoma.
    Cell Oncol (Dordr). 2021;44:1133-1150.
    Abstract     Related articles   

  411. NGUYEN A, Fassas S, Freidberg N, Sullo E, et al
    Recurrence and treatment of adult primary nonmetastatic bladder rhabdomyosarcoma: A systematic review.
    Urol Oncol. 2021;39:774-780.
    Abstract     Related articles   

  412. LE BRUN IC, Benderra MA
    [New approval: Avelumab - maintenance therapy for advanced or metastatic urothelial carcinoma].
    Bull Cancer. 2021;108:784-786.
    Abstract     Related articles   

  413. GHANDOUR RA, Freifeld Y, Cheaib J, Singla N, et al
    Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinoma.
    Urol Oncol. 2021;39:788.
    Abstract     Related articles   

  414. CHEN H, Wang M, Weng T, Wei Y, et al
    The prognostic and clinicopathological significance of Tim-3 and PD-1 expression in the prognosis of upper urinary tract urothelial carcinoma.
    Urol Oncol. 2021;39:743-753.
    Abstract     Related articles   

  415. COLLA RUVOLO C, Wenzel M, Nocera L, Wurnschimmel C, et al
    The effect of race on stage at presentation and survival in upper tract urothelial carcinoma.
    Urol Oncol. 2021;39:788.
    Abstract     Related articles   

  416. ISHIYAMA Y, Kondo T, Nemoto Y, Kobari Y, et al
    Antibiotic use and survival of patients receiving pembrolizumab for chemotherapy-resistant metastatic urothelial carcinoma.
    Urol Oncol. 2021;39:834.
    Abstract     Related articles   

  417. TACHIBANA I, Calaway AC, Abedali Z, Szymanski KM, et al
    Definitive surgical therapy for refractory radiation cystitis: Evaluating effectiveness, tolerability, and extent of surgical approach.
    Urol Oncol. 2021;39:789.
    Abstract     Related articles   

  418. KOBAYASHI T, Ito K, Kojima T, Maruyama S, et al
    Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR.
    Cancer Immunol Immunother. 2022;71:461-471.
    Abstract     Related articles   

  419. MATSUMOTO A, Matsui I, Mano K, Mizuno H, et al
    Recurrent membranous nephropathy with a possible alteration in the etiology: a case report.
    BMC Nephrol. 2021;22:253.
    Abstract     Related articles   

  420. AJIB K, Berjaoui MB, Herrera-Caceres J, Nason G, et al
    Characterization and management of NMIBC recurrences after TMT: a matched cohort analysis.
    Urol Oncol. 2021;39:835.
    Abstract     Related articles   

  421. RUVOLO CC, Nocera L, Stolzenbach FL, Wenzel M, et al
    Contemporary analysis of the effect of marital status on survival in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: A population-based study.
    Urol Oncol. 2021;39:789.
    Abstract     Related articles   

  422. HUBERT P, Selmani Z, Loriot Y, Thiery-Vuillemin A, et al
    FGFR alterations in urothelial carcinoma: Picking the right target.
    Bull Cancer. 2021;108:566-570.
    Abstract     Related articles   

  423. MILOJEVIC B, Dzamic Z, Grozdic Milojevic I, Bumbasirevic U, et al
    Prognostic value of Balkan endemic nephropathy and gender on upper tract urothelial carcinoma outcomes after radical nephroureterectomy: A cohort study.
    Urol Oncol. 2021;39:786.
    Abstract     Related articles   

  424. NICHOLS MM, Reynolds JP, McKenney JK, Nicolas MM, et al
    Urine cytology findings in patients with biopsy-confirmed urothelial carcinoma in situ with plasmacytoid features.
    Cancer Cytopathol. 2021;129:798-804.
    Abstract     Related articles   

  425. OKITA K, Hatakeyama S, Hagiwara K, Suzuki Y, et al
    The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinoma.
    Urol Oncol. 2021;39:832.
    Abstract     Related articles   

  426. RODRIGUES PESSOA R, Morrison JC, Konety B, Gershman B, et al
    National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy.
    Urol Oncol. 2021;39:832.
    Abstract     Related articles   

  427. KIM HD, Im HS, Kim JH, Jeong H, et al
    Use of Gemcitabine plus Carboplatin is Associated with Poor Outcomes in Urothelial Carcinoma Patients with Chronic Kidney Disease Stage 4-5.
    Cancer Res Treat. 2021;53:1166-1173.
    Abstract     Related articles   

  428. MOREIRA I, Coelho S, Rodrigues A, Patrao AS, et al
    Urachal carcinoma: A case of a rare neoplasm.
    Curr Probl Cancer. 2021;45:100711.
    Abstract     Related articles   

  429. LIU L, Zhu J, Tian Y
    Carcinosarcoma is an aggressive subtype of bladder cancer: A population-based study.
    Cancer Med. 2022 Feb 18. doi: 10.1002/cam4.4611.
    Abstract     Related articles   

  430. KACHANOV M, Vetterlein MW, Soave A, Karakiewicz PI, et al
    Oncologic impact of concomitant prostate cancer characteristics at the time of radical cystoprostatectomy for bladder cancer: a population-based analysis.
    Aging Male. 2022;25:54-61.
    Abstract     Related articles   

  431. HAGIMOTO H, Makita N, Mine Y, Kokubun H, et al
    Correction to: Comparison between 5-aminolevulinic acid photodynamic diagnosis and narrow-band imaging for bladder cancer detection.
    BMC Urol. 2022;22:23.
    Abstract     Related articles   

  432. ZHANG S, Zhang J, Zhang Q, Liang Y, et al
    Identification of Prognostic Biomarkers for Bladder Cancer Based on DNA Methylation Profile.
    Front Cell Dev Biol. 2022;9:817086.
    Abstract     Related articles   

  433. XU J, Zeng S, Li J, Gao L, et al
    Novel Non-Invasive Diagnosis of Bladder Cancer in Urine Based on Multifunctional Nanoparticles.
    Front Cell Dev Biol. 2022;9:813420.
    Abstract     Related articles   

  434. CHEN X, Wang P, Ou T, Li J, et al
    KLF16 Downregulates the Expression of Tumor Suppressor Gene TGFBR3 to Promote Bladder Cancer Proliferation and Migration.
    Cancer Manag Res. 2022;14:465-477.
    Abstract     Related articles   

  435. GAKIS G
    [Adjuvant instillation therapy for non-muscle invasive bladder cancer - beyond BCG und mitomycin C].
    Aktuelle Urol. 2022 Feb 16. doi: 10.1055/a-1677-0952.
    Abstract     Related articles   

  436. LONG Y, Wu Z, Yang X, Chen L, et al
    [Retracted] MicroRNA101 inhibits the proliferation and invasion of bladder cancer cells via targeting cFOS.
    Mol Med Rep. 2022;25.
    Abstract     Related articles   

  437. WANG Z, Zhu L, Li L, Stebbing J, et al
    Identification of an immune gene-associated prognostic signature in patients with bladder cancer.
    Cancer Gene Ther. 2022 Feb 15. pii: 10.1038/s41417-022-00438.
    Abstract     Related articles   

  438. SINGH AK, Praharaj M, Lombardo KA, Yoshida T, et al
    Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer.
    Nat Commun. 2022;13:878.
    Abstract     Related articles   

  439. GOLLA V, Shan Y, Farran EJ, Stewart CA, et al
    Long term cost comparisons of radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer.
    Urol Oncol. 2022 Feb 12. pii: S1078-1439(22)00025.
    Abstract     Related articles   

  440. PEKALA KR, Yabes JG, Bandari J, Yu M, et al
    Corrigendum to 'The centralization of bladder cancer care and its implications for patient travel distance' [Urologic Oncology: Seminars and Original Investigations volume 39 (2021) 834.e.9-834.e.20/9680].
    Urol Oncol. 2022 Feb 12. pii: S1078-1439(21)00567.
    Abstract     Related articles   

  441. LIU T, Zhang Z, Wang C, Huang H, et al
    BRD4 promotes the migration and invasion of bladder cancer through the Sonic hedgehog signaling pathway and enhances cisplatin resistance.
    Biochem Cell Biol. 2022 Feb 15. doi: 10.1139/bcb-2021-0552.
    Abstract     Related articles   

  442. YEARY KHK, Clark N, Saad-Harfouche F, Erwin D, et al
    Cruciferous Vegetable Intervention to Reduce the Risk of Cancer Recurrence in Non-Muscle-Invasive Bladder Cancer Survivors: Development Using a Systematic Process.
    JMIR Cancer. 2022;8:e32291.
    Abstract     Related articles   

  443. KORKES F, Timoteo F, Soledade LCB, Bugalho LS, et al
    Stage-Related Cost of Treatment of Bladder Cancer in Brazil.
    Pharmacoecon Open. 2022 Feb 14. pii: 10.1007/s41669-022-00325.
    Abstract     Related articles   

  444. LIU CQ, Xia QD, Sun JX, Xu JZ, et al
    Identification and validation of a twelve immune infiltration-related lncRNA prognostic signature for bladder cancer.
    Aging (Albany NY). 2022;14.
    Abstract     Related articles   

  445. KUBRAK T, Karakula M, Czop M, Kawczyk-Krupka A, et al
    Advances in Management of Bladder Cancer-The Role of Photodynamic Therapy.
    Molecules. 2022;27.
    Abstract     Related articles   

  446. ADAMCZYK P, Poblocki P, Kadlubowski M, Ostrowski A, et al
    A Comprehensive Approach to Clinical Staging of Bladder Cancer.
    J Clin Med. 2022;11.
    Abstract     Related articles   

  447. LA CROCE G, Naspro R, Finati M, Pellucchi F, et al
    The Accuracy of Transurethral Bladder Resection in Detecting Bladder Cancer Histological Variants and Their Prognostic Value at Radical Cystectomy.
    J Clin Med. 2022;11.
    Abstract     Related articles   

  448. PARDO JC, Sanhueza T, Ruiz de Porras V, Etxaniz O, et al
    Prognostic Impact of CD36 Immunohistochemical Expression in Patients with Muscle-Invasive Bladder Cancer Treated with Cystectomy and Adjuvant Chemotherapy.
    J Clin Med. 2022;11.
    Abstract     Related articles   

  449. AUDISIO A, Buttigliero C, Delcuratolo MD, Parlagreco E, et al
    New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond.
    Cells. 2022;11.
    Abstract     Related articles   

  450. SHISHIDO SN, Sayeed S, Courcoubetis G, Djaladat H, et al
    Characterization of Cellular and Acellular Analytes from Pre-Cystectomy Liquid Biopsies in Patients Newly Diagnosed with Primary Bladder Cancer.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  451. DEININGER S, Torzsok P, Mitterberger M, Pallauf M, et al
    From Interferon to Checkpoint Inhibition Therapy-A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette-Guerin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC).
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  452. SINGER G, Ramakrishnan VM, Rogel U, Schotzau A, et al
    The Role of New Technologies in the Diagnosis and Surveillance of Non-Muscle Invasive Bladder Carcinoma: A Prospective, Double-Blinded, Monocentric Study of the XPERT(c) Bladder Cancer Monitor and Narrow Band Imaging(c) Cystoscopy.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  453. BOSKOVIC M, Roje B, Chung FF, Gelemanovic A, et al
    DNA Methylome Changes of Muscle- and Neuronal-Related Processes Precede Bladder Cancer Invasiveness.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  454. FASULO V, Paciotti M, Lazzeri M, Contieri R, et al
    Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study.
    Front Oncol. 2022;12:832835.
    Abstract     Related articles   

  455. LI Y, Cheng X, Yan J, Jiang S, et al
    CTHRC1 facilitates bladder cancer cell proliferation and invasion through regulating the PI3K/Akt signaling pathway.
    Arch Med Sci. 2019;18:183-194.
    Abstract     Related articles   

  456. WEI B, Wang Z, Lian Q, Chi B, et al
    hsa_circ_0139402 Promotes Bladder Cancer Progression by Regulating hsa-miR-326/PAX8 Signaling.
    Dis Markers. 2022;2022:9899548.
    Abstract     Related articles   

  457. LU Z, Tang F, Li Z, Lai Y, et al
    Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Bladder Cancer.
    Dis Markers. 2022;2022:7931393.
    Abstract     Related articles   

  458. SHIMIZU R, Ohira T, Yagyu T, Yumioka T, et al
    Activation of PPARgamma in bladder cancer via introduction of the long arm of human chromosome 9.
    Oncol Lett. 2022;23:92.
    Abstract     Related articles   

  459. KAYID M
    Applications of Bladder Cancer Data Using a Modified Log-Logistic Model.
    Appl Bionics Biomech. 2022;2022:6600278.
    Abstract     Related articles   

  460. LU H, Wu J, Liang L, Wang X, et al
    Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
    Front Immunol. 2022;13:803355.
    Abstract     Related articles   

  461. LI T, Tang Z, Li C, Liu X, et al
    Magnesium-Assisted Cisplatin Inhibits Bladder Cancer Cell Survival by Modulating Wnt/beta-Catenin Signaling Pathway.
    Front Pharmacol. 2022;12:804615.
    Abstract     Related articles   

  462. PATTOU M, Baboudjian M, Pinar U, Parra J, et al
    Continent cutaneous urinary diversion with an ileal pouch with the Mitrofanoff principle versus a Miami pouch in patients undergoing cystectomy for bladder cancer: results of a comparative study.
    World J Urol. 2022 Feb 12. pii: 10.1007/s00345-022-03954.
    Abstract     Related articles   

  463. FUKUHARA H, Yamamoto S, Lai HW, Karashima T, et al
    Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2(nd) report): reduced bladder recurrence after PDD-TURBT.
    Photodiagnosis Photodyn Ther. 2022 Feb 10:102757.
    Abstract     Related articles   

  464. D'SOUZA AA, Tulpule V, Zang PD, Quinn DI, et al
    Bladder cancer: from a therapeutic wilderness to so many options; a guide to practice in a changing landscape.
    Ann Oncol. 2022;33:242-243.
    Abstract     Related articles   

  465. SHEN Y, Ye H, Zhang D, Yang M, et al
    The role of exosomal CDC6 in the hirudin-mediated suppression of the malignant phenotype of bladder cancer cells.
    Gene. 2022 Feb 9:146269. doi: 10.1016/j.gene.2022.146269.
    Abstract     Related articles   

  466. ZHANG J, Dong Y, Shi Z, He H, et al
    P3H4 and PLOD1 expression associates with poor prognosis in bladder cancer.
    Clin Transl Oncol. 2022 Feb 11. pii: 10.1007/s12094-022-02791.
    Abstract     Related articles   

  467. LI F, Xu M, Zhuang J
    Dual biomineralized metal-organic frameworks-mediated conversion of chemical energy to electricity enabling portable PEC sensing of telomerase activity in bladder cancer tissues.
    Biosens Bioelectron. 2022;204:114070.
    Abstract     Related articles   

  468. TACHIBANA I, Mahmoud M, Abedali ZA, Flack C, et al
    Does pathological sub stratification of T2 bladder cancer predict outcome in a contemporary pure urothelial carcinoma cohort?
    Urol Oncol. 2022 Feb 8. pii: S1078-1439(21)00556.
    Abstract     Related articles   

  469. CUI J, Zhu Y, Liu X, Wang W, et al
    Comprehensive analysis of N(6)-methyladenosine regulators with the tumor immune landscape and correlation between the insulin-like growth factor 2 mRNA-binding protein 3 and programmed death ligand 1 in bladder cancer.
    Cancer Cell Int. 2022;22:72.
    Abstract     Related articles   

  470. GALLIOLI A, Pradere B, Albisinni S, Moschini M, et al
    Robot-assisted radical cystectomy: towards a future of sexual-sparing surgery?
    Minerva Urol Nephrol. 2021;73:697-699.
    Abstract     Related articles   

  471. BANI-HANI M, Abdel Majid A, Al-Zubi MT, Al Demour S, et al
    Continuous Saline Bladder Irrigation in Reducing Recurrence and Progression When Compared to Immediate Mitomycin- C Instillation Post- Resection of Bladder Tumor: A Short Communication.
    Asian Pac J Cancer Prev. 2022;23:171-175.
    Abstract     Related articles   

  472. MASONE MC
    NMIBC risk factors in patients treated with BCG.
    Nat Rev Urol. 2022;19:67.
    Abstract     Related articles   

  473. YIN H, Yongkang M, Bao G, Shiming Z, et al
    PD-1 inhibitor toripalimab with gemcitabine as a neoadjuvant therapy for muscle-invasive bladder urothelial carcinoma: A case report.
    Medicine (Baltimore). 2022;101:e28591.
    Abstract     Related articles   

  474. THOMAS T
    Bladder EpiCheck for NMIBC.
    Nat Rev Urol. 2022;19:67.
    Abstract     Related articles   

  475. MAEDA S, Sakai K, Kaji K, Iio A, et al
    Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs.
    Sci Rep. 2022;12:4.
    Abstract     Related articles   

  476. DOSNE AG, Valade E, Goeyvaerts N, De Porre P, et al
    Exposure-response analyses of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma.
    Cancer Chemother Pharmacol. 2022;89:151-164.
    Abstract     Related articles   

  477. ZOU X, Wei Y, Qi T, Wang X, et al
    A novel 6-gene signature derived from tumor-infiltrating T cells and neutrophils predicts survival of bladder urothelial carcinoma.
    Aging (Albany NY). 2021;13:25496-25517.
    Abstract     Related articles   

  478. LIN S, Wang L, Shi Z, Zhu A, et al
    Circular RNA circFLNA inhibits the development of bladder carcinoma through microRNA miR-216a-3p/BTG2 axis.
    Bioengineered. 2021;12:11376-11389.
    Abstract     Related articles   

  479. HARVEY M, Chislett B, Perera M, Lawrentschuk N, et al
    Critical shortage in BCG immunotherapy: How did we get here and where will it take us?
    Urol Oncol. 2022;40:1-3.
    Abstract     Related articles   

  480. YAMADA S, Abe T, Sazawa A, Katano H, et al
    Comparative study of postoperative complications after radical cystectomy during the past two decades in Japan: Radical cystectomy remains associated with significant postoperative morbidities.
    Urol Oncol. 2022;40:11.
    Abstract     Related articles   

  481. HURLE R, Guazzoni G, Colombo P, Santoro A, et al
    Oncofid-P-B: a novel treatment for BCG unresponsive carcinoma in situ (CIS) of the bladder: Results of a prospective European Multicentre study at 15 months from treatment start.
    Urol Oncol. 2022;40:11.
    Abstract     Related articles   

  482. AHN AR, Noh SJ, Hussein UK, Park HS, et al
    FAM83H and Nectin1 expression are related with survival and relapse of bladder urothelial carcinoma patients.
    BMC Urol. 2021;21:143.
    Abstract     Related articles   

  483. COMPERAT E, Oszwald A, Wasinger G, Wacquet J, et al
    PD-L1 (SP142) testing is concordant between Benchmark Ultra and Bond-III stainers.
    World J Urol. 2021;39:4067-4071.
    Abstract     Related articles   

  484. KOSSAI M, Radulescu C, Adam J, Dziegielewski A, et al
    Plasmacytoid urothelial carcinoma (UC) are luminal tumors with similar CD8+ Tcell density and PD-L1 protein expression on immune cells as compared to conventional UC.
    Urol Oncol. 2022;40:12.
    Abstract     Related articles   

  485. MURTHY PB, Lone Z, Corrigan D, Campbell R, et al
    Survival outcomes following radical cystectomy in patients with prior pelvic radiation for prostate cancer: A matched cohort analysis.
    Urol Oncol. 2022;40:10.
    Abstract     Related articles   

  486. NECCHI A, Raggi D, Gallina A, Bandini M, et al
    Molecular subtyping and immune-gene signatures identify a subset of early bladder tumors as candidates for single-agent immune-checkpoint inhibition.
    Urol Oncol. 2021;39:734.
    Abstract     Related articles   

  487. GOUTAS D, Savvidou K, Vrettou K, Meletis E, et al
    Comparison of conventional and liquid-based cytology using The Paris System for Reporting Urinary Cytology.
    Cytopathology. 2021;32:795-801.
    Abstract     Related articles   

  488. ZHOU YW, Long YX, Song K, Liang LB, et al
    Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas.
    Cancer Med. 2021;10:5415-5428.
    Abstract     Related articles   

  489. MORGANS AK, Hepp Z, Shah SN, Shah A, et al
    Real-world burden of illness and unmet need in locally advanced or metastatic urothelial carcinoma following discontinuation of PD-1/L1 inhibitor therapy: A Medicare claims database analysis.
    Urol Oncol. 2021;39:733.
    Abstract     Related articles   

  490. MUSANGILE FY, Matsuzaki I, Okodo M, Shirasaki A, et al
    Detection of HPV infection in urothelial carcinoma using RNAscope: Clinicopathological characterization.
    Cancer Med. 2021;10:5534-5544.
    Abstract     Related articles   

  491. BEBANE S, Denize J, Goujon A, Meria P, et al
    Perioperative outcomes of transurethral resection for t1 bladder tumors: quality evaluation based on patient, tumor and surgeon criteria.
    World J Urol. 2021;39:4159-4165.
    Abstract     Related articles   

  492. SUBIELA JD, Faba OR, Aumatell J, Krajewski W, et al
    Impact of clinical and pathological subtypes of carcinoma in situ (CIS) of the bladder: Lessons learned from long-term follow-up of a series of CIS patients treated with BCG.
    Urol Oncol. 2022;40:9.
    Abstract     Related articles   

  493. JANA S, Deo R, Hough RP, Liu Y, et al
    mRNA translation is a therapeutic vulnerability necessary for bladder epithelial transformation.
    JCI Insight. 2021;6.
    Abstract     Related articles   

  494. MAAS M, Mischinger J, Comperat E, Scharpf M, et al
    Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?
    World J Urol. 2021;39:4021-4027.
    Abstract     Related articles   

  495. AUMATELL J, Huguet J, Subiela JD, Gaya JM, et al
    Endoscopic exploration directly impacts clinical decision making in the management of patients with suspected upper tract urothelial carcinoma following radical cystectomy.
    Urol Oncol. 2021;39:732.
    Abstract     Related articles   

  496. BATEN E, Van der Aa F, Goethuys H, Slabbert K, et al
    A randomized trial regarding antimicrobial prophylaxis (AMP) in transurethral resection of bladder tumor (TURB).
    World J Urol. 2021;39:3839-3844.
    Abstract     Related articles   

  497. CALO B, Sanguedolce F, Falagario UG, Chirico M, et al
    Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary?
    World J Urol. 2021;39:3815-3821.
    Abstract     Related articles   

  498. KATAYAMA S, Kobayashi Y, Takamoto A, Edamura K, et al
    Impact of paclitaxel, cisplatin, and gemcitabine as first-line chemotherapy in cisplatin-fit and -unfit patients with advanced/metastatic urothelial carcinoma.
    Urol Oncol. 2021;39:731.
    Abstract     Related articles   

  499. CHENG HL, Chou LP, Tsai HW, Lee CT, et al
    Urothelial carcinoma with trophoblastic differentiation: Reappraisal of the clinical implication and immunohistochemically features.
    Urol Oncol. 2021;39:732.
    Abstract     Related articles   

  500. OSZWALD A, Wasinger G, Larnaudie L, Varinot J, et al
    Pathological reporting of cystectomy lymph nodes: a retrospective analysis of experience in Paris.
    World J Urol. 2021;39:4029-4035.
    Abstract     Related articles   

  501. MORMILE R
    Letter to the editor: What about cholesterol as a novel biomarker for bladder and kidney cancer diagnosis and surveillance? In memory of my dad Sossio Mormile.
    Investig Clin Urol. 2021;62:239-240.
    Abstract     Related articles   

  502. DE VLAMING A, Mathews KG, Hash JA, Keenihan EK, et al
    Creation of a Continent Urinary Bladder Reservoir Vascularized by Omentum as a Possible Surgical Option for Canine Trigonal/Urethral Urothelial Carcinoma.
    J Invest Surg. 2022;35:481-495.
    Abstract     Related articles   

  503. ERCOLINO A, Droghetti M, Schiavina R, Bianchi L, et al
    Postoperative outcomes of Fast-Track-enhanced recovery protocol in open radical cystectomy: comparison with standard management in a high-volume center and Trifecta proposal.
    Minerva Urol Nephrol. 2021;73:763-772.
    Abstract     Related articles   

  504. TUDERTI G, Mastroianni R, Brassetti A, Bove AM, et al
    Robot-assisted radical cystectomy with intracorporeal neobladder: impact of learning curve and long-term assessment of functional outcomes.
    Minerva Urol Nephrol. 2021;73:754-762.
    Abstract     Related articles   

  505. ROUMIGUIE M, Comperat E, Chaltiel L, Nouhaud FX, et al
    PD-L1 expression and pattern of immune cells in pre-treatment specimens are associated with disease-free survival for HR-NMIBC undergoing BCG treatment.
    World J Urol. 2021;39:4055-4065.
    Abstract     Related articles   

  506. SMELSER WW, Jones CP
    Management of anticoagulation and antiplatelet agents in the radical cystectomy patient.
    Urol Oncol. 2021;39:691-697.
    Abstract     Related articles   

  507. GUO CC, Al-Ahmadie HA, Flaig TW, Kamat AM, et al
    Contribution of bladder cancer pathology assessment in planning clinical trials.
    Urol Oncol. 2021;39:713-719.
    Abstract     Related articles   

  508. JIANG X, Li H, Fang Y, Xu C, et al
    LncRNA PVT1 contributes to invasion and doxorubicin resistance of bladder cancer cells through promoting MDM2 expression and AURKB-mediated p53 ubiquitination.
    Environ Toxicol. 2022 Feb 25. doi: 10.1002/tox.23501.
    Abstract     Related articles   

  509. LOBO N, Martini A, Kamat AM
    Evolution of immunotherapy in the treatment of non-muscle-invasive bladder cancer.
    Expert Rev Anticancer Ther. 2022 Feb 25. doi: 10.1080/14737140.2022.2046466.
    Abstract     Related articles   

  510. LIU J, Zhang Z, Liu X, Zhang W, et al
    Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response.
    World J Surg Oncol. 2022;20:47.
    Abstract     Related articles   

  511. LEE SW, Tae BS, Choi YJ, Yoon SM, et al
    A Comparison of the Anesthetic Methods for Recurrence Rates of Bladder Cancer after Transurethral Resection of Bladder Tumors Using National Health Insurance Claims Data of South Korea.
    J Clin Med. 2022;11.
    Abstract     Related articles   

  512. SARRIO-SANZ P, Martinez-Cayuelas L, Gil-Guillen VF, Quesada JA, et al
    Mortality Trends Related to Bladder Cancer in Spain, 1999-2018.
    J Clin Med. 2022;11.
    Abstract     Related articles   

  513. IBRAHIM NK, Eraky A, Eggers J, Steiert TA, et al
    Detection of Cancer Mutations by Urine Liquid Biopsy as a Potential Tool in the Clinical Management of Bladder Cancer Patients.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  514. HUANG CS, Tsai CH, Yu CP, Wu YS, et al
    Long Noncoding RNA LINC02470 Sponges MicroRNA-143-3p and Enhances SMAD3-Mediated Epithelial-to-Mesenchymal Transition to Promote the Aggressive Properties of Bladder Cancer.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  515. BEEREN I, Goeij L, Dandis R, Vidra N, et al
    Limited Changes in Lifestyle Behaviours after Non-Muscle Invasive Bladder Cancer Diagnosis.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  516. DEL GIUDICE F, Flammia RS, Chung BI, Moschini M, et al
    Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  517. YAO X, Qi X, Wang Y, Zhang B, et al
    Identification and Validation of an Annexin-Related Prognostic Signature and Therapeutic Targets for Bladder Cancer: Integrative Analysis.
    Biology (Basel). 2022;11.
    Abstract     Related articles   

  518. CROCETTO F, Pandolfo SD, Aveta A, Martino R, et al
    A Comparative Study of the Triglycerides/HDL Ratio and Pseudocholinesterase Levels in Patients with Bladder Cancer.
    Diagnostics (Basel). 2022;12.
    Abstract     Related articles   

  519. SHAHAB U, Habib S, Alsulimani A, Alshammari QT, et al
    N-OH-AABP Modifications in Human DNA May Lead to Auto-Antibodies in Bladder Cancer Subjects.
    Diagnostics (Basel). 2022;12.
    Abstract     Related articles   

  520. MAIORANO BA, De Giorgi U, Ciardiello D, Schinzari G, et al
    Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day.
    Biomedicines. 2022;10.
    Abstract     Related articles   

  521. NOWAK L, Krajewski W, Malkiewicz B, Szydelko T, et al
    Characteristics and Applications of Canine In Vitro Models of Bladder Cancer in Veterinary Medicine: An Up-to-Date Mini Review.
    Animals (Basel). 2022;12.
    Abstract     Related articles   

  522. ABUDUREXITI M, Ma J, Li Y, Hu C, et al
    Clinical Outcomes and Prognosis Analysis of Younger Bladder Cancer Patients.
    Curr Oncol. 2022;29:578-588.
    Abstract     Related articles   

  523. ZUO L, Zhu Y, Han J, Liu H, et al
    Circular RNA circSHPRH inhibits the malignant behaviors of bladder cancer by regulating the miR-942/BARX2 pathway.
    Aging (Albany NY). 2022;14.
    Abstract     Related articles   

  524. SAH AK, Maharjan B, Adhikari MB, Rana R, et al
    Radical Cystectomy for Intradiverticular Bladder Carcinoma: A Case Report.
    JNMA J Nepal Med Assoc. 2021;59:1069-1071.
    Abstract     Related articles   

  525. GUNERI-SOZERI PY, Erkek-Ozhan S
    Identification of the gene expression changes and gene regulatory aspects in ELF3 mutant bladder cancer.
    Mol Biol Rep. 2022 Feb 24. pii: 10.1007/s11033-022-07145.
    Abstract     Related articles   

  526. PARRA-GRANDE M, Ore-Arce M, Martinez-Priego L, D'Auria G, et al
    Profiling the Bladder Microbiota in Patients With Bladder Cancer.
    Front Microbiol. 2022;12:718776.
    Abstract     Related articles   

  527. RIGHETTO M, Modonutti D, Celso FG, Fulcoli V, et al
    Metabolic syndrome and bladder cancer.
    Panminerva Med. 2022 Feb 22. pii: S0031-0808.22.04641.
    Abstract     Related articles   

  528. SHANG W, Peng L, He K, Guo P, et al
    A clinical study of a CD44v6-targeted fluorescent agent for the detection of non-muscle invasive bladder cancer.
    Eur J Nucl Med Mol Imaging. 2022 Feb 21. pii: 10.1007/s00259-022-05701.
    Abstract     Related articles   

  529. ZHAN X, Jiang M, Deng W, Liu X, et al
    Development and Validation of a Prognostic Nomogram for Predicting Cancer-Specific Survival in Patients With Lymph Node Positive Bladder Cancer: A Study Based on SEER Database.
    Front Oncol. 2022;12:789028.
    Abstract     Related articles   

  530. YANG X, Lv J, Zhou Z, Feng D, et al
    Clinical Application of Circulating Tumor Cells and Circulating Endothelial Cells in Predicting Bladder Cancer Prognosis and Neoadjuvant Chemosensitivity.
    Front Oncol. 2022;11:802188.
    Abstract     Related articles   

  531. WESTHOFEN T, Eismann L, Buchner A, Schlenker B, et al
    Baseline Health-related Quality of Life Predicts Bladder Cancer-specific Survival Following Radical Cystectomy.
    Eur Urol Focus. 2022 Feb 17. pii: S2405-4569(22)00045.
    Abstract     Related articles   

  532. CHEN CW
    Comment on 'Long noncoding RNA UCA1 promotes glutamine-driven anaplerosis of bladder cancer by interacting with hnRNP I/L to upregulate GPT2 expression' by Chen et al.'".
    Transl Oncol. 2022;18:101372.
    Abstract     Related articles   

  533. MICHEL F, Cancrini F, Bensadoun H, Cussenot O, et al
    Incidence of bladder cancer in neuro-urological patients in France: a nationwide study.
    World J Urol. 2022 Feb 19. pii: 10.1007/s00345-022-03955.
    Abstract     Related articles   

  534. HOU DY, Zhang NY, Wang MD, Xu SX, et al
    In Situ Constructed Nano-drug Depots through Intracellular Hydrolytic Condensation for Chemotherapy of Bladder Cancer.
    Angew Chem Int Ed Engl. 2022 Feb 18. doi: 10.1002/anie.202116893.
    Abstract     Related articles   

  535. FENG Y, Zhong K, Chen R, Zhou W, et al
    Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) for the detection of muscle-invasive bladder cancer: a meta-analysis.
    Abdom Radiol (NY). 2022 Feb 18. pii: 10.1007/s00261-022-03449.
    Abstract     Related articles   

  536. LI M, Zhang N, Shan W, Guan B, et al
    ALG3 Is a Potential Biomarker for the Prognosis of Bladder Cancer.
    Ann Clin Lab Sci. 2022;52:117-125.
    Abstract     Related articles   

  537. MIR MC, Marchioni M, Zargar H, Zargar-Shoshtari K, et al
    Corrigendum to "Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium" [Eur Urol Focus 2021;7:1347-54].
    Eur Urol Focus. 2022 Feb 15. pii: S2405-4569(22)00016.
    Abstract     Related articles   

  538. KAWASAKI M, Nagase K, Aoki S, Udo K, et al
    Bystander effects induced by the interaction between urothelial cancer cells and irradiated adipose tissue-derived stromal cells in urothelial carcinoma.
    Hum Cell. 2022;35:613-627.
    Abstract     Related articles   

  539. SIEFKER-RADTKE AO, Necchi A, Park SH, Garcia-Donas J, et al
    Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study.
    Lancet Oncol. 2022;23:248-258.
    Abstract     Related articles   

  540. HONG T, Piao S, Sun L, Tao Y, et al
    Tumor protein P63 Regulated 1 contributes to inflammation and cell proliferation of cystitis glandularis through regulating the NF-small ka, CyrillicB/cyclooxygenase-2/prostaglandin E2 axis.
    Bosn J Basic Med Sci. 2022;22:100-109.
    Abstract     Related articles   

  541. POWLES T, Sridhar SS, Loriot Y, Bellmunt J, et al
    Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial.
    Nat Med. 2021;27:2200-2211.
    Abstract     Related articles   

  542. YANAGI M, Hamasaki T, Akatsuka J, Endo Y, et al
    Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma.
    BMC Urol. 2021;21:167.
    Abstract     Related articles   

  543. LOMBARDO KA, Obradovic A, Singh AK, Liu JL, et al
    BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer.
    J Pathol. 2022;256:223-234.
    Abstract     Related articles   

  544. ZAZA SI, Ghasemzadeh A, Bennett KM
    Mycobacterium Bovis Causing Mycotic Aneurysm Secondary to Intravesical Treatment with Bacillus Calmette-Guerin: A Case Report.
    Ann Vasc Surg. 2022;79:437.
    Abstract     Related articles   

  545. ZHOU X, Wang F, Wu H, Chen X, et al
    Thymoquinone Suppresses the Proliferation, Migration and Invasiveness through Regulating ROS, Autophagic Flux and miR-877-5p in Human Bladder Carcinoma Cells.
    Int J Biol Sci. 2021;17:3456-3475.
    Abstract     Related articles   

  546. TANIGUCHI Y, Nishikawa H, Kimata T, Yoshinaga Y, et al
    Reactive Arthritis After Intravesical Bacillus Calmette-Guerin Therapy.
    J Clin Rheumatol. 2022;28:e583-e588.
    Abstract     Related articles   

  547. WHELAN P, Kim C, Tabib C, Preminger GM, et al
    Evolution of Single-Use Urologic Endoscopy: Benchtop and Initial Clinical Assessment of a New Single-Use Flexible Cystoscope.
    J Endourol. 2022;36:13-21.
    Abstract     Related articles   

  548. VRANIC S, Gatalica Z
    Trop-2 protein as a therapeutic target: A focused review on Trop-2-based antibody-drug conjugates and their predictive biomarkers.
    Bosn J Basic Med Sci. 2022;22:14-21.
    Abstract     Related articles   

  549. PIZZIGHELLA M, Bruyere F, Peyronnet B, Graffeille V, et al
    The Management of Distal Ureter During Radical Nephroureterectomy Does Not Influence Bladder Recurrence.
    J Endourol. 2022;36:77-82.
    Abstract     Related articles   

  550. SUN T, Hutchinson L, Tomaszewicz K, Caporelli ML, et al
    Diagnostic value of a comprehensive, urothelial carcinoma-specific next-generation sequencing panel in urine cytology and bladder tumor specimens.
    Cancer Cytopathol. 2021;129:537-547.
    Abstract     Related articles   

  551. FARRAG MA, Ezz MK, Ibrahim NK, Ahmed EK, et al
    Chemopreventive Potential of Myrtenal against Nitrosamine-Initiated, Radiation-Promoted Rat Bladder Carcinogenesis.
    Nutr Cancer. 2022;74:288-298.
    Abstract     Related articles   

  552. HUI J, Wang C, Miao Y, Liu R, et al
    The pancancer landscape of Wnt family expression reveals potential biomarkers in urinary system tumors.
    Cancer Gene Ther. 2021;28:1035-1045.
    Abstract     Related articles   

  553. REIS IB, Tibo LHS, Socca EAR, de Souza BR, et al
    OncoTherad(R) (MRB-CFI-1) nano-immunotherapy reduced tumoral progression in non-muscle invasive bladder cancer through activation of Toll-like signaling pathway.
    Tissue Cell. 2022;76:101762.
    Abstract     Related articles   

  554. KIM JH, Choi J, Kim M, Kang SJ, et al
    Immunotherapeutic effects of recombinant Bacillus Calmette-Guerin containing sic gene in ex vivo and in vivo bladder cancer models.
    Investig Clin Urol. 2022;63:228-237.
    Abstract     Related articles   

  555. CHOI SY, Ha MS, Kim JH, Chi BH, et al
    Low-dose versus standard-dose bacille Calmette-Guerin for non-muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized controlled trials.
    Investig Clin Urol. 2022;63:140-150.
    Abstract     Related articles   

  556. HADJI M, Rashidian H, Marzban M, Naghibzadeh-Tahami A, et al
    Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran.
    Int J Epidemiol. 2022 Mar 4. pii: 6542534. doi: 10.1093.
    Abstract     Related articles   

  557. HENTSCHEL AE, Blankvoort CJ, Bosschieter J, Vis AN, et al
    Trial-based Cost-effectiveness Analysis of an Immediate Postoperative Mitomycin C Instillation in Patients with Non-muscle-invasive Bladder Cancer.
    Eur Urol Open Sci. 2022;37:7-13.
    Abstract     Related articles   

  558. LI X, Yang L, Huang W, Jia B, et al
    Immunological significance of alternative splicing prognostic signatures for bladder cancer.
    Heliyon. 2022;8:e08994.
    Abstract     Related articles   

  559. ZHU J, Lu Z, Chen W, Ke M, et al
    Systematic review and meta-analysis on laparoscopic cystectomy in bladder cancer.
    Transl Androl Urol. 2022;11:67-78.
    Abstract     Related articles   

  560. FAN X, Zou X, Liu C, Peng S, et al
    Global analysis of miRNA-mRNA regulation pair in bladder cancer.
    World J Surg Oncol. 2022;20:66.
    Abstract     Related articles   

  561. HAN Z, Gu J, Xin J, Liu H, et al
    Genetic variants in choline metabolism pathway are associated with the risk of bladder cancer in the Chinese population.
    Arch Toxicol. 2022 Mar 3. pii: 10.1007/s00204-022-03258.
    Abstract     Related articles   

  562. REN W, Zuo S, Yang L, Tu R, et al
    Identification of a novel immune-related long noncoding RNA signature to predict the prognosis of bladder cancer.
    Sci Rep. 2022;12:3444.
    Abstract     Related articles   

  563. LONATI C, Mordasini L, Afferi L, De Cobelli O, et al
    Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: A multicenter cohort from the European Association of Urology - Young Academic Urologists.
    Urol Oncol. 2022 Feb 27. pii: S1078-1439(22)00003.
    Abstract     Related articles   

  564. ZHAN X, Chen L, Jiang M, Fu B, et al
    Trends in the cause of death among patients with bladder cancer in the US SEER population, 1992-2018.
    World J Urol. 2022 Mar 2. pii: 10.1007/s00345-022-03971.
    Abstract     Related articles   

  565. STOMP-AGENANT M, van Dijk T, Onur AR, Grimbergen MCM, et al
    In vivo Raman spectroscopy for bladder cancer detection using a superficial Raman probe compared to a non-superficial Raman probe.
    J Biophotonics. 2022 Mar 1:e202100354. doi: 10.1002/jbio.202100354.
    Abstract     Related articles   

  566. CAZENAVE L, Faucher M, Tourret M, Marques M, et al
    Intravenous lidocaine and cancer outcomes after radical cystectomy.
    Eur J Anaesthesiol. 2022;39:396-399.
    Abstract     Related articles   

  567. DUTTA EK, Lewis MG, Albert S
    Risk factors associated with gall bladder cancer in high incidence areas in India: a systematic review protocol.
    BMJ Open. 2022;12:e056849.
    Abstract     Related articles   

  568. GARCIA-PERDOMO HA, Sanchez AL, Spiess PE
    Immune checkpoints inhibitors in the management of high-risk non-muscle-invasive bladder cancer. A scoping review.
    Urol Oncol. 2022 Feb 26. pii: S1078-1439(22)00038.
    Abstract     Related articles   

  569. REBHAN K, Gust KM
    [Erratum to: Locally advanced or oligometastatic bladder cancer-role of local treatment of the primary tumor and metastases].
    Urologe A. 2022 Mar 1. pii: 10.1007/s00120-022-01789.
    Abstract     Related articles   

  570. RANGSITRATKUL C, Lawson C, Bernier-Godon F, Niavarani SR, et al
    Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer.
    Mol Ther Oncolytics. 2022;24:507-521.
    Abstract     Related articles   

  571. JAHANGIRIAN E, Jamal GA, Nouroozi M, Mohammadpour A, et al
    A Novel Multiepitope Vaccine Against Bladder Cancer Based on CTL and HTL Epitopes for Induction of Strong Immune Using Immunoinformatics Approaches.
    Int J Pept Res Ther. 2022;28:71.
    Abstract     Related articles   

  572. TABER A, Prip F, Lamy P, Agerbaek M, et al
    Immune Contexture and Differentiation Features Predict Outcome in Bladder Cancer.
    Eur Urol Oncol. 2022 Feb 25. pii: S2588-9311(22)00009.
    Abstract     Related articles   

  573. LIEDBERG F, Kjellstrom S, Lind AK, Sherif A, et al
    Swedish National Guidelines on Urothelial Carcinoma: 2021 update on non-muscle invasive bladder cancer and upper tract urothelial carcinoma.
    Scand J Urol. 2022 Feb 28:1-10. doi: 10.1080/21681805.2022.2041086.
    Abstract     Related articles   

  574. YANG F, Liu XQ, He JZ, Xian SP, et al
    Occludin facilitates tumour angiogenesis in bladder cancer by regulating IL8/STAT3 through STAT4.
    J Cell Mol Med. 2022 Feb 27. doi: 10.1111/jcmm.17257.
    Abstract     Related articles   

  575. HU R, Tao T, Yu L, Ding Q, et al
    Multi-Omics Characterization of Tumor Microenvironment Heterogeneity and Immunotherapy Resistance Through Cell States-Based Subtyping in Bladder Cancer.
    Front Cell Dev Biol. 2022;9:809588.
    Abstract     Related articles   

  576. YI R, Hong S, Zhang Y, Lin A, et al
    MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer.
    Front Cell Dev Biol. 2022;10:757137.
    Abstract     Related articles   

  577. EL AHANIDI H, El Azzouzi M, Hafidi Alaoui C, Tetou M, et al
    Immune Checkpoint and Telomerase Crosstalk Is Mediated by miRNA-138 in Bladder Cancer.
    Front Oncol. 2022;11:795242.
    Abstract     Related articles   

  578. ALVAREZ-MAESTRO M, Chierigo F, Mantica G, Quesada-Olarte JM, et al
    The effect of neoadjuvant chemotherapy among patients undergoing radical cystectomy for variant histology bladder cancer: A systematic review.
    Arab J Urol. 2021;20:1-13.
    Abstract     Related articles   

  579. SU G, Yao L, Han X, Liao X, et al
    A synthetic targeted RNA demethylation system based on CRISPR-Cas13b inhibits bladder cancer progression.
    Clin Transl Med. 2022;12:e734.
    Abstract     Related articles   

  580. HELTE E, Save-Soderbergh M, Ugge H, Fall K, et al
    Chlorination by-products in drinking water and risk of bladder cancer - A population-based cohort study.
    Water Res. 2022;214:118202.
    Abstract     Related articles   

  581. LI G, Tao T, Deng D, Zhang S, et al
    Collagen-targeted tumor-specific transepithelial penetration enhancer mediated intravesical chemoimmunotherapy for non-muscle-invasive bladder cancer.
    Biomaterials. 2022;283:121422.
    Abstract     Related articles   

  582. BROUGHTON EI, Gooden KM, Mycock KL, Rajkovic I, et al
    Multi-country clinical practice patterns, including use of biomarkers, among physicians' treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC).
    BMC Urol. 2022;22:27.
    Abstract     Related articles   

  583. LONATI C, Afferi L, Mari A, Minervini A, et al
    Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration.
    World J Urol. 2022 Feb 26. pii: 10.1007/s00345-022-03958.
    Abstract     Related articles   

  584. HOU J, Liang S, Xie Z, Qu G, et al
    An immune-related lncRNA model for predicting prognosis, immune landscape and chemotherapeutic response in bladder cancer.
    Sci Rep. 2022;12:3225.
    Abstract     Related articles   

  585. KOTHA NV, Kumar A, Nelson TJ, Qiao EM, et al
    Outcomes by time to definitive chemoradiation treatment for patients with muscle-invasive bladder cancer.
    Urol Oncol. 2022 Feb 22. pii: S1078-1439(22)00028.
    Abstract     Related articles   

  586. CIMADAMORE A, Lonati C, Di Trapani E, De Cobelli O, et al
    Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy?
    Urol Oncol. 2022 Feb 22. pii: S1078-1439(22)00026.
    Abstract     Related articles   

  587. LIN CH, Chang HH, Lai CR, Wang HH, et al
    Fatty Acid Binding Protein 6 Inhibition Decreases Cell Cycle Progression, Migration and Autophagy in Bladder Cancers.
    Int J Mol Sci. 2022;23.
    Abstract     Related articles   

  588. VENKATRAMANI V, Reis IM, Gonzalgo ML, Castle EP, et al
    Comparison of Robot-Assisted and Open Radical Cystectomy in Recovery of Patient-Reported and Performance-Related Measures of Independence: A Secondary Analysis of a Randomized Clinical Trial.
    JAMA Netw Open. 2022;5:e2148329.
    Abstract     Related articles   

  589. SINGHAL S, Ruprecht NA, Sens D, Tavakolian K, et al
    Association between Arsenic Level, Gene Expression in Asian Population, and In Vitro Carcinogenic Bladder Tumor.
    Oxid Med Cell Longev. 2022;2022:3459855.
    Abstract     Related articles   

  590. OLKHOV-MITSEL E, Hodgson A, Liu SK, Vesprini D, et al
    Upregulation of IFN-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinoma.
    Sci Rep. 2022;12:716.
    Abstract     Related articles   

  591. MA C, Wang J, Zhao N, Pan Z, et al
    Network Pharmacology-Based Study on the Active Component and Mechanism of the Anti-Non-Invasive and Invasive Bladder Urothelial Carcinoma Effects of Zhuling Jisheng Decoction.
    Comput Math Methods Med. 2021;2021:7667707.
    Abstract     Related articles   

  592. JIN HJ, Shim JS, Kwon TG, Kim TH, et al
    Gender-related outcomes in robot-assisted radical cystectomy: A multi-institutional study.
    Investig Clin Urol. 2022;63:53-62.
    Abstract     Related articles   

  593. LEE K, Jeong SH, Yoo SH, Ku JH, et al
    Evaluating the efficacy of secondary transurethral resection of the bladder for high-grade Ta tumors.
    Investig Clin Urol. 2022;63:14-20.
    Abstract     Related articles   

  594. CHAN TC, Chen YT, Tan KT, Wu CL, et al
    Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis.
    Clin Transl Med. 2021;11:e674.
    Abstract     Related articles   

  595. PEHALOVA L, Krejci D, Buchler T, Janosek J, et al
    Incidence, mortality and survival of bladder neoplasms in the Czech Republic in the period 1977-2017: a time trend analysis.
    Klin Onkol. 2021;34:467-476.
    Abstract     Related articles   

  596. KOBAYASHI S, Ito M, Takemura K, Suzuki H, et al
    Preoperative models incorporating the systemic immune-inflammation index for predicting prognosis and muscle invasion in patients with non-metastatic upper tract urothelial carcinoma.
    Int J Clin Oncol. 2022;27:574-584.
    Abstract     Related articles   

  597. MATSUMURA T, Inoue K, Toyooka K, Inoue M, et al
    Clinical trajectory of a patient with filaminopathy who developed arrhythmogenic cardiomyopathy, myofibrillar myopathy, and multiorgan tumors.
    Neuromuscul Disord. 2021;31:1282-1286.
    Abstract     Related articles   

  598. ZAKI SA, Hazeem AA, Rashid A
    Bacillus Calmette-Guerin scar reactivation in multisystem inflammatory syndrome in children.
    Trop Doct. 2022;52:222-223.
    Abstract     Related articles   

  599. TURAL D, Selcukbiricik F, Olmez OF, Sumbul AT, et al
    Response to first-line chemotherapy regimen is associated with efficacy of immune checkpoint blockade therapies in patients with metastatic urothelial carcinoma.
    Int J Clin Oncol. 2022;27:585-591.
    Abstract     Related articles   

  600. DA SILVA GOMES PR, Candido P, Ghazarian V, Camargo JA, et al
    Can increased expression of miR-Let-7c reduce the transition potential of high-grade urothelial carcinoma?
    Mol Biol Rep. 2021;48:7947-7952.
    Abstract     Related articles   

  601. GUPTA P, Kumar N, Garg M
    Emerging roles of autophagy in the development and treatment of urothelial carcinoma of the bladder.
    Expert Opin Ther Targets. 2021;25:787-797.
    Abstract     Related articles   

  602. LIEDBERG F
    Adjuvant checkpoint inhibition after cystectomy - why, when, and for whom?
    Scand J Urol. 2022;56:73-74.
    Abstract     Related articles   

  603. ALI D, Sawhney R, Billah M, Harrison R, et al
    Single-Port Robotic Radical Cystectomy with Intracorporeal Bowel Diversion: Initial Experience and Review of Surgical Outcomes.
    J Endourol. 2022;36:216-223.
    Abstract     Related articles   

  604. NIELSEN MO, Elversang J, Martin Poulsen A, Persson Theilgaard Z, et al
    A case of visible diffuse peritoneal Bacillus Calmette-Guerin infection at the time of planned radical cystectomy.
    Scand J Urol. 2021;55:505-506.
    Abstract     Related articles   

  605. NISHIYAMA N, Kobayashi T, Narita S, Hidaka Y, et al
    Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matching.
    J Geriatr Oncol. 2022;13:88-93.
    Abstract     Related articles   

  606. SERAG ELDIEN MM, Abdou AG, Elghrabawy GRA, Alhanafy AM, et al
    Stratification of urothelial bladder carcinoma depending on immunohistochemical expression of GATA3 and CK5/6.
    J Immunoassay Immunochem. 2021;42:662-678.
    Abstract     Related articles   

  607. VENKATRAMANI V, Parekh DJ
    Surgery for Bladder and Upper Tract Urothelial Cancer.
    Hematol Oncol Clin North Am. 2021;35:543-566.
    Abstract     Related articles   

  608. NADAL R, Clara JA, Valderrama BP, Bellmunt J, et al
    Current Therapy for Metastatic Urothelial Carcinoma.
    Hematol Oncol Clin North Am. 2021;35:469-493.
    Abstract     Related articles   

  609. JENSEN JB
    Patients with NMIBC with the highest risk of progression are correctly selected for cystectomy in Sweden.
    Scand J Urol. 2021;55:54-55.
    Abstract     Related articles   

  610. HEMDAN T, Einarsson R, Malmstrom PU
    The new classification of urinary cytology - is it an improvement?
    Scand J Urol. 2021;55:98-99.
    Abstract     Related articles   

  611. ZHANG X, Wei X, Qi J, Shen J, et al
    Simultaneous Detection of Bladder Cancer Exosomal MicroRNAs Based on Inorganic Nanoflare and DNAzyme Walker.
    Anal Chem. 2022 Mar 11. doi: 10.1021/acs.analchem.1c05588.
    Abstract     Related articles   

  612. TEODOROVICH OV, Shatokhin MN, Kholimenko IM, Abdullaev MI, et al
    [Application of laser technologies in the treatment of non-muscle-invasive bladder cancer].
    Urologiia. 2022;:89-95.
    Abstract     Related articles   

  613. NIK AB KADIR MN, Hairon SM, Yaacob NM, Ab Manan A, et al
    Prognostic Factors for Bladder Cancer Patients in Malaysia: A Population-Based Study.
    Int J Environ Res Public Health. 2022;19.
    Abstract     Related articles   

  614. HOEH B, Flammia RS, Hohenhorst L, Sorce G, et al
    Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical Cystectomy.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  615. JACYNA J, Kordalewska M, Artymowicz M, Markuszewski M, et al
    Pre- and Post-Resection Urine Metabolic Profiles of Bladder Cancer Patients: Results of Preliminary Studies on Time Series Metabolomics Analysis.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  616. GONZALEZ-DEL-ALBA A, Conde-Moreno AJ, Garcia Vicente AM, Gonzalez-Peramato P, et al
    Management of Patients with Metastatic Bladder Cancer in the Real-World Setting from the Multidisciplinary Team: Current Opinion of the SOGUG Multidisciplinary Working Group.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  617. OZLER S, Pazarci P
    Anti-tumoral effect of beta-blockers on prostate and bladder cancer cells via mitogen-activated protein kinase pathways.
    Anticancer Drugs. 2022;33:384-388.
    Abstract     Related articles   

  618. MULAWKAR PM, Sharma G, Tamhankar A, Shah U, et al
    Role of Macroscopic Image Enhancement in Diagnosis of Non-Muscle-Invasive Bladder Cancer: An Analytical Review.
    Front Surg. 2022;9:762027.
    Abstract     Related articles   

  619. SONG X, Xin S, Zhang Y, Mao J, et al
    Identification and Quantification of Iron Metabolism Landscape on Therapy and Prognosis in Bladder Cancer.
    Front Cell Dev Biol. 2022;10:810272.
    Abstract     Related articles   

  620. LUO Y, Tao T, Tao R, Huang G, et al
    Single-Cell Transcriptome Comparison of Bladder Cancer Reveals Its Ecosystem.
    Front Oncol. 2022;12:818147.
    Abstract     Related articles   

  621. ALANEE S, El-Zawahry A
    Robotic-Assisted Partial Cystectomy for Muscle Invasive Bladder Cancer: Contemporary Experience.
    Int J Med Robot. 2022 Mar 8:e2390. doi: 10.1002/rcs.2390.
    Abstract     Related articles   

  622. NERONI B, Zingaropoli MA, Radocchia G, Ciardi MR, et al
    Evaluation of the anti-proliferative activity of violacein, a natural pigment of bacterial origin, in urinary bladder cancer cell lines.
    Oncol Lett. 2022;23:132.
    Abstract     Related articles   

  623. NISHIHARA K, Ueda K, Kurose H, Ogasawara N, et al
    Survival outcomes of non-definitive therapy for muscle-invasive bladder cancer.
    Oncol Lett. 2022;23:126.
    Abstract     Related articles   

  624. IYA AM, Beyer K, Kotecha P, Kibaru J, et al
    Scoping review: bladder cancer in Nigeria - what are the gaps in clinical care and research?
    BMJ Open. 2022;12:e049241.
    Abstract     Related articles   

  625. KANO K, Ishiyama R, Yagisawa T, Odani K, et al
    [Primary Carcinoid Tumor of the Urinary Bladder : A Case Report].
    Hinyokika Kiyo. 2022;68:53-57.
    Abstract     Related articles   

  626. BELLUT L, Kunath F
    [Blue versus white light for transurethral resection of non-muscle invasive bladder cancer (Review)].
    Urologe A. 2022 Mar 8. pii: 10.1007/s00120-022-01790.
    Abstract     Related articles   

  627. POURKERMAN M, Rashidkhani B, Moslehi N
    Correlating Dietary Pattern and Bladder Cancer Risk Using Principal Component and Reduced Rank Regression Analyses.
    Nutr Cancer. 2022 Mar 7:1-9. doi: 10.1080/01635581.2022.2047739.
    Abstract     Related articles   

  628. NAKASATO T, Inoue T, Kato R, Nakagami Y, et al
    A case of complete response following the administration of pembrolizumab and metastasectomy for lung and bone metastases of bladder cancer.
    IJU Case Rep. 2021;5:92-94.
    Abstract     Related articles   

  629. DU H, Tao T, Xu S, Xu C, et al
    4-Methoxydalbergione Inhibits Bladder Cancer Cell Growth via Inducing Autophagy and Inhibiting Akt/ERK Signaling Pathway.
    Front Mol Biosci. 2022;8:789658.
    Abstract     Related articles   

  630. ZHAO J, Huang S, Tan D, Yang K, et al
    PGM1 and ENO1 Promote the Malignant Progression of Bladder Cancer via Comprehensive Analysis of the m6A Signature and Tumor Immune Infiltration.
    J Oncol. 2022;2022:8581805.
    Abstract     Related articles   

  631. PAPAETIS GS
    Pioglitazone, Bladder Cancer and the Presumption of Innocence.
    Curr Drug Saf. 2022 Mar 4. pii: CDS-EPUB-121335.
    Abstract     Related articles   

  632. TONYALI S
    Combining Clinical Parameters and Immunohistochemical Markers Might Strengthen Prediction of Recurrence of Non-Muscle Invasive Bladder Cancer.
    J Invest Surg. 2022 Mar 6:1-2. doi: 10.1080/08941939.2022.2047244.
    Abstract     Related articles   

  633. BEIJE N, de Kruijff IE, de Jong JJ, Klaver SO, et al
    Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.
    ESMO Open. 2022;7:100416.
    Abstract     Related articles   

  634. LIU KL, Yin YW, Lu BS, Niu YL, et al
    E2F6/KDM5C promotes SF3A3 expression and bladder cancer progression through a specific hypomethylated DNA promoter.
    Cancer Cell Int. 2022;22:109.
    Abstract     Related articles   

  635. XU D, Cao Q, Wang L, Wang J, et al
    A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer.
    Mol Cancer Ther. 2022 Feb 28. pii: 681956. doi: 10.1158/1535-7163.MCT-21-0613.
    Abstract     Related articles   

  636. WANG L, Hu C, Zhao Y, Hu X, et al
    Novel smac mimetic ASTX660 (Tolinapant) and TNF-alpha synergistically induce necroptosis in bladder cancer cells in vitro upon apoptosis inhibition.
    Biochem Biophys Res Commun. 2022;602:8-14.
    Abstract     Related articles   

  637. MOFID B, Razzaghdoust A, Ghajari M, Basiri A, et al
    The Oncological Outcomes of Neoadjuvant Gemcitabine plus Carboplatin versus Gemcitabine plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective Analysis.
    Urol J. 2022 Mar 5. pii: 6841. doi: 10.22037/uj.v19i.6841.
    Abstract     Related articles   

  638. PARAMANANTHAM Y, Chung I, Bm Said NA
    The role of tumour microenvironment-driven miRNAs in the chemoresistance of muscle-invasive bladder cancer-a review.
    Urol Oncol. 2022 Mar 1. pii: S1078-1439(22)00031.
    Abstract     Related articles   

  639. HAO J, Zhang W, Huang Z
    Bupivacaine modulates the apoptosis and ferroptosis in bladder cancer via phosphatidylinositol 3-kinase (PI3K)/AKT pathway.
    Bioengineered. 2022;13:6794-6806.
    Abstract     Related articles   

  640. KAO CC, Chang YL, Liu HY, Wu ST, et al
    DNA Hypomethylation Is Associated with the Overexpression of INHBA in Upper Tract Urothelial Carcinoma.
    Int J Mol Sci. 2022;23.
    Abstract     Related articles   

  641. PATELLI G, Zeppellini A, Spina F, Righetti E, et al
    The evolving panorama of HER2-targeted treatments in metastatic urothelial cancer: A systematic review and future perspectives.
    Cancer Treat Rev. 2022;104:102351.
    Abstract     Related articles   

  642. MARTINI A, Raggi D, Fallara G, Nocera L, et al
    Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis.
    Cancer Treat Rev. 2022;104:102360.
    Abstract     Related articles   

  643. IACOVINO ML, Miceli CC, De Felice M, Barone B, et al
    Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors.
    Int J Mol Sci. 2022;23.
    Abstract     Related articles   

  644. OKAMATSU Y, Tsubouchi K, Iwasaki T, Nakamura T, et al
    Recurrent Massive Hemothorax of Unknown Etiology in an 85-Year-Old Man.
    Chest. 2022;161:e103-e110.
    Abstract     Related articles   

  645. ALTAHA MA, Tarulli M, Bajwa J, Mafeld S, et al
    Endovascular coil embolization of inferior mesenteric artery to ileal-conduit fistula: a case report.
    BMC Urol. 2022;22:11.
    Abstract     Related articles   

  646. ALLEN G
    A Systematic Review and Meta-Analysis of Enhanced Recovery After Surgery Protocols for Radical Cystectomy.
    AORN J. 2022;115:186-189.
    Abstract     Related articles   

  647. ZHONG W, Yang M, Cheng S, Hou W, et al
    Identification of an IDO1-based immune classifier for survival prediction of upper tract urothelial carcinoma.
    Cancer Sci. 2022;113:852-863.
    Abstract     Related articles   

  648. YU J, Zheng J
    Comparative efficacy and safety of transurethral laser surgery with holmium laser, KTP laser, 2-micron laser or thulium laser for the treatment of non-muscle invasive bladder carcinoma: a protocol of network meta-analysis.
    BMJ Open. 2021;11:e055840.
    Abstract     Related articles   

  649. BAECKER D, Sagasser J, Karaman S, Hormann AA, et al
    Development of methylated cobalt-alkyne complexes with selective cytotoxicity against COX-positive cancer cell lines.
    Arch Pharm (Weinheim). 2022;355:e2100408.
    Abstract     Related articles   

  650. MEZA L, Malhotra J, Favorito C, Pal SK, et al
    Cabozantinib plus immunotherapy combinations in metastatic renal cell and urothelial carcinoma.
    Future Oncol. 2022;18:21-33.
    Abstract     Related articles   

  651. NORGAARD M, Andersen IT, Heide-Jorgensen U, Erichsen R, et al
    Ranitidine and Risk of Bladder and Kidney Cancer: A Population-Based Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2022;31:45-50.
    Abstract     Related articles   

  652. QUAQUARINI E, Saltalamacchia G, Tresoldi MM, Schmid M, et al
    Primary melanoma of the bladder: a case report and review of the literature.
    Eur Rev Med Pharmacol Sci. 2021;25:5122-5128.
    Abstract     Related articles   

  653. PAL SK, Frankel PH, Mortazavi A, Milowsky M, et al
    Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical Trial.
    JAMA Oncol. 2021;7:1536-1543.
    Abstract     Related articles   

  654. COLLINS K, Alkashash AM, Hwang M, Kaimakliotis HZ, et al
    Somatic-Type Yolk Sac Tumor Arising as a Predominant Component of Bladder Urothelial Carcinoma.
    Int J Surg Pathol. 2022;30:207-213.
    Abstract     Related articles   

  655. GUPTA M, Sancheti S, Sali AP, Somal PK, et al
    Ectopic Prostate Tissue Presenting as Urinary Bladder Tumor: The Imitation Game!
    Int J Surg Pathol. 2022;30:160-162.
    Abstract     Related articles   

  656. ZHENG G, Sundquist K, Sundquist J, Forsti A, et al
    Bladder and upper urinary tract cancers as first and second primary cancers.
    Cancer Rep (Hoboken). 2021;4:e1406.
    Abstract     Related articles   

  657. SHASH LS, Ibrahim RA, Elgohary SA
    E-cadherin and N-cadherin Immunohistochemical Expression in Proliferating Urothelial Lesions: Potential Novel Cancer Predictive EMT Profiles.
    Appl Immunohistochem Mol Morphol. 2021;29:657-666.
    Abstract     Related articles   

  658. FUJIWARA M, Yuasa T, Urasaki T, Komai Y, et al
    Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single-center analysis in Japan.
    Cancer Rep (Hoboken). 2021;4:e1398.
    Abstract     Related articles   

  659. KYRIAZOGLOU A, Beuselinck B
    Equivocal evaluation of progressive disease in patients treated with immune checkpoint inhibitors: a challenge for clinical trials and biomarker research.
    Acta Clin Belg. 2022;77:406-409.
    Abstract     Related articles   

  660. DELLI PIZZI A, Mastrodicasa D, Taraschi A, Civitareale N, et al
    Conspicuity and muscle-invasiveness assessment for bladder cancer using VI-RADS: a multi-reader, contrast-free MRI study to determine optimal b-values for diffusion-weighted imaging.
    Abdom Radiol (NY). 2022 Mar 18. pii: 10.1007/s00261-022-03490.
    Abstract     Related articles   

  661. COOK GS, Howard JM
    Patterns in the Management of Low-Grade Non-Muscle-Invasive Bladder Cancer-the Human and Economic Costs of Excessive Surveillance.
    JAMA Netw Open. 2022;5:e223055.
    Abstract     Related articles   

  662. BREE KK, Shan Y, Hensley PJ, Lobo N, et al
    Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non-Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013.
    JAMA Netw Open. 2022;5:e223050.
    Abstract     Related articles   

  663. SHANGGUAN W, Hu J, Xie Y, Chen Z, et al
    Conditional survival of trimodal therapy for nonmetastatic muscle-invasive bladder cancer: A SEER database analysis.
    Cancer Med. 2022 Mar 18. doi: 10.1002/cam4.4625.
    Abstract     Related articles   

  664. ROUPRET M, Gontero P, McCracken SRC, Dudderidge T, et al
    Reducing the Frequency of Follow-up Cystoscopy in Low-grade pTa Non-muscle-invasive Bladder Cancer Using the ADXBLADDER Biomarker.
    Eur Urol Focus. 2022 Mar 14. pii: S2405-4569(22)00051.
    Abstract     Related articles   

  665. ZHONG Z, Huang M, Lv M, He Y, et al
    Corrigendum to "Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway" [Cancer Letter 403(2017) 305-317].
    Cancer Lett. 2022 Mar 14:215631. doi: 10.1016/j.canlet.2022.215631.
    Abstract     Related articles   

  666. ZHANG M, Du G, Li Z, Li D, et al
    An Oxidative Stress-Related Genes Signature for Predicting Survival in Bladder Cancer: Based on TCGA Database and Bioinformatics.
    Int J Gen Med. 2022;15:2645-2667.
    Abstract     Related articles   

  667. LEMINSKI A, Kaczmarek K, Golab A, Kotfis K, et al
    Increased One-Year Mortality Among Elderly Patients After Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective, Observational Comparative Study.
    Clin Interv Aging. 2022;17:255-263.
    Abstract     Related articles   

  668. GHAFOURI-FARD S, Najafi S, Hussen BM, Basiri A, et al
    The Role of Circular RNAs in the Carcinogenesis of Bladder Cancer.
    Front Oncol. 2022;12:801842.
    Abstract     Related articles   

  669. YUAN Z, Guo G, Sun G, Li Q, et al
    Magnesium isoglycyrrhizinate suppresses bladder cancer progression by modulating the miR-26b/Nox4 axis.
    Bioengineered. 2022;13:7986-7999.
    Abstract     Related articles   

  670. MIAO L, Liu HY, Zhou C, He X, et al
    Correction to: LINC00612 enhances the proliferation and invasion ability of bladder cancer cells as ceRNA by sponging miR-590 to elevate expression of PHF14.
    J Exp Clin Cancer Res. 2022;41:103.
    Abstract     Related articles   

  671. LI D, Zhen F, Le J, Chen G, et al
    Identification of hub genes and pathways in bladder cancer using bioinformatics analysis.
    Am J Clin Exp Urol. 2022;10:13-24.
    Abstract     Related articles   

  672. DALLA E, Picco R, Novara G, Moro FD, et al
    Identification of a gene signature for the prediction of recurrence and progression in non-muscle-invasive bladder cancer.
    Mol Biomed. 2022;3:9.
    Abstract     Related articles   

  673. PAWAR D, Arif D, Raghunath A, Rehman S, et al
    Urothelial carcinoma with mandibular metastasis and synchronous prostate cancer.
    BMJ Case Rep. 2022;15.
    Abstract     Related articles   

  674. TELEKA S, Jochems SHJ, Jirstrom K, Stocks T, et al
    The interaction between smoking and bladder cancer genetic variants on urothelial cancer risk by disease aggressiveness.
    Cancer Med. 2022 Mar 13. doi: 10.1002/cam4.4654.
    Abstract     Related articles   

  675. WIECZOREK E, Farooqi AA, Reszka E
    Androgen receptor modulation and bladder cancer prevention - a short review.
    Med Pr. 2022 Mar 14. pii: 146548. doi: 10.13075/mp.5893.01229.
    Abstract     Related articles   

  676. MARTINI A, Raggi D, Marandino L, Montorsi F, et al
    The Paradoxical Role of Body Mass Index in Patients with Muscle-invasive Bladder Cancer Receiving Neoadjuvant Immunotherapy.
    Eur Urol Oncol. 2022 Mar 10. pii: S2588-9311(22)00030.
    Abstract     Related articles   

  677. ELUMALAI T, Croxford W, Buijtenhuijs B, Conroy R, et al
    Using Real-world Data to Define a Validated Nomogram for Advanced Bladder Cancer Patients Who Respond to Immunotherapy.
    Clin Oncol (R Coll Radiol). 2022 Mar 10. pii: S0936-6555(22)00106.
    Abstract     Related articles   

  678. WANG W, Liu X, Zhang C, Sheng F, et al
    Identification of two-dimensional copper signatures in human blood for bladder cancer with machine learning.
    Chem Sci. 2022;13:1648-1656.
    Abstract     Related articles   

  679. SOIPI S, Vucic M, Spajic B, Kruslin B, et al
    REVIEW OF THE BLADDER CANCER MOLECULAR CLASSIFICATION PROPOSED: A NEW ERA - NEW TAXONOMY.
    Acta Clin Croat. 2022;60:519-524.
    Abstract     Related articles   

  680. CHEN W, Jiang T, Mao H, Gao R, et al
    Erratum: Nodal Promotes the Migration and Invasion of Bladder Cancer Cells via Regulation of Snail: Erratum.
    J Cancer. 2022;13:1385.
    Abstract     Related articles   

  681. TONG S, Yin H, Fu J, Li Y, et al
    Niban apoptosis regulator 1 promotes gemcitabine resistance by activating the focal adhesion kinase signaling pathway in bladder cancer.
    J Cancer. 2022;13:1103-1118.
    Abstract     Related articles   

  682. ZHAN X, Chen T, Jiang M, Deng W, et al
    A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Muscle-Invasive Bladder Cancer Patients after Partial Cystectomy.
    J Oncol. 2022;2022:2665711.
    Abstract     Related articles   

  683. DONG Y, Hao L, Shi ZD, Fang K, et al
    Solasonine Induces Apoptosis and Inhibits Proliferation of Bladder Cancer Cells by Suppressing NRP1 Expression.
    J Oncol. 2022;2022:7261486.
    Abstract     Related articles   

  684. YE L, Chen Y, Xu H, Wang Z, et al
    Radiomics of Contrast-Enhanced Computed Tomography: A Potential Biomarker for Pretreatment Prediction of the Response to Bacillus Calmette-Guerin Immunotherapy in Non-Muscle-Invasive Bladder Cancer.
    Front Cell Dev Biol. 2022;10:814388.
    Abstract     Related articles   

  685. HU J, Lai C, Shen Z, Yu H, et al
    A Prognostic Model of Bladder Cancer Based on Metabolism-Related Long Non-Coding RNAs.
    Front Oncol. 2022;12:833763.
    Abstract     Related articles   

  686. ZHONG Z, Wang Z, Li Y, Zhong Y, et al
    Sintilimab treatment for ureteral carcinoma following bladder cancer leads to leukopenia: a case report.
    Transl Androl Urol. 2022;11:277-284.
    Abstract     Related articles   

  687. LIU S, Yao Y, Guan F, Sun L, et al
    Neoadjuvant Chemotherapy for Different Stages of Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Dis Markers. 2022;2022:8493519.
    Abstract     Related articles   

  688. ZHOU R, Liang J, Tian H, Chen Q, et al
    An Immunosenescence-Related Gene Signature to Evaluate the Prognosis, Immunotherapeutic Response, and Cisplatin Sensitivity of Bladder Cancer.
    Dis Markers. 2022;2022:2143892.
    Abstract     Related articles   

  689. YAN R, Dai W, Wu R, Huang H, et al
    Therapeutic targeting m6A-guided miR-146a-5p signaling contributes to the melittin-induced selective suppression of bladder cancer.
    Cancer Lett. 2022;534:215615.
    Abstract     Related articles   

  690. KULCHAVENYA EV, Kholtobin DP, Telina EV, Neymark AI, et al
    [Practice of urological departments during the COVID-19 pandemic].
    Urologiia. 2022;:35-40.
    Abstract     Related articles   

  691. CAMPOBASSO D, Puliatti S, Micali S, Maestroni UV, et al
    Conservative treatment of upper urinary tract urothelial carcinoma (UTUC) in patients with imperative indications: not only an option.
    Minerva Urol Nephrol. 2022;74:129-130.
    Abstract     Related articles   

  692. DEL GIUDICE F, Chung BI, Moschini M, Mari A, et al
    Comment on: Postoperative outcomes of Fast-Track-enhanced recovery protocol in open radical cystectomy: comparison with standard management in a high-volume center and Trifecta proposal.
    Minerva Urol Nephrol. 2022;74:119-121.
    Abstract     Related articles   

  693. KIM MS, Koom WS, Cho JH, Kim SY, et al
    Optimal management of recurrent and metastatic upper tract urothelial carcinoma: Implications of intensity modulated radiation therapy.
    Radiat Oncol. 2022;17:51.
    Abstract     Related articles   

  694. XIONG S, Huang W, Liu X, Chen Q, et al
    Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity and EMT Inhibition Via AKT and ERK Pathways in Human Urothelial Carcinoma.
    Cell Transplant. 2022;31:9636897221077921.
    Abstract     Related articles   

  695. WANG Z, Zhao Y, Shen X, Zhao Y, et al
    Single-Cell Genomics-Based Molecular Algorithm for Early Cancer Detection.
    Anal Chem. 2022;94:2607-2614.
    Abstract     Related articles   

  696. PHRUTTINARAKORN B, Plumworasawat S, Kayankarnnavee J, Lualon J, et al
    Application of the Paris Reporting System for Urine Cytology: The Three-Year Experience of a Single Tertiary Care Institute in Thailand.
    Acta Cytol. 2022;66:134-141.
    Abstract     Related articles   

  697. LI P, Qiao G, Lu J, Ji W, et al
    PVT1 is a prognostic marker associated with immune invasion of bladder urothelial carcinoma.
    Math Biosci Eng. 2022;19:169-190.
    Abstract     Related articles   

  698. ROPERTO S
    Role of BAG3 in bovine Deltapapillomavirus-mediated autophagy.
    J Cell Biochem. 2022;123:59-64.
    Abstract     Related articles   

  699. STRUCK JP, Schnoor M, Schulze A, Hupe MC, et al
    Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals.
    World J Urol. 2022;40:409-418.
    Abstract     Related articles   

  700. OSUMO B, Radzevich J, Nashed N, Ustwani O, et al
    Primary Parotid Non-Hodgkin's B-Cell Lymphoma in an Elderly Woman on Pembrolizumab for Metastatic Invasive Papillary Urothelial Cell Carcinoma of the Bladder.
    Am Surg. 2021 Nov 8:31348211054526. doi: 10.1177/00031348211054526.
    Abstract     Related articles   

  701. LI M, Xu X, Bechmann N, Pamporaki C, et al
    Differences in clinical presentation and management between pre- and postsurgical diagnoses of urinary bladder paraganglioma: is there clinical relevance? A systematic review.
    World J Urol. 2022;40:385-390.
    Abstract     Related articles   

  702. TARANTINO P, Modi S, Tolaney SM, Cortes J, et al
    Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates: A Review.
    JAMA Oncol. 2021;7:1873-1881.
    Abstract     Related articles   

  703. SUN K, Wang D, Wu G, Ma J, et al
    Mirabegron improves the irritative symptoms caused by BCG immunotherapy after transurethral resection of bladder tumors.
    Cancer Med. 2021;10:7534-7541.
    Abstract     Related articles   

  704. WARD M, Albertson D, Furtado LV, Deftereos G, et al
    PD-L1 Tumor Cell Expression in Upper Tract Urothelial Carcinomas is Associated With Higher Pathologic Stage.
    Appl Immunohistochem Mol Morphol. 2022;30:56-61.
    Abstract     Related articles   

  705. AFFERI L, Abufaraj M, Soria F, D'Andrea D, et al
    A comparison of perioperative outcomes of laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma: a propensity score matching analysis.
    Minerva Urol Nephrol. 2022;74:49-56.
    Abstract     Related articles   

  706. CEYLAN OM, Durukan AH, Uysal Y, Ozge G, et al
    Ocular Complications of Intravesicular BCG Treatment for Bladder Carcinoma.
    Ocul Immunol Inflamm. 2022;30:111-114.
    Abstract     Related articles   

  707. FENG F, Yang J, Chen A, Cui M, et al
    Long non-coding RNA long intergenic non-protein coding RNA 1232 promotes cell proliferation, migration and invasion in bladder cancer via modulating miR-370-5p/PIM3 axis.
    J Tissue Eng Regen Med. 2022 Mar 26. doi: 10.1002/term.3291.
    Abstract     Related articles   

  708. XU Y, Zeng H, Jin K, Liu Z, et al
    Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer.
    J Immunother Cancer. 2022;10.
    Abstract     Related articles   

  709. ROBERTS ME, Contreras-Sanz A, Black PC
    Establishing a Foundation for Studying the Immune Contexture Across the Spectrum of Bladder Cancer.
    Eur Urol Oncol. 2022 Mar 22. pii: S2588-9311(22)00032.
    Abstract     Related articles   

  710. WILSON F, Joseph N, Choudhury A
    Biomarkers in muscle invasive bladder cancer.
    Adv Clin Chem. 2022;107:265-297.
    Abstract     Related articles   

  711. WIGNER P, Bijak M, Saluk-Bijak J
    Clinical Potential of Fruit in Bladder Cancer Prevention and Treatment.
    Nutrients. 2022;14.
    Abstract     Related articles   

  712. CLAPS F, Mir C, Rubio-Briones J
    Optimization of the different therapeutic strategies in muscle invasive bladder cancer using biomarkers.
    Arch Esp Urol. 2022;75:144-155.
    Abstract     Related articles   

  713. LOZANO F, Raventos CX, Carrion A, Trilla E, et al
    [Optimization biomarkers in the surveillance of non muscle invasive bladder cancer.]
    Arch Esp Urol. 2022;75:133-143.
    Abstract     Related articles   

  714. DOMINGUEZ ESCRIG JL, Rubio Briones J
    Urinary biomarkers for the optimization of bladder cancer screening.
    Arch Esp Urol. 2022;75:126-132.
    Abstract     Related articles   

  715. TAN Z, Fu S, Huang Y, Duan X, et al
    HSPB8 is a Potential Prognostic Biomarker that Correlates With Immune Cell Infiltration in Bladder Cancer.
    Front Genet. 2022;13:804858.
    Abstract     Related articles   

  716. AHN JH, Kang CK, Kim EM, Kim AR, et al
    Proteomics for Early Detection of Non-Muscle-Invasive Bladder Cancer: Clinically Useful Urine Protein Biomarkers.
    Life (Basel). 2022;12.
    Abstract     Related articles   

  717. ORTIZ-BONILLA CJ, Uccello TP, Gerber SA, Lord EM, et al
    Bladder Cancer Extracellular Vesicles Elicit a CD8 T Cell-Mediated Antitumor Immunity.
    Int J Mol Sci. 2022;23.
    Abstract     Related articles   

  718. FERRO M, Tataru OS, Musi G, Lucarelli G, et al
    Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy.
    Diagnostics (Basel). 2022;12.
    Abstract     Related articles   

  719. TAKEUCHI T, Hattori-Kato M, Okuno Y, Zaitsu M, et al
    Genome-Wide Association Study Adjusted for Occupational and Environmental Factors for Bladder Cancer Susceptibility.
    Genes (Basel). 2022;13.
    Abstract     Related articles   

  720. WESSOLLY M, Mairinger FD, Herold T, Hadaschik B, et al
    Proteasomal Processing Immune Escape Mechanisms in Platinum-Treated Advanced Bladder Cancer.
    Genes (Basel). 2022;13.
    Abstract     Related articles   

  721. LAMY L, Thomas J, Leroux A, Bisson JF, et al
    Antitumor Effect and Induced Immune Response Following Exposure of Hexaminolevulinate and Blue Light in Combination with Checkpoint Inhibitor in an Orthotopic Model of Rat Bladder Cancer.
    Biomedicines. 2022;10.
    Abstract     Related articles   

  722. MORI K, Matsumoto K, Amano N, Koguchi D, et al
    Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  723. HUAN J, Grivas P, Birch J, Hansel DE, et al
    Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  724. BOROWCZAK J, Szczerbowski K, Maniewski M, Zdrenka M, et al
    The Prognostic Role of CDK9 in Bladder Cancer.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  725. SZKLENER K, Chmiel P, Michalski A, Mandziuk S, et al
    New Directions and Challenges in Targeted Therapies of Advanced Bladder Cancer: The Role of FGFR Inhibitors.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  726. RASTEIRO AM, Sa E Lemos E, Oliveira PA, Gil da Costa RM, et al
    Molecular Markers in Urinary Bladder Cancer: Applications for Diagnosis, Prognosis and Therapy.
    Vet Sci. 2022;9.
    Abstract     Related articles   

  727. SINHA A, West A, Hayes J, Teoh J, et al
    Methods of Sentinel Lymph Node Detection and Management in Urinary Bladder Cancer-A Narrative Review.
    Curr Oncol. 2022;29:1335-1348.
    Abstract     Related articles   

  728. WANG J, Zhao X, Jiang XL, Lu D, et al
    Diagnostic performance of nuclear matrix protein 22 and urine cytology for bladder cancer: A meta-analysis.
    Diagn Cytopathol. 2022 Mar 24. doi: 10.1002/dc.24954.
    Abstract     Related articles   

  729. NOTGHI AAA, Hosseini F, Tsogas N
    Severe diffuse proliferative bronchiolitis complicating culture-proven disseminated BCG infection after intravesical instillation for bladder cancer.
    BMJ Case Rep. 2022;15.
    Abstract     Related articles   

  730. ROBLES VEGA J, Yankovic Barcelo F
    [Inverted urothelial papilloma of the bladder in an adolescent].
    Andes Pediatr. 2021;92:777-780.
    Abstract     Related articles   

  731. WU S, Xu H, Zhang R, Wang X, et al
    Circular RNA circLAMA3 inhibits the proliferation of bladder cancer by directly binding an mRNA.
    Mol Ther Oncolytics. 2022;24:742-754.
    Abstract     Related articles   

  732. EL AHANIDI H, El Azzouzi M, Arrouchi H, Alaoui CH, et al
    AKT1 and PIK3CA activating mutations in Moroccan bladder cancer patients biopsies and matched urine.
    Pan Afr Med J. 2022;41:59.
    Abstract     Related articles   


  733. [Expert consensus of multi-disciplinary collaboration on bladder-preserving treatment for bladder cancer in China].
    Zhonghua Zhong Liu Za Zhi. 2022;44:209-218.
    Abstract     Related articles   

  734. SUN D, Hadjiiski L, Alva A, Zakharia Y, et al
    Computerized Decision Support for Bladder Cancer Treatment Response Assessment in CT Urography: Effect on Diagnostic Accuracy in Multi-Institution Multi-Specialty Study.
    Tomography. 2022;8:644-656.
    Abstract     Related articles   

  735. MASUDA T, Tanaka N, Takamatsu K, Hakozaki K, et al
    Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer.
    J Immunother Cancer. 2022;10.
    Abstract     Related articles   

  736. MOTTERLE G, Morlacco A, Giovannini G, Vecchiato E, et al
    Role of Renin-Angiotensin System Blockers on BCG Response in Nonmuscle Invasive, High Risk Bladder Cancer.
    Clin Genitourin Cancer. 2022 Feb 24. pii: S1558-7673(22)00044.
    Abstract     Related articles   

  737. GAKIS G, Schmid MA, Hassan F, Stenzl A, et al
    The Predictive and Prognostic Value of Precystectomy Serum Gamma-Glutamyltransferase Levels in Patients With Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2022 Feb 24. pii: S1558-7673(22)00041.
    Abstract     Related articles   

  738. CHEN YH, Tseng JS
    Concurrent urachal abscess and florid cystitis glandularis masquerading as malignancy: a case report and literature review.
    BMC Surg. 2022;22:105.
    Abstract     Related articles   

  739. HUANG KC, Chanda D, McGrath S, Dixit V, et al
    Pharmacological Activation of STING in Bladder Induces Potent Anti-tumor Immunity in Non-Muscle Invasive Murine Bladder Cancer.
    Mol Cancer Ther. 2022 Mar 21. pii: 682323. doi: 10.1158/1535-7163.MCT-21-0780.
    Abstract     Related articles   

  740. HONG JH, Tong ZJ, Wei TE, Lu YC, et al
    Cigarette smoke containing acrolein contributes to cisplatin resistance in human bladder cancers through the regulation of HER2 pathway or FGFR3 pathway.
    Mol Cancer Ther. 2022 Mar 21. pii: 682320. doi: 10.1158/1535-7163.MCT-21-0725.
    Abstract     Related articles   

  741. CHEN Y, Ji S, Ying J, Sun Y, et al
    KRT6A expedites bladder cancer progression, regulated by miR-31-5p.
    Cell Cycle. 2022 Mar 20:1-12. doi: 10.1080/15384101.2022.2054095.
    Abstract     Related articles   

  742. DENG H, Tang F, Zhou M, Shan D, et al
    Identification and Validation of N6-Methyladenosine-Related Biomarkers for Bladder Cancer: Implications for Immunotherapy.
    Front Oncol. 2022;12:820242.
    Abstract     Related articles   

  743. SU F, Liu M, Zhang W, Tang M, et al
    Bacillus Calmette-Guerin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer.
    Front Oncol. 2022;12:842182.
    Abstract     Related articles   

  744. DU Y, Sui Y, Cao J, Jiang X, et al
    Dynamic Changes in Myofibroblasts Affect the Carcinogenesis and Prognosis of Bladder Cancer Associated With Tumor Microenvironment Remodeling.
    Front Cell Dev Biol. 2022;10:833578.
    Abstract     Related articles   

  745. ZHENG H, Luo W, Li Y, Peng G, et al
    Identification and Development of Inflammatory Response-Related Genes Signature Associated With Prognosis Evaluation and Immune Status of Bladder Cancer.
    Front Cell Dev Biol. 2022;10:837849.
    Abstract     Related articles   

  746. BEARDO P, Pinto R, Ayerra H, Aguera J, et al
    Optimizing treatment for non muscle-invasive bladder cancer with an app.
    Actas Urol Esp (Engl Ed). 2022 Mar 17. pii: S2173-5786(22)00026.
    Abstract     Related articles   

  747. MAIORANO S, Gulden-Sala W, Gerber B, Ghilardi G, et al
    Anti-PD-L1 monoclonal antibody for the management of chronic disseminated intravascular coagulation secondary to a urothelial carcinoma: a case report.
    J Med Case Rep. 2022;16:113.
    Abstract     Related articles   

  748. ZHANG X, Wang Y, Zhang J, Xu X, et al
    Muscle-invasive bladder cancer: pretreatment prediction of response to neoadjuvant chemotherapy with diffusion-weighted MR imaging.
    Abdom Radiol (NY). 2022 Mar 20. pii: 10.1007/s00261-022-03455.
    Abstract     Related articles   

  749. HU C, Shang X, Zheng T, Hu X, et al
    Ipatasertib (GDC-0068) and erdafitinib co-treatment for inducing mitochondrial apoptosis through Bim upregulation in bladder cancer cells.
    Biochem Biophys Res Commun. 2022;604:165-171.
    Abstract     Related articles   

  750. RAMMANT E, Leung TM, Gore JL, Berry D, et al
    Associations of self-efficacy, social support and coping strategies with health-related quality of life after radical cystectomy for bladder cancer: A cross-sectional study.
    Eur J Cancer Care (Engl). 2022 Mar 18. doi: 10.1111/ecc.13571.
    Abstract     Related articles   

  751. DANG E, Vallee A, Lepage-Seydoux C, Sejean K, et al
    Clinical Benefit of Pembrolizumab in Advanced Urothelial Cancer Patients in Real-Life Setting: An Efficacy and Safety Monocentric Study.
    Curr Oncol. 2022;29:945-955.
    Abstract     Related articles   

  752. CALIFANO G, Ouzaid I, Laine-Caroff P, Peyrottes A, et al
    Current Advances in Immune Checkpoint Inhibition and Clinical Genomics in Upper Tract Urothelial Carcinoma: State of the Art.
    Curr Oncol. 2022;29:687-697.
    Abstract     Related articles   

  753. LI X, Wan Z, Liu X, Ou K, et al
    A 12-chemokine gene signature is associated with the enhanced immunogram scores and is relevant for precision immunotherapy.
    Med Oncol. 2022;39:43.
    Abstract     Related articles   

  754. NIEGISCH G, von Amsberg G, Rehlinghaus M, Grunewald CM, et al
    [Metastatic urothelial carcinoma-guideline-based therapy and new options].
    Urologe A. 2022;61:265-272.
    Abstract     Related articles   

  755. CHEN S, Cui J, Sun H, Wang W, et al
    "Two-zone and Three-segment" Laparoscopic Radical Cystectomy vs Conventional Laparoscopic Radical Cystectomy for Male Patients With Bladder Urothelial Carcinoma: A Retrospective Analysis.
    Urol J. 2022;19:34-40.
    Abstract     Related articles   

  756. LU J, Zhao M, Wu C, Chu C, et al
    Comparison of RNAscope and immunohistochemistry for evaluation of the UPK2 status in urothelial carcinoma tissues.
    Diagn Pathol. 2022;17:10.
    Abstract     Related articles   

  757. SAMAL V, Jirasek T, Paldus V, Richter I, et al
    Urachal yolk sac tumor penetrating the bladder as a diagnostic challenge: a case report and review of the literature.
    Diagn Pathol. 2022;17:8.
    Abstract     Related articles   

  758. ZHANG J, Bai X, Yuan J, Zhang X, et al
    Bladder paraganglioma: CT and MR imaging characteristics in 16 patients.
    Radiol Oncol. 2021;56:46-53.
    Abstract     Related articles   

  759. LUO S, Wang W, Feng J, Li R, et al
    TEX10 Promotes the Tumorigenesis and Radiotherapy Resistance of Urinary Bladder Carcinoma by Stabilizing XRCC6.
    J Immunol Res. 2021;2021:5975893.
    Abstract     Related articles   

  760. HAUDEBERT C, Hascoet J, Freton L, Khene ZE, et al
    Cystectomy and ileal conduit for neurogenic bladder: Comparison of the open, laparoscopic and robotic approaches.
    Neurourol Urodyn. 2022;41:601-608.
    Abstract     Related articles   

  761. KERIOUI M, Desmee S, Mercier F, Lin A, et al
    Assessing the impact of organ-specific lesion dynamics on survival in patients with recurrent urothelial carcinoma treated with atezolizumab or chemotherapy.
    ESMO Open. 2022;7:100346.
    Abstract     Related articles   

  762. ISHIYAMA Y, Kondo T, Ishihara H, Yoshida K, et al
    Association between Ureteral Clamping Time and Acute Kidney Injury during Robot-Assisted Radical Cystectomy.
    Curr Oncol. 2021;28:4986-4997.
    Abstract     Related articles   

  763. SINGH A, Gupta N, Khandakar H, Kaushal S, et al
    Autophagy-associated HMGB-1 as a novel potential circulating non-invasive diagnostic marker for detection of Urothelial Carcinoma of Bladder.
    Mol Cell Biochem. 2022;477:493-505.
    Abstract     Related articles   

  764. DONG Y, Zhu GY, Hao L, Liang Q, et al
    High S100A7 expression is associated with early muscle invasion and poor survival in bladder carcinoma.
    Ann Diagn Pathol. 2022;56:151847.
    Abstract     Related articles   

  765. WEI H, Wang M, Wasilijiang W, Zhou X, et al
    Propensity score-matched analysis for ileal conduit and orthotopic neobladder intracorporeally accomplished following laparoscopic radical cystectomy.
    Asian J Surg. 2022;45:987-992.
    Abstract     Related articles   

  766. LENIS AT, Litwin MS
    Does Artificial Intelligence Meaningfully Enhance Cystoscopy?
    J Natl Cancer Inst. 2022;114:174-175.
    Abstract     Related articles   

  767. SARIER M, Usta SS, Turgut H, Ozturk SA, et al
    Prognostic value of HPV DNA in Urothelial Carcinoma of the Bladder: A Preliminary Report of 2-Year Follow-up Results.
    Urol J. 2021;19:45-49.
    Abstract     Related articles   

  768. KRIMPHOVE MJ, Szymaniak J, Marchese M, Tully KH, et al
    Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy.
    Eur Urol Focus. 2021;7:124-131.
    Abstract     Related articles   

  769. LAMBERT E, D'Hondt F, Mazzone E, Vollemaere J, et al
    Time to Move On: The Impending Need for a New Disease-specific Comorbidity Index for Bladder Cancer Patients Undergoing Robot-assisted Radical Cystectomy.
    Eur Urol Focus. 2021;7:139-141.
    Abstract     Related articles   

  770. MINNELLA EM, Awasthi R, Bousquet-Dion G, Ferreira V, et al
    Multimodal Prehabilitation to Enhance Functional Capacity Following Radical Cystectomy: A Randomized Controlled Trial.
    Eur Urol Focus. 2021;7:132-138.
    Abstract     Related articles   

  771. WU SC, Kwon D, Jue JS, Chen FV, et al
    Androgen Suppression Therapy Is Associated with Lower Recurrence of Non-muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2021;7:142-147.
    Abstract     Related articles   

  772. JUBBER I, Pang KH, Groves R, Reed O, et al
    Impact of Anaesthetist Volume on Radical Cystectomy Outcomes.
    Eur Urol Focus. 2021;7:117-123.
    Abstract     Related articles   

  773. XU T, Junge JA, Delfarah A, Lu YT, et al
    Bladder cancer cells shift rapidly and spontaneously to cisplatin-resistant oxidative phosphorylation that is trackable in real time.
    Sci Rep. 2022;12:5518.
    Abstract     Related articles   

  774. MOISOIU T, Dragomir MP, Iancu SD, Schallenberg S, et al
    Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer.
    Mol Med. 2022;28:39.
    Abstract     Related articles   

  775. WU X, Cao W, Lu C, Zuo L, et al
    circ3323 Motivates Host Gene to Promote the Aggressiveness of Bladder Cancer.
    Biochem Genet. 2022 Apr 1. pii: 10.1007/s10528-022-10210.
    Abstract     Related articles   

  776. YE L, Chen Y, Xu H, Xie H, et al
    Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: a systematic review and meta-analysis.
    Eur Radiol. 2022 Apr 1. pii: 10.1007/s00330-022-08696.
    Abstract     Related articles   

  777. TEOH JY, Kamat AM, Black PC, Grivas P, et al
    Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective.
    Nat Rev Urol. 2022 Mar 31. pii: 10.1038/s41585-022-00578.
    Abstract     Related articles   

  778. ZHANG Y, Huo F, Cao Q, Jia R, et al
    FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer.
    J Immunother Cancer. 2022;10.
    Abstract     Related articles   

  779. YUAN S, Zhai Y, Tao T, Zhang X, et al
    Conflicting Roles of ZFP36L1 in Regulating the Progression of Muscle Invasive Bladder Cancer.
    Front Mol Biosci. 2022;9:687786.
    Abstract     Related articles   

  780. ASTROM LM, Behrens CP, Calmels L, Sjostrom D, et al
    Online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: initial experience and dosimetric benefits.
    Radiother Oncol. 2022 Mar 28. pii: S0167-8140(22)00152.
    Abstract     Related articles   

  781. ZHANG X, Xiong H, Zhao Y, Lin S, et al
    Circular RNA LONP2 regulates proliferation, invasion, and apoptosis of bladder cancer cells by sponging microRNA-584-5p.
    Bioengineered. 2022;13:8823-8835.
    Abstract     Related articles   

  782. GRUNEWALD CM, Feldmeier V, Supprian T, Albers P, et al
    Cognitive function in patients undergoing cystectomy for bladder cancer - results from a prospective observational study.
    Ther Adv Urol. 2022;14:17562872221087660.
    Abstract     Related articles   

  783. GUALLAR-GARRIDO S, Campo-Perez V, Perez-Trujillo M, Cabrera C, et al
    Mycobacterial surface characters remodeled by growth conditions drive different tumor-infiltrating cells and systemic IFN-gamma/IL-17 release in bladder cancer treatment.
    Oncoimmunology. 2022;11:2051845.
    Abstract     Related articles   

  784. KITAMURA K, Isotani S, Muto S, Horie S, et al
    Efficacy of pembrolizumab in a rare type of bladder cancer arising 25 years after augmentation cystoplasty.
    BMJ Case Rep. 2022;15.
    Abstract     Related articles   

  785. THANGAVELU M, Ismail A, Zakaria A, Elmansy H, et al
    Aristolochic acid: What urologists should know.
    Arch Ital Urol Androl. 2022;94:123-125.
    Abstract     Related articles   

  786. MEHRNOUSH V, Keramati S, Ismail A, Shabana W, et al
    Adverse pathological outcomes of patients with de novo muscle invasive bladder cancer in Northern Ontario.
    Arch Ital Urol Androl. 2022;94:41-45.
    Abstract     Related articles   

  787. DURSUN F, Elshabrawy A, Wang H, Wu S, et al
    Histological variants of non-muscle invasive bladder cancer: Survival outcomes of radical cystectomy vs. bladder preservation therapy.
    Urol Oncol. 2022 Mar 26. pii: S1078-1439(22)00039.
    Abstract     Related articles   

  788. LIU J, Zhu X, Yu L, Mao M, et al
    Discovery of novel sulphonamide hybrids that inhibit LSD1 against bladder cancer cells.
    J Enzyme Inhib Med Chem. 2022;37:866-875.
    Abstract     Related articles   

  789. ZHOU W, He L, Dai Y, Zhang Y, et al
    MicroRNA-124 inhibits cell proliferation, invasion and migration by targeting CAV1 in bladder cancer.
    Exp Ther Med. 2022;23:312.
    Abstract     Related articles   

  790. TRAN TML, Abdelrahman H, Tran C, Abraham R, et al
    A Curious Case of Hypercalcemia.
    R I Med J (2013). 2022;105:39-41.
    Abstract     Related articles   

  791. NOVRUZOV E, Dendl K, Ndlovu H, Choyke PL, et al
    Head-to-head Intra-individual Comparison of [(68)Ga]-FAPI and [(18)F]-FDG PET/CT in Patients with Bladder Cancer.
    Mol Imaging Biol. 2022 Mar 29. pii: 10.1007/s11307-022-01715.
    Abstract     Related articles   

  792. VALDERRAMA BP, Gonzalez-Del-Alba A, Morales-Barrera R, Pelaez Fernandez I, et al
    SEOM-SOGUG clinical guideline for localized muscle invasive and advanced bladder cancer (2021).
    Clin Transl Oncol. 2022 Mar 26. pii: 10.1007/s12094-022-02815.
    Abstract     Related articles   

  793. YU K, Du Z, Xuan H, Chen Q, et al
    Comprehensive analysis based in silico study of organophosphate flame retardants - environmental explanation of bladder cancer progression.
    Environ Toxicol Pharmacol. 2022;92:103851.
    Abstract     Related articles   

  794. TAGUCHI S, Watanabe M, Tambo M, Machida H, et al
    Proposal for a New Vesical Imaging-Reporting and Data System (VI-RADS)-Based Algorithm for the Management of Bladder Cancer: A Paradigm Shift From the Current Transurethral Resection of Bladder Tumor (TURBT)-Dependent Practice.
    Clin Genitourin Cancer. 2022 Mar 4. pii: S1558-7673(22)00047.
    Abstract     Related articles   

  795. FREITAS NR, Vieira PM, Cordeiro A, Tinoco C, et al
    Detection of bladder cancer with feature fusion, transfer learning and CapsNets.
    Artif Intell Med. 2022;126:102275.
    Abstract     Related articles   

  796. MALLY D, Pfister D, Heidenreich A, Albers P, et al
    [Does robotic radical cystectomy affect oncological outcomes in bladder cancer patients?]
    Aktuelle Urol. 2022;53:153-158.
    Abstract     Related articles   

  797. FAN W, Xiong Q, Ge Y, Liu T, et al
    Identifying the grade of bladder cancer cells using microfluidic chips based on impedance.
    Analyst. 2022 Mar 28. doi: 10.1039/d2an00026.
    Abstract     Related articles   

  798. ZHANG L, Shao G, Shao J, Zhao J, et al
    PRMT5-activated c-Myc promote bladder cancer proliferation and invasion through up-regulating NF-kappaB pathway.
    Tissue Cell. 2022;76:101788.
    Abstract     Related articles   

  799. DANCIK GM, Theodorescu D
    Using Cell Lines To Guide Neoadjuvant Therapy in Bladder Cancer: COXEN and SWOG S1314.
    Eur Urol Focus. 2022 Mar 23. pii: S2405-4569(22)00067.
    Abstract     Related articles   

  800. BUAC NP, Khusid JA, Sturgis MR, Gupta M, et al
    Disparities in patient and system factors explain racial/ethnic disparities in delayed time to treatment in muscle invasive bladder cancer.
    Urol Oncol. 2022 Mar 23. pii: S1078-1439(22)00060.
    Abstract     Related articles   

  801. OKA T, Matsuzaki K, Izumi H, Nonomura D, et al
    Osteosarcoma of the bladder: a case report.
    J Med Case Rep. 2022;16:118.
    Abstract     Related articles   

  802. LI K, Yang X, Zhuang J, Cai L, et al
    External validation of Pentafecta in patients undergoing laparoscopic radical cystectomy: results from a high-volume center.
    BMC Urol. 2022;22:41.
    Abstract     Related articles   

  803. KAWAI T, Taguchi S, Nakagawa T, Kamei J, et al
    Impact of immune-related adverse events on the therapeutic efficacy of pembrolizumab in urothelial carcinoma: a multicenter retrospective study using time-dependent analysis.
    J Immunother Cancer. 2022;10.
    Abstract     Related articles   

  804. CHEN C, Shang A, Sun Z, Gao Y, et al
    Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma.
    J Immunol Res. 2022;2022:9038808.
    Abstract     Related articles   

  805. KADKHODA S, Ghafouri-Fard S
    Function of miRNA-145-5p in the pathogenesis of human disorders.
    Pathol Res Pract. 2022;231:153780.
    Abstract     Related articles   

  806. RIZZO A, Mollica V, Santoni M, Ricci AD, et al
    Impact of clinicopathological features on immune-based combinations for advanced urothelial carcinoma: a meta-analysis.
    Future Oncol. 2022;18:739-748.
    Abstract     Related articles   

  807. SAMADDAR S, Mazur J, Sargent J, Thompson DH, et al
    Immunostimulatory Response of RWFV Peptide-Targeted Lipid Nanoparticles on Bladder Tumor Associated Cells.
    ACS Appl Bio Mater. 2021;4:3178-3188.
    Abstract     Related articles   

  808. HENG HG, Ramos-Vara JA, Fulkerson CM, Fourez LM, et al
    Ultrasonographic detection of apex nodules in the urinary bladder of Scottish Terriers.
    Vet Radiol Ultrasound. 2022;63:234-239.
    Abstract     Related articles   

  809. LOUAR M, Morel-Journel N, Ruffion A, Carnicelli D, et al
    Female Sexual Function and Body Image After Urinary Diversion for Benign Conditions.
    J Sex Med. 2022;19:263-269.
    Abstract     Related articles   

  810. BROSE A, Krombach GA, Roller FC

    Rofo. 2022;194:205-207.
    Abstract     Related articles   

  811. SASAKI Y, Takahashi M, Fukuta K, Shiozaki K, et al
    The patient-side surgeon plays a key role in facilitating robot-assisted intracorporeal ileal conduit urinary diversion in men.
    J Robot Surg. 2022;16:437-444.
    Abstract     Related articles   

  812. NIELENS N, Marot L, Baeck M
    Sporotrichoid distributed tuberculous panniculitis as a late complication of intravesical bacillus Calmette-Guerin (BCG) immunotherapy.
    Int J Infect Dis. 2022;117:247-250.
    Abstract     Related articles   

  813. DE BROT S, Lothion-Roy J, Grau-Roma L, White E, et al
    Histological and immunohistochemical investigation of canine prostate carcinoma with identification of common intraductal carcinoma component.
    Vet Comp Oncol. 2022;20:38-49.
    Abstract     Related articles   

  814. VECCIA A, Carbonara U, Derweesh I, Mehrazin R, et al
    Single-stage Xi(R) robotic radical nephroureterectomy for upper tract urothelial carcinoma: surgical technique and outcomes.
    Minerva Urol Nephrol. 2022;74:233-241.
    Abstract     Related articles   

  815. HIROTSU KE, Rana J, Wang JY, Raghavan SS, et al
    Clinicopathologic characterization of enfortumab vedotin-associated cutaneous toxicity in patients with urothelial carcinoma.
    J Am Acad Dermatol. 2021;85:1610-1611.
    Abstract     Related articles   

  816. DELL'OGLIO P, Mazzone E, Lambert E, Vollemaere J, et al
    The Effect of Surgical Experience on Perioperative and Oncological Outcomes After Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Evidence from a Referral Centre with Extensive Experience in Robotic Surgery.
    Eur Urol Focus. 2021;7:352-358.
    Abstract     Related articles   

  817. OURFALI S, Ohannessian R, Fassi-Fehri H, Pages A, et al
    Recurrence Rate and Cost Consequence of the Shortage of Bacillus Calmette-Guerin Connaught Strain for Bladder Cancer Patients.
    Eur Urol Focus. 2021;7:111-116.
    Abstract     Related articles   

  818. YANG J, Qi M, Fei X, Wang X, et al
    Hsa_circRNA_0088036 acts as a ceRNA to promote bladder cancer progression by sponging miR-140-3p.
    Cell Death Dis. 2022;13:322.
    Abstract     Related articles   

  819. STONE L
    Urinary VOCs as bladder cancer biomarkers.
    Nat Rev Urol. 2022 Apr 8. pii: 10.1038/s41585-022-00595.
    Abstract     Related articles   

  820. SUN B, Bte Rahmat JN, Kim HJ, Mahendran R, et al
    Wirelessly Activated Nanotherapeutics for In Vivo Programmable Photodynamic-Chemotherapy of Orthotopic Bladder Cancer.
    Adv Sci (Weinh). 2022 Apr 7:e2200731. doi: 10.1002/advs.202200731.
    Abstract     Related articles   

  821. LAI LY, Tafuri SM, Ginier EC, Herrel LA, et al
    Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer.
    Cochrane Database Syst Rev. 2022;4:CD014887.
    Abstract     Related articles   

  822. ABEDI Z, MotieGhader H, Hosseini SS, Sheikh Beig Goharrizi MA, et al
    mRNA-miRNA bipartite networks reconstruction in different tissues of bladder cancer based on gene co-expression network analysis.
    Sci Rep. 2022;12:5885.
    Abstract     Related articles   

  823. MCLOUGHLIN LC, O'Halloran S, Tjong M, Ajib K, et al
    The prognostic value of urinary cytology after trimodal therapy (TMT) for muscle-invasive bladder cancer.
    Urol Oncol. 2022 Apr 4. pii: S1078-1439(22)00072.
    Abstract     Related articles   

  824. XIONG Q, Feng D, Wang Z, Ying Y, et al
    Fatty Acid Synthase Is the Key Regulator of Fatty Acid Metabolism and Is Related to Immunotherapy in Bladder Cancer.
    Front Immunol. 2022;13:836939.
    Abstract     Related articles   

  825. MAEYAMA R, Ikeda M, Shimura S, Amano N, et al
    Patients with Non-Muscle Invasive Bladder Cancer Previously Treated with Nephroureterectomy Have a High Risk of Recurrence after Bacillus Calmette-Guerin Intravesical Instillation Therapy.
    Chemotherapy. 2022 Apr 7. pii: 000524449. doi: 10.1159/000524449.
    Abstract     Related articles   

  826. YU J, Cai L, Chen C, Fu X, et al
    Cascade Path Augmentation Unet for Bladder Cancer Segmentation in MRI.
    Med Phys. 2022 Apr 7. doi: 10.1002/mp.15646.
    Abstract     Related articles   

  827. ABUHASANEIN S, Jahnson S, Aljabery F, Gardmark T, et al
    Standardized care pathways for patients with suspected urinary bladder cancer: the Swedish experience.
    Scand J Urol. 2022 Apr 7:1-6. doi: 10.1080/21681805.2022.2058605.
    Abstract     Related articles   

  828. JIANG Y, Zhang Z, Wang X, Feng Z, et al
    A Novel Prognostic Factor TIPE2 in Bladder Cancer.
    Pathol Oncol Res. 2022;28:1610282.
    Abstract     Related articles   

  829. LI M, Che N, Jin Y, Li J, et al
    CDKN3 Overcomes Bladder Cancer Cisplatin Resistance via LDHA-Dependent Glycolysis Reprogramming.
    Onco Targets Ther. 2022;15:299-311.
    Abstract     Related articles   

  830. VAN DER HEIJDEN MS, Powles T, Petrylak D, de Wit R, et al
    Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.
    Nat Commun. 2022;13:1878.
    Abstract     Related articles   

  831. PATTENDEN T, Samaranayake D, Morton A, Thangasamy I, et al
    Bladder cancer in Aboriginal and Torres Strait Islander people living in Australia: a scoping review protocol.
    BMJ Open. 2022;12:e059144.
    Abstract     Related articles   

  832. ZEMLICKOVA B, Brisuda A
    Prognostic factors of early second transurethral resection of non-muscle invasive bladder cancer 10 years of experience of a referral center.
    Rozhl Chir. 2022;101:119-128.
    Abstract     Related articles   

  833. HORNAK J, Brisuda A, Babjuk M
    Management of BCG failure in non-muscle-invasive bladder cancer the present and the future.
    Rozhl Chir. 2022;101:108-113.
    Abstract     Related articles   

  834. GREER MD, Schaub SK, Bowen SR, Liao JJ, et al
    A Prospective Study of a Resorbable Intravesical Fiducial Marker for Bladder Cancer Radiation Therapy.
    Adv Radiat Oncol. 2021;7:100858.
    Abstract     Related articles   

  835. YANG M, Wang B, Hou W, Yu H, et al
    Negative Effects of Stromal Neutrophils on T Cells Reduce Survival in Resectable Urothelial Carcinoma of the Bladder.
    Front Immunol. 2022;13:827457.
    Abstract     Related articles   

  836. XIA QD, Sun JX, Liu CQ, Xu JZ, et al
    Ferroptosis Patterns and Tumor Microenvironment Infiltration Characterization in Bladder Cancer.
    Front Cell Dev Biol. 2022;10:832892.
    Abstract     Related articles   

  837. LU D, Yang T, Tang N, Li C, et al
    A pH-Dependent rhodamine fluorophore with antiproliferative activity of bladder cancer in Vitro/Vivo and apoptosis mechanism.
    Eur J Med Chem. 2022;236:114293.
    Abstract     Related articles   

  838. ZABOR EC, Kaizer AM, Garrett-Mayer E, Hobbs BP, et al
    Optimal Sequential Predictive Probability Designs for Early-Phase Oncology Expansion Cohorts.
    JCO Precis Oncol. 2022;6:e2100390.
    Abstract     Related articles   

  839. MONTEIRO CRA, Korkes F, Krutman-Zveibil D, Glina S, et al
    Fibroblast growth factor receptor 3 gene (FGFR3) mutations in high-grade muscle-invasive urothelial bladder cancer in a Brazilian population: evaluation and prevalence.
    Einstein (Sao Paulo). 2022;20:eAO6450.
    Abstract     Related articles   

  840. KE HL, Lee YC, Li WM, Wang CS, et al
    High Ubiquitin-Specific Protease 2a Expression Level Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma.
    Appl Immunohistochem Mol Morphol. 2022;30:304-310.
    Abstract     Related articles   

  841. HAROLD JA, Casilla-Lennon M, Kenney PA, Ratner ES, et al
    Vesical clear cell adenocarcinoma of Mullerian origin treated conservatively with partial cystectomy.
    BMJ Case Rep. 2022;15.
    Abstract     Related articles   

  842. PIAO XM, Kim YU, Byun YJ, Zheng CM, et al
    Expression of RPL9 predicts the recurrence of non-muscle invasive bladder cancer with BCG therapy.
    Urol Oncol. 2022 Apr 2. pii: S1078-1439(21)00557.
    Abstract     Related articles   

  843. YAMASAKI M, Taoka R, Katakura K, Matsunaga T, et al
    The Paris System for reporting urinary cytology improves the negative predictive value of high-grade urothelial carcinoma.
    BMC Urol. 2022;22:51.
    Abstract     Related articles   

  844. LIU L, Qiu M, Tan G, Liang Z, et al
    Correction to: miR-200c Inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3.
    J Transl Med. 2022;20:153.
    Abstract     Related articles   

  845. ADNAN S, Abu Bakar M, Khalil MAI, Fiaz S, et al
    Outcomes of Uretero-ileal Anastomosis in Bladder Cancer Cystectomies: Bricker vs. Wallace 1.
    Cureus. 2022;14:e22782.
    Abstract     Related articles   

  846. ZRAIK I, Krege S
    [Follow-up in superficial and metastatic bladder cancer].
    Urologe A. 2022 Apr 5. pii: 10.1007/s00120-022-01813.
    Abstract     Related articles   

  847. GURAL Z, Yucel S, Oskeroglu S, Agaoglu F, et al
    Urachal adenocarcinoma: A case report and review of the literature.
    J Cancer Res Ther. 2022;18:291-293.
    Abstract     Related articles   

  848. LI K, Wang F, Wang J, Fan C, et al
    Marital status independently predicts survival of patients with upper urinary tract urothelial carcinoma: A population-based study.
    J Cancer Res Ther. 2021;17:1709-1717.
    Abstract     Related articles   

  849. ELSHETRY ASF, El-Fawakry RM, Hamed EM, Metwally MI, et al
    Diagnostic accuracy and discriminative power of biparametric versus multiparametric MRI in predicting muscle-invasive bladder cancer.
    Eur J Radiol. 2022;151:110282.
    Abstract     Related articles   

  850. TAOKA R, Matsuoka Y, Yamasaki M, Kani N, et al
    Photodynamic diagnosis-assisted transurethral resection using oral 5-aminolevulinic acid decreases residual cancer and improves recurrence-free survival in patients with non-muscle-invasive bladder cancer.
    Photodiagnosis Photodyn Ther. 2022 Apr 2:102838.
    Abstract     Related articles   

  851. THEODORESCU D, Li Z, Li X
    Sex differences in bladder cancer: emerging data and call to action.
    Nat Rev Urol. 2022 Apr 4. pii: 10.1038/s41585-022-00591.
    Abstract     Related articles   

  852. ALHALABI O, Chen J, Zhang Y, Lu Y, et al
    MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers.
    Nat Commun. 2022;13:1797.
    Abstract     Related articles   

  853. TABER A, Christensen E, Lamy P, Nordentoft I, et al
    Author Correction: Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis.
    Nat Commun. 2022;13:1916.
    Abstract     Related articles   

  854. TALWAR HS, Kumar S, Mittal A, Narain TA, et al
    Incidental encounter of intraperitoneal tuberculosis during renal surgeries: A surgeon's dilemma.
    Indian J Tuberc. 2022;69:246-249.
    Abstract     Related articles   

  855. FAVORITO LA
    Upper tract urothelial carcinoma and bladder cancer in review in this number of International Brazilian Journal of Urology.
    Int Braz J Urol. 2022;48:386-388.
    Abstract     Related articles   

  856. LI Z, Wang S, Chen Y, Huang Y, et al
    5-Methylcytosine-Related Long Noncoding RNAs Are Potential Biomarkers to Predict Overall Survival and Regulate Tumor-Immune Environment in Patients with Bladder Cancer.
    Dis Markers. 2022;2022:3117359.
    Abstract     Related articles   

  857. SHAO C, Sun A, Xue H, Di X, et al
    Three-Dimensional Ultrasound Images in the Assessment of Bladder Tumor Health Monitoring under Deep Learning Algorithms.
    Comput Math Methods Med. 2022;2022:9170274.
    Abstract     Related articles   

  858. YANG X, Lv H, Jiang W, Zhang J, et al
    Clinical Value Analysis of Xiaozheng Decoction Combined with Bladder Perfusion for Postoperative Treatment of Bladder Cancer and Its Effect on Serum miR-143 and miR-92a.
    J Healthc Eng. 2022;2022:8177674.
    Abstract     Related articles   

  859. CUI Y, Sun Z, Liu X, Zhang X, et al
    CT-based radiomics for the preoperative prediction of the muscle-invasive status of bladder cancer and comparison to radiologists' assessment.
    Clin Radiol. 2022 Mar 30. pii: S0009-9260(22)00130.
    Abstract     Related articles   

  860. YANISHI M, Kinoshita H
    Urinary L-type fatty acid-binding protein is a predictor of cisplatin-induced acute kidney injury.
    BMC Nephrol. 2022;23:125.
    Abstract     Related articles   

  861. TAUBER R, von Amsberg G, De Santis M
    [Update on systemic treatment of urothelial cancer: therapy in transition].
    Aktuelle Urol. 2022;53:167-179.
    Abstract     Related articles   



  862. Aktuelle Urol. 2022;53:119-121.
    Abstract     Related articles   



  863. Aktuelle Urol. 2022;53:116.
    Abstract     Related articles   



  864. Aktuelle Urol. 2022;53:114-116.
    Abstract     Related articles   



  865. Aktuelle Urol. 2022;53:112-114.
    Abstract     Related articles   



  866. Aktuelle Urol. 2022;53:110-112.
    Abstract     Related articles   

  867. NIEGISCH G

    Aktuelle Urol. 2022;53:135-136.
    Abstract     Related articles   

  868. ZHAO C, Xiong K, Ji Z, Liu F, et al
    The Prognostic Value and Immunological Role of STEAP1 in Pan-Cancer: A Result of Data-Based Analysis.
    Oxid Med Cell Longev. 2022;2022:8297011.
    Abstract     Related articles   

  869. HURST CD, Cheng G, Platt FM, Alder O, et al
    Molecular profile of pure squamous cell carcinoma of the bladder identifies major roles for OSMR and YAP signalling.
    J Pathol Clin Res. 2022;8:279-293.
    Abstract     Related articles   

  870. CASARIN M, Fortunato TM, Imran S, Todesco M, et al
    Porcine Small Intestinal Submucosa (SIS) as a Suitable Scaffold for the Creation of a Tissue-Engineered Urinary Conduit: Decellularization, Biomechanical and Biocompatibility Characterization Using New Approaches.
    Int J Mol Sci. 2022;23.
    Abstract     Related articles   

  871. CINQUE A, Capasso A, Vago R, Floris M, et al
    MicroRNA Signatures in the Upper Urinary Tract Urothelial Carcinoma Scenario: Ready for the Game Changer?
    Int J Mol Sci. 2022;23.
    Abstract     Related articles   

  872. LIU E, Guan X, Wei R, Jiang Z, et al
    Association Between Radiotherapy and Death From Cardiovascular Disease Among Patients With Cancer: A Large Population-Based Cohort Study.
    J Am Heart Assoc. 2022;11:e023802.
    Abstract     Related articles   

  873. CHAN TC, Hsing CH, Shiue YL, Huang SK, et al
    Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression.
    Cells. 2022;11.
    Abstract     Related articles   

  874. DENG M, Wang N, Li Z, Chen R, et al
    FXR1 can bind with the CFIm25/CFIm68 complex and promote the progression of urothelial carcinoma of the bladder by stabilizing TRAF1 mRNA.
    Cell Death Dis. 2022;13:170.
    Abstract     Related articles   

  875. BOLENZ C, Ohlmann CH, Gschwend J
    [Do's and Dont's for radical cystectomy and urinary diversion - how to minimise postoperative complications].
    Aktuelle Urol. 2022;53:159-166.
    Abstract     Related articles   

  876. YIN Y, Song L, Shi D, Liu B, et al
    Identification of Recurrent Insertions and Deletions in Exon 18 and 19 of Human Epidermal Growth Factor Receptor 2 as Potential Drivers in Non-Small-Cell Lung Cancer and Other Cancer Types.
    JCO Precis Oncol. 2022;6:e2100325.
    Abstract     Related articles   

  877. BOULEFTOUR W, Guillot A, Magne N
    The Anti-Nectin 4: A Promising Tumor Cells Target. A Systematic Review.
    Mol Cancer Ther. 2022;21:493-501.
    Abstract     Related articles   

  878. BERNARDO C, Eriksson P, Marzouka NA, Liedberg F, et al
    Molecular pathology of the non-luminal Ba/Sq-like and Sc/NE-like classes of urothelial tumours: An integrated immunohistochemical analysis.
    Hum Pathol. 2022;122:11-24.
    Abstract     Related articles   

  879. WOJCIK EM, Kurtycz DFI, Rosenthal DL
    We'll always have Paris The Paris System for Reporting Urinary Cytology 2022.
    J Am Soc Cytopathol. 2022;11:62-66.
    Abstract     Related articles   

  880. XIAO JF, Kua LF, Ding LW, Sun QY, et al
    KDM6A Depletion in Breast Epithelial Cells Leads to Reduced Sensitivity to Anticancer Agents and Increased TGFbeta Activity.
    Mol Cancer Res. 2022;20:637-649.
    Abstract     Related articles   

  881. GAO X, Lin B, Lin Q, Ye T, et al
    A HALP score-based prediction model for survival of patients with the upper tract urothelial carcinoma undergoing radical nephroureterectomy.
    Bosn J Basic Med Sci. 2022;22:280-290.
    Abstract     Related articles   

  882. ZHANG H, Lu X, Huang G, Hua M, et al
    A genomic mutation spectrum of collecting duct carcinoma in the Chinese population.
    BMC Med Genomics. 2022;15:1.
    Abstract     Related articles   

  883. KOBAYASHI G, Uraoka N, Sentani K, Shibata J, et al
    Cytological and histological findings of upper tract mucinous urothelial carcinoma with clear cell component: A case report and review of literature.
    Diagn Cytopathol. 2022;50:E129-E135.
    Abstract     Related articles   

  884. ALGER J, Mallahan C, Deng T, Marshall J, et al
    Neuroendocrine tumor causing ureteral obstruction in a patient with prior ileal conduit.
    Can J Urol. 2021;28:10953-10955.
    Abstract     Related articles   

  885. O'CONNOR A, Sabri S, Muhammad K
    The use of methylene blue to aid identification of ileal conduit anatomy during subsequent surgery.
    Ann R Coll Surg Engl. 2022;104:1.
    Abstract     Related articles   

  886. SHANG D, Li G, Zhang C, Liu Y, et al
    Synergistic inhibitory effects of 5-aza-2'-deoxycytidine and cisplatin on urothelial carcinoma growth via suppression of TGFBI-MAPK signaling pathways.
    Biochem Cell Biol. 2022;100:115-124.
    Abstract     Related articles   

  887. ALLISON DB, Kates M, VandenBussche CJ
    Indeterminate atypia in urinary tract cytology: Does it really matter?
    Diagn Cytopathol. 2022;50:176-183.
    Abstract     Related articles   

  888. LOGHIN A, Nechifor-Boila A, Borda A, Nechifor-Boila IA, et al
    Programmed death ligand-1 (PD-L1) immunohistochemical assessment using the QR1 clone in muscle-invasive urothelial carcinomas: a comparison with reference clones 22C3 and SP263.
    Virchows Arch. 2022;480:303-313.
    Abstract     Related articles   


  889. Bicyclic Peptide Makes Targeting EphA2 Possible.
    Cancer Discov. 2021;11:2951-2952.
    Abstract     Related articles   

  890. KAMEI J, Fujisaki A, Saito K, Sugihara T, et al
    Less invasive and equivalent short-term outcomes with simultaneous en bloc robot-assisted radical cystectomy and laparoscopic nephroureterectomy: Comparison with conventional open radical cystectomy and nephroureterectomy.
    Asian J Endosc Surg. 2022;15:255-260.
    Abstract     Related articles   

  891. VOLKEL C, De Wispelaere N, Weidemann S, Gorbokon N, et al
    Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications.
    Virchows Arch. 2022;480:433-447.
    Abstract     Related articles   

  892. MURAKAMI K, Kamat AM, Dai Y, Pagano I, et al
    Application of a multiplex urinalysis test for the prediction of intravesical BCG treatment response: A pilot study.
    Cancer Biomark. 2022;33:151-157.
    Abstract     Related articles   

  893. PATEL SH
    Clinician's commentary: Atypia in urinary tract cytology specimens.
    Diagn Cytopathol. 2022;50:184-185.
    Abstract     Related articles   

  894. TATJANA A, Tjota MY, O'Donnell PH, Eggener SE, et al
    EZR-ROS1 fusion renal cell carcinoma mimicking urothelial carcinoma: report of a previously undescribed gene fusion in renal cell carcinoma.
    Virchows Arch. 2022;480:487-492.
    Abstract     Related articles   

  895. SHARMA G, Yadav AK, Pareek T, Kaundal P, et al
    Impact of pathological factors on survival in patients with upper tract urothelial carcinoma: a systematic review and meta-analysis.
    Int Braz J Urol. 2022;48:406-455.
    Abstract     Related articles   

  896. LUNA-VELEZ MV, Dijkstra JJ, Heuschkel MA, Smit FP, et al
    Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder.
    Mol Oncol. 2021;15:1882-1900.
    Abstract     Related articles   

  897. HUSSAIN SA, Lester JF, Jackson R, Gornall M, et al
    Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial.
    Lancet Oncol. 2022 Apr 11. pii: S1470-2045(22)00158.
    Abstract     Related articles   

  898. LI X, Zhou L, Lu T, Zhang L, et al
    Constructing an immune- and ferroptosis-related lncRNA signature to predict the immune landscape of human bladder cancer.
    J Clin Lab Anal. 2022 Apr 14:e24389. doi: 10.1002/jcla.24389.
    Abstract     Related articles   

  899. MAO C, Gao Y, Wan M, Xu N, et al
    Identification of glycolysis-associated long non-coding RNA regulatory subtypes and construction of prognostic signatures by transcriptomics for bladder cancer.
    Funct Integr Genomics. 2022 Apr 14. pii: 10.1007/s10142-022-00845.
    Abstract     Related articles   

  900. WANG F, Dong X, Yang F, Xing N, et al
    Comparative Analysis of Differentially Mutated Genes in Non-Muscle and Muscle-Invasive Bladder Cancer in the Chinese Population by Whole Exome Sequencing.
    Front Genet. 2022;13:831146.
    Abstract     Related articles   

  901. XIA QD, Sun JX, Xun Y, Xiao J, et al
    SUMOylation Pattern Predicts Prognosis and Indicates Tumor Microenvironment Infiltration Characterization in Bladder Cancer.
    Front Immunol. 2022;13:864156.
    Abstract     Related articles   

  902. SUN J, Ma X, Ying Y, Wang W, et al
    SMAD3 and FTO are involved in miR-5581-3p-mediated inhibition of cell migration and proliferation in bladder cancer.
    Cell Death Discov. 2022;8:199.
    Abstract     Related articles   

  903. OU L, Wei Z, Xu J, Li W, et al
    FAM107A as a Tumor Suppressor in Bladder Cancer Inhibits Cell Proliferation, Migration, and Invasion.
    Ann Clin Lab Sci. 2022;52:260-268.
    Abstract     Related articles   

  904. SHARMA G, Sharma A, Krishna M, Ahluwalia P, et al
    Diagnostic performance of minichromosome maintenance 5 (MCM5) in bladder cancer: A systematic review and meta-analysis.
    Urol Oncol. 2022 Apr 9. pii: S1078-1439(22)00075.
    Abstract     Related articles   

  905. YAMAMOTO A, Kawashima A, Uemura T, Yamamichi G, et al
    Biological distinction between grades 2 and 3 with respect to intravesical recurrence in T1 high-grade bladder tumors: a retrospective study.
    BMC Urol. 2022;22:59.
    Abstract     Related articles   

  906. ABUHASANEIN S, Hansen C, Vojinovic D, Jahnson S, et al
    Computed tomography urography with corticomedullary phase can exclude urinary bladder cancer with high accuracy.
    BMC Urol. 2022;22:60.
    Abstract     Related articles   

  907. AL-ZALABANI AH, Wesselius A, Yi-Wen Yu E, van den Brandt P, et al
    Tea consumption and risk of bladder cancer in the Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) Study: Pooled analysis of 12 international cohort studies.
    Clin Nutr. 2022;41:1122-1130.
    Abstract     Related articles   

  908. DING K, Wang L, Zhu J, He D, et al
    Photo-Enhanced Chemotherapy Performance in Bladder Cancer Treatment via Albumin Coated AIE Aggregates.
    ACS Nano. 2022 Apr 12. doi: 10.1021/acsnano.1c10770.
    Abstract     Related articles   

  909. LI G, Wang Y, Guo XB, Zhao B, et al
    CDC42 Regulates Cell Proliferation and Apoptosis in Bladder Cancer via the IQGAP3-Mediated Ras/ERK Pathway.
    Biochem Genet. 2022 Apr 12. pii: 10.1007/s10528-022-10223.
    Abstract     Related articles   

  910. ABDULLAH O, Parashar D, Mustafa IJ, Young AM, et al
    Venous Thromboembolism Rate in Patients With Bladder Cancer According to the Type of Treatment: A Systematic Review.
    Cureus. 2022;14:e22945.
    Abstract     Related articles   

  911. LIN MH, Islam A, Liu YH, Weng CW, et al
    Antibiotic heliomycin and its water-soluble 4-aminomethylated derivative provoke cell death in T24 bladder cancer cells by targeting sirtuin 1 (SIRT1).
    Am J Cancer Res. 2022;12:1042-1055.
    Abstract     Related articles   

  912. QIAN H, Wang Y, Ma Z, Qian L, et al
    Surface-Enhanced Raman Spectroscopy of Pretreated Plasma Samples Predicts Disease Recurrence in Muscle-Invasive Bladder Cancer Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy.
    Int J Nanomedicine. 2022;17:1635-1646.
    Abstract     Related articles   

  913. WARD DG, Baxter L, Ott S, Gordon NS, et al
    Highly Sensitive and Specific Detection of Bladder Cancer via Targeted Ultra-deep Sequencing of Urinary DNA.
    Eur Urol Oncol. 2022 Apr 8. pii: S2588-9311(22)00036.
    Abstract     Related articles   

  914. HOLM JS, Funt SA, Borch A, Munk KK, et al
    Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma.
    Nat Commun. 2022;13:1935.
    Abstract     Related articles   

  915. XU L, Su B, Mo L, Zhao C, et al
    Norcantharidin Induces Immunogenic Cell Death of Bladder Cancer Cells through Promoting Autophagy in Acidic Culture.
    Int J Mol Sci. 2022;23.
    Abstract     Related articles   

  916. THOMAS J, Sonpavde G
    Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder Cancer.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  917. LU YT, Xu T, Iqbal M, Hsieh TC, et al
    FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  918. SJODAHL G, Abrahamsson J, Bernardo C, Eriksson P, et al
    Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer-A Narrative Review.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  919. WEIDLE UH, Birzele F
    Bladder Cancer-related microRNAs With In Vivo Efficacy in Preclinical Models.
    Cancer Diagn Progn. 2021;1:245-263.
    Abstract     Related articles   

  920. LI X, Liu H, Lv C, Du J, et al
    Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer.
    Biomed Res Int. 2022;2022:9304552.
    Abstract     Related articles   

  921. MA Q, Xu C, Han X, Wang X, et al
    The effects of modified RNA-binding proteins HuR on the biological behavior of the bladder cancer T24 cell line.
    Transl Androl Urol. 2022;11:348-357.
    Abstract     Related articles   

  922. LIU F, Liu X, Deng W, Yang X, et al
    Overexpression of F-box and WD repeat domain containing 7 prevents tumor growth of bladder cancer cells through regulating SREBP1a.
    Transl Androl Urol. 2022;11:367-376.
    Abstract     Related articles   

  923. LI YD, Gao L, Gou YQ, Tan W, et al
    Age of menarche and primary bladder cancer risk: A meta-analysis and systematic review.
    Urol Oncol. 2022 Apr 7. pii: S1078-1439(22)00074.
    Abstract     Related articles   

  924. WATANABE K, Tamura K, Matsushita Y, Watanabe H, et al
    Significance of 5-Aminolevulinic Acid-mediated Photodynamic Diagnosis Following Standard Transurethral Resection in Non-muscle Invasive Bladder Cancer.
    Cancer Diagn Progn. 2021;1:201-205.
    Abstract     Related articles   

  925. LIN N, Chen L, Zhang Y, Yang Y, et al
    KIF4A promotes tumor progression of bladder cancer via CXCL5 dependent myeloid-derived suppressor cells recruitment.
    Sci Rep. 2022;12:6015.
    Abstract     Related articles   

  926. SHINWARI K, Chen Z, Liu G, Chen L, et al
    Identification of The Immune Subtype Among Muscle-invasive Bladder Cancer Patients by Multiple Datasets.
    Acta Med Indones. 2022;54:62-71.
    Abstract     Related articles   

  927. REESINK DJ, van de Garde EMW, van der Nat P, Somford DM, et al
    Hospital variation in treatment patterns and oncological outcomes for patients with muscle-invasive and metastatic bladder cancer in the Netherlands.
    World J Urol. 2022 Apr 10. pii: 10.1007/s00345-022-03987.
    Abstract     Related articles   

  928. YE JB, Chen Q, Zeng K, Li XB, et al
    Eosinophilic cystitis complicated with cystitis glandularis: a case report.
    BMC Urol. 2022;22:55.
    Abstract     Related articles   

  929. YILDIRIM S, Ozkan EI, Sadioglu A, Gonul II, et al
    Bone in bladder.
    J Nephrol. 2022;35:1043-1044.
    Abstract     Related articles   

  930. NIKOLOS F, Hayashi K, Hoi XP, Alonzo ME, et al
    Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors.
    Nat Commun. 2022;13:1487.
    Abstract     Related articles   

  931. RUSSELL BM, Boussi L, Bellmunt J
    Management of Advanced Urothelial Carcinoma in Older and Frail Patients: Have Novel Treatment Approaches Improved Their Care?
    Drugs Aging. 2022;39:271-284.
    Abstract     Related articles   

  932. VOUTSADAKIS IA
    Urothelial Bladder Carcinomas with High Tumor Mutation Burden Have a Better Prognosis and Targetable Molecular Defects beyond Immunotherapies.
    Curr Oncol. 2022;29:1390-1407.
    Abstract     Related articles   

  933. HASHIMOTO H, Tanaka Y, Murata M, Ito T, et al
    Nectin-4: a Novel Therapeutic Target for Skin Cancers.
    Curr Treat Options Oncol. 2022;23:578-593.
    Abstract     Related articles   

  934. DAUBISSE-MARLIAC L, Grosclaude P, Carulla M, Parada D, et al
    Registration of Urothelial Tumours in Cancer Registries: How to Improve and Make It More Useful?
    Int J Environ Res Public Health. 2022;19.
    Abstract     Related articles   

  935. UNGARO A, Tucci M, Audisio A, Di Prima L, et al
    Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside.
    Cells. 2022;11.
    Abstract     Related articles   

  936. MATHEW THOMAS V, Tripathi N, Agarwal N, Swami U, et al
    Current and emerging role of sacituzumab govitecan in the management of urothelial carcinoma.
    Expert Rev Anticancer Ther. 2022;22:335-341.
    Abstract     Related articles   

  937. DIAMANTOPOULOS LN, Korentzelos D, Alevizakos M, Wright JL, et al
    Sarcomatoid Urothelial Carcinoma: A Population-Based Study of Clinicopathologic Characteristics and Survival Outcomes.
    Clin Genitourin Cancer. 2022;20:139-147.
    Abstract     Related articles   

  938. TALUKDER R, Makrakis D, Diamantopoulos LN, Carril-Ajuria L, et al
    Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
    Clin Genitourin Cancer. 2022;20:165-175.
    Abstract     Related articles   

  939. WILSON J, Drach D, Zanghi J, Siegert J, et al
    Improving practice patterns in patients with newly diagnosed bladder masses treated with transurethral resection.
    J Osteopath Med. 2022;122:169-173.
    Abstract     Related articles   

  940. LIN TW, Lee HY, Yang SF, Li CC, et al
    ASO Visual Abstract: Perineural Invasion is a Powerful Prognostic Factor for Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy.
    Ann Surg Oncol. 2022;29:3320-3321.
    Abstract     Related articles   

  941. ADIBI M, McCormick B, Economides MP, Petros F, et al
    Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma.
    Clin Genitourin Cancer. 2022;20:176-182.
    Abstract     Related articles   

  942. SPARWASSER P, Epple S, Thomas A, Dotzauer R, et al
    First completely robot-assisted retroperitoneal nephroureterectomy with bladder cuff: a step-by-step technique.
    World J Urol. 2022;40:1019-1026.
    Abstract     Related articles   

  943. FERRO M, Chiujdea S, Musi G, Lucarelli G, et al
    Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis.
    Clin Genitourin Cancer. 2022;20:e166-e172.
    Abstract     Related articles   

  944. DEL GIUDICE F, van Uem S, Li S, Vilson FL, et al
    Contemporary Trends of Systemic Neoadjuvant and Adjuvant Intravesical Chemotherapy in Patients With Upper Tract Urothelial Carcinomas Undergoing Minimally Invasive or Open Radical Nephroureterectomy: Analysis of US Claims on Perioperative Outcomes and
    Clin Genitourin Cancer. 2022;20:198.
    Abstract     Related articles   

  945. RAGGI D, Giannatempo P, Marandino L, Pierantoni F, et al
    Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study.
    Clin Genitourin Cancer. 2022;20:155-164.
    Abstract     Related articles   

  946. JINDAL T, Chou J, Friedlander T, Barata PC, et al
    Repeat Treatment of Patients With Advanced Urothelial Carcinoma With Immune Checkpoint Inhibitors Following Prior Progression on a Checkpoint Inhibitor Regimen: A Case Series.
    Clin Genitourin Cancer. 2022;20:189-194.
    Abstract     Related articles   

  947. LAYMON M, Mosbah A, Hashem A, Mahmoud O, et al
    Oncologic Outcomes of Squamous Cell Carcinoma Versus Urothelial Carcinoma With Squamous Differentiation After Radical Cystectomy for Bladder Carcinoma.
    Clin Genitourin Cancer. 2022;20:148-154.
    Abstract     Related articles   

  948. KARAM A, Mjaess G, Albisinni S, El Daccache Y, et al
    Uncovering the role of urinary microbiota in urological tumors: a systematic review of literature.
    World J Urol. 2022;40:951-964.
    Abstract     Related articles   

  949. LIN TW, Lee HY, Yang SF, Li CC, et al
    Perineural Invasion is a Powerful Prognostic Factor for Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy.
    Ann Surg Oncol. 2022;29:3306-3317.
    Abstract     Related articles   

  950. LIN TW, Yeh HC
    ASO Author Reflections: Prognostic Significance of Perineural Invasion in Upper Tract Urothelial Carcinoma.
    Ann Surg Oncol. 2022;29:3318-3319.
    Abstract     Related articles   

  951. TANG CH, Chen YC, Hsieh WT, Sue YM, et al
    Gender and Age Differences of Genitourinary Cancers Among Chronic Dialysis Patients in Taiwan.
    Clin Genitourin Cancer. 2022;20:e126-e134.
    Abstract     Related articles   

  952. ABUHELWA AY, Bellmunt J, Kichenadasse G, McKinnon RA, et al
    Enhanced Bellmunt Risk Score for Survival Prediction in Urothelial Carcinoma Treated With Immunotherapy.
    Clin Genitourin Cancer. 2022;20:132-138.
    Abstract     Related articles   

  953. MIYAKE M, Shimizu T, Nishimura N, Kiba K, et al
    Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy in Cisplatin-Unfit Patients With Advanced Urothelial Carcinoma.
    Clin Genitourin Cancer. 2022;20:196.
    Abstract     Related articles   

  954. KOSIBA M, Stolzenbach LF, Colla Ruvolo C, Nocera L, et al
    Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder.
    Clin Genitourin Cancer. 2022;20:195.
    Abstract     Related articles   

  955. GRIVAS P, Huber C, Pawar V, Roach M, et al
    Management of Patients With Advanced Urothelial Carcinoma in an Evolving Treatment Landscape: A Qualitative Study of Provider Perspectives of First-Line Therapies.
    Clin Genitourin Cancer. 2022;20:114-122.
    Abstract     Related articles   

  956. KOBAYASHI G, Hayashi T, Sentani K, Babasaki T, et al
    Clinicopathological significance of claspin overexpression and its efficacy as a novel biomarker for the diagnosis of urothelial carcinoma.
    Virchows Arch. 2022;480:621-633.
    Abstract     Related articles   

  957. MONTOYA-CERRILLO D, Briski LM, Jorda M, Kryvenko ON, et al
    Utility of GATA-3 and Cytokeratin 5/6 Immunostains in Separating Condyloma Acuminatum Arising in the Urinary Tract From Non-Invasive Papillary Urothelial Carcinoma.
    Int J Surg Pathol. 2022;30:260-264.
    Abstract     Related articles   

  958. MALDE S, Grover S, Raj S, Yuan C, et al
    A Systematic Review of the Efficacy and Safety of Outpatient Bladder Tumour Ablation.
    Eur Urol Focus. 2022;8:141-151.
    Abstract     Related articles   

  959. SEISEN T, Mari A, Campi R, Peyronnet B, et al
    Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology Review.
    Eur Urol Focus. 2021;7:1075-1083.
    Abstract     Related articles   

  960. DELL'OGLIO P, Turri F, Larcher A, D'Hondt F, et al
    Definition of a Structured Training Curriculum for Robot-assisted Radical Cystectomy with Intracorporeal Ileal Conduit in Male Patients: A Delphi Consensus Study Led by the ERUS Educational Board.
    Eur Urol Focus. 2022;8:160-164.
    Abstract     Related articles   

  961. TURAL D, Olmez OF, Sumbul AT, Artac M, et al
    Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences.
    Eur Urol Focus. 2021;7:1061-1066.
    Abstract     Related articles   

  962. DEUKER M, Stolzenbach LF, Colla Ruvolo C, Nocera L, et al
    Micropapillary Versus Urothelial Carcinoma of the Urinary Bladder: Stage at Presentation and Efficacy of Chemotherapy Across All Stages-A SEER-based Study.
    Eur Urol Focus. 2021;7:1332-1338.
    Abstract     Related articles   

  963. MASTROIANNI R, Brassetti A, Krajewski W, Zdrojowy R, et al
    Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival.
    Eur Urol Focus. 2021;7:1324-1331.
    Abstract     Related articles   

  964. NECCHI A, Madison R, Pal SK, Ross JS, et al
    Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma.
    Eur Urol Focus. 2021;7:1339-1346.
    Abstract     Related articles   

  965. FURRER MA, Kiss B, Wuthrich PY, Thomas BC, et al
    Long-term Outcomes of Cystectomy and Crossfolded Ileal Reservoir Combined with an Afferent Tubular Segment for Heterotopic Continent Urinary Diversion: A Longitudinal Single-centre Study.
    Eur Urol Focus. 2021;7:629-637.
    Abstract     Related articles   

  966. PANG KH, Thomas F, Novara G, Din OS, et al
    The Impact of Centralised Services on Metric Reflecting High-quality Performance: Outcomes from 1110 Consecutive Radical Cystectomies at a Single Centre.
    Eur Urol Focus. 2021;7:554-565.
    Abstract     Related articles   

  967. CONG Z, Tang S, Xie L, Yang M, et al
    Magnetic-Powered Janus Cell Robots Loaded with Oncolytic Adenovirus for Active and Targeted Virotherapy of Bladder Cancer.
    Adv Mater. 2022 Apr 22:e2201042. doi: 10.1002/adma.202201042.
    Abstract     Related articles   

  968. GRUNEWALD CM, Niegisch G, Albers P
    Using Circulating Tumor DNA To Guide Adjuvant Therapy in Bladder Cancer: IMvigor010 and IMvigor011.
    Eur Urol Focus. 2022 Apr 18. pii: S2405-4569(22)00078.
    Abstract     Related articles   

  969. ZHAO H, Chen Z, Fang Y, Su M, et al
    Prediction of Prognosis and Recurrence of Bladder Cancer by ECM-Related Genes.
    J Immunol Res. 2022;2022:1793005.
    Abstract     Related articles   

  970. D'ELIA C, Trenti E, Krause P, Pycha A, et al
    Xpert(R) bladder cancer detection as a diagnostic tool in upper urinary tract urothelial carcinoma: preliminary results.
    Ther Adv Urol. 2022;14:17562872221090320.
    Abstract     Related articles   

  971. HWANG TI, Chen PC, Tsai TF, Lin JF, et al
    Hsa-miR-30a-3p overcomes the acquired protective autophagy of bladder cancer in chemotherapy and suppresses tumor growth and muscle invasion.
    Cell Death Dis. 2022;13:390.
    Abstract     Related articles   

  972. XU H, Shi HL, Hao JW, Shu KP, et al
    [Casticin inhibits the proliferation, migration and invasion of bladder cancer cells by inhibition of TM7SF4 expression].
    Zhonghua Zhong Liu Za Zhi. 2022;44:334-340.
    Abstract     Related articles   

  973. SU Z, Monshaugen I, Wilson B, Wang F, et al
    TRMT6/61A-dependent base methylation of tRNA-derived fragments regulates gene-silencing activity and the unfolded protein response in bladder cancer.
    Nat Commun. 2022;13:2165.
    Abstract     Related articles   

  974. UEMURA T, Ishibashi T, Pae S, Shirakawa N, et al
    [CLINICAL STUDY OF OPEN RADICAL CYSTECTOMY AND ILEAL CONDUIT CONSTRUCTION FOR BLADDER CANCER: RESULTS OF 15-YEAR SINGLE CENTER EXPERIENCE].
    Nihon Hinyokika Gakkai Zasshi. 2021;112:89-95.
    Abstract     Related articles   

  975. MATSUMURA S, Yoshida T, Imanaka T, Yamanaka K, et al
    [OUTCOMES OF BLADDER CANCER IN NONAGENARIANS].
    Nihon Hinyokika Gakkai Zasshi. 2021;112:58-64.
    Abstract     Related articles   

  976. MAEDA K, Mori Y, Nakamura M, Harada Y, et al
    [SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION AS A SIDE EFFECT OF CHEMOTHERAPY FOR URACHAL CARCINOMA: A CASE REPORT].
    Nihon Hinyokika Gakkai Zasshi. 2021;112:100-104.
    Abstract     Related articles   

  977. XIA Y, Ge M, Xia L, Shan G, et al
    CTSV (cathepsin V) promotes bladder cancer progression by increasing NF-kappaB activity.
    Bioengineered. 2022;13:10180-10190.
    Abstract     Related articles   

  978. LIU T, Li T, Zheng Y, Xu X, et al
    Evaluating adipose-derived stem cell exosomes as miRNA drug delivery systems for the treatment of bladder cancer.
    Cancer Med. 2022 Apr 20. doi: 10.1002/cam4.4745.
    Abstract     Related articles   

  979. TAE BS, Oh JJ, Jeong BC, Ku JH, et al
    Catheter-associated urinary tract infections in patients who have undergone radical cystectomy for bladder cancer: A prospective randomized clinical study of two silicone catheters (clinical benefit of antibiotic silicone material).
    Investig Clin Urol. 2022 Mar 28. pii: 63.e32. doi: 10.4111/icu.20210436.
    Abstract     Related articles   

  980. JUNG A, Crandell JL, Nielsen ME, Smith SK, et al
    Relationships among uncertainty, post-traumatic stress disorder symptoms, and quality of life in non-muscle-invasive bladder cancer survivors.
    Support Care Cancer. 2022 Apr 18. pii: 10.1007/s00520-022-07034.
    Abstract     Related articles   

  981. BIERI U, Scharl M, Sigg S, Szczerba BM, et al
    Prospective observational study of the role of the microbiome in BCG responsiveness prediction (SILENT-EMPIRE): a study protocol.
    BMJ Open. 2022;12:e061421.
    Abstract     Related articles   

  982. HARDY CSC, Ghaedi H, Slotman A, Sjodahl G, et al
    Immunohistochemical Assays for Bladder Cancer Molecular Subtyping: Optimizing Parsimony and Performance of Lund Taxonomy Classifiers.
    J Histochem Cytochem. 2022 Apr 19:221554221095530.
    Abstract     Related articles   

  983. YAMUC E, Barisik NO, Sensu S, Tarhan F, et al
    Correlation of REG1A, Claudin 7 and Ki67 expressions with tumor recurrence and prognostic factors in superficial urothelial urinary bladder carcinomas.
    Indian J Pathol Microbiol. 2022;65:355-361.
    Abstract     Related articles   

  984. ELIZALDE BENITO FX, Sieso Gracia MR, Dolezal P, Martin Anoro LF, et al
    Abdominal mass as the first manifestation of bladder tumor.
    Arch Esp Urol. 2022;75:306-307.
    Abstract     Related articles   

  985. RUIBAL GAGO L
    [Altered urinary pH as an aetiology of granulomas in urostomised patients.]
    Arch Esp Urol. 2022;75:296-299.
    Abstract     Related articles   

  986. SALAS E, Enguita L, Espilez R, Santander C, et al
    [Lymphoepithelioma-like bladder tumor. A rare variant.]
    Arch Esp Urol. 2022;75:300-305.
    Abstract     Related articles   

  987. LEI Y, Jiao D, Yao Z, Wang L, et al
    Prognostic values of preoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and lymphocyte- to-monocyte ratio for patients with muscle- invasive bladder cancer undergoing radical cystectomy.
    Arch Esp Urol. 2022;75:287-294.
    Abstract     Related articles   

  988. WANG F, Yang J
    Correlations between forkhead box D1 expression and clinicopathological characteristics of patients with bladder cancer and influence on biological behaviors of bladder cancer cells.
    Arch Esp Urol. 2022;75:274-281.
    Abstract     Related articles   

  989. CHENG J, Yang Q, Han X, Wang H, et al
    Yin Yang 1-stimulated long noncoding RNA bladder cancer-associated transcript 1 upregulation facilitates esophageal carcinoma progression via the microRNA-5590-3p/programmed cell death-ligand 1 pathway.
    Bioengineered. 2022;13:10244-10257.
    Abstract     Related articles   

  990. HUANG M, Dong W, Xie R, Wu J, et al
    HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5-WDR5-dependent transcriptional program.
    Cancer Commun (Lond). 2022 Apr 18. doi: 10.1002/cac2.12284.
    Abstract     Related articles   

  991. GU H, Liang C
    Construction and Validation of a 15-Top-prognostic-gene-based Signature to Indicate the Dichotomized Clinical Outcome and Response to Targeted Therapy for Bladder Cancer Patients.
    Front Cell Dev Biol. 2022;10:725024.
    Abstract     Related articles   

  992. HUANG Z, Gao H, Qing L, Wang B, et al
    A long noncoding RNA GTF2IRD2P1 suppresses cell proliferation in bladder cancer by inhibiting the Wnt/betacatenin signaling pathway.
    PeerJ. 2022;10:e13220.
    Abstract     Related articles   

  993. RAZZAGHDOUST A, Muhammadnejad S, Parvin M, Mofid B, et al
    Development and immunohistochemical characterization of patient-derived xenograft models for muscle invasive bladder cancer.
    Iran J Basic Med Sci. 2021;24:1650-1655.
    Abstract     Related articles   

  994. SORCE G, Chierigo F, Flammia RS, Hoeh B, et al
    Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race/ethnicity.
    Urol Oncol. 2022 Apr 14. pii: S1078-1439(22)00105.
    Abstract     Related articles   

  995. DANESHMAND S, Brummelhuis ISG, Pohar KS, Steinberg GD, et al
    The safety, tolerability, and efficacy of a neoadjuvant gemcitabine intravesical drug delivery system (TAR-200) in muscle-invasive bladder cancer patients: a phase I trial.
    Urol Oncol. 2022 Apr 14. pii: S1078-1439(22)00059.
    Abstract     Related articles   

  996. WANG SS, Zhai GQ, Chen G, Huang ZG, et al
    Decreased expression of transcription factor Homeobox A11 and its potential target genes in bladder cancer.
    Pathol Res Pract. 2022;233:153847.
    Abstract     Related articles   

  997. MUZAAIL HH, El-Assmy A, Harraz AM, Awadalla A, et al
    Prediction of recurrence of non-muscle invasive bladder cancer: The role of androgen receptor and miRNA-2909.
    Urol Oncol. 2022 Apr 13. pii: S1078-1439(22)00078.
    Abstract     Related articles   

  998. GONZALEZ-PADILLA DA, Subiela JD, Gonzalez-Diaz A, Hernandez-Arroyo M, et al
    Mitomycin C allergy after passive and device-assisted hyperthermia for non-muscle invasive bladder cancer treatment: A retrospective cohort from a high-volume center.
    Urol Oncol. 2022 Apr 14. pii: S1078-1439(22)00067.
    Abstract     Related articles   

  999. TEPLITSKY SL, Hensley PJ, Bettis A, James A, et al
    Operative duration and short term morbidity and mortality following radical cystectomy with urinary diversion.
    Can J Urol. 2022;29:11087-11094.
    Abstract     Related articles   

  1000. DIETRICH F, Cappellari AR, Filippi-Chiela EC, de Paula PB, et al
    High P2X6 receptor expression in human bladder cancer predicts good survival prognosis.
    Mol Cell Biochem. 2022 Apr 16. pii: 10.1007/s11010-022-04425.
    Abstract     Related articles   

  1001. AL-ZUBAIDI M, Viswambaram P, McCombie S, Liow E, et al
    (89)Zirconium-labelled girentuximab ((89)Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP): protocol for a phase I trial of a novel staging modality for urothelial carcinoma.
    BMJ Open. 2022;12:e060478.
    Abstract     Related articles   

  1002. FISHER L
    Retraction: Exosome-derived PTENP1 suppresses cisplatin resistance of bladder cancer (BC) by suppressing cell proliferation, migration and inducing apoptosis via the miR-103a/PDCD4 axis.
    RSC Adv. 2021;11:6254.
    Abstract     Related articles   

  1003. MIYAKE M, Nishimura N, Ohnishi S, Oda Y, et al
    Association between urine 6-sulfatoxy-melatonin level and intravesical Bacillus Calmette-Guerin treatment-induced sleep quality deterioration in patients with non-muscle invasive bladder cancer.
    Support Care Cancer. 2022 Apr 14. pii: 10.1007/s00520-022-07043.
    Abstract     Related articles   

  1004. LIU Q, Wang Y, Gao H, Sun F, et al
    An Individualized Prognostic Signature for Clinically Predicting the Survival of Patients With Bladder Cancer.
    Front Genet. 2022;13:837301.
    Abstract     Related articles   

  1005. ZHAO Y, Che J, Tian A, Zhang G, et al
    PBX1 Participates in Estrogen-Mediated Bladder Cancer Progression and Chemo-Resistance Affecting Estrogen Receptors.
    Curr Cancer Drug Targets. 2022 Apr 13. pii: CCDT-EPUB-122508.
    Abstract     Related articles   

  1006. ZHANG Y, Liu Z, Wang X, Jian H, et al
    SHMT2 promotes cell viability and inhibits ROS-dependent, mitochondrial-mediated apoptosis via the intrinsic signaling pathway in bladder cancer cells.
    Cancer Gene Ther. 2022 Apr 14. pii: 10.1038/s41417-022-00470.
    Abstract     Related articles   

  1007. SINGH YP, Roy D, Jois B, Shetti M, et al
    Reactive arthritis following treatment with intravesical Bacillus Calmette-Guerin for papillary carcinoma of bladder.
    BMJ Case Rep. 2022;15.
    Abstract     Related articles   

  1008. FUKATA S, Mizutani K, Yamamoto S, Kuno T, et al
    Sarcopenia and the rate of change of the neutrophil/lymphocyte ratio as predictors of pembrolizumab efficacy in advanced urothelial carcinoma.
    Anticancer Drugs. 2022;33:459-466.
    Abstract     Related articles   

  1009. LEWICKI P, Basourakos SP, Arenas-Gallo C, Qiu Y, et al
    Use of Intravesical Chemotherapy in the US Following Publication of a Randomized Clinical Trial.
    JAMA Netw Open. 2022;5:e220602.
    Abstract     Related articles   

  1010. SHVERO A, Hubosky SG
    Management of Upper Tract Urothelial Carcinoma.
    Curr Oncol Rep. 2022;24:611-619.
    Abstract     Related articles   

  1011. KUMAR D, Adeniran AJ
    Clinicopathological Review of Micropapillary Urothelial Carcinoma.
    Curr Oncol Rep. 2022;24:603-610.
    Abstract     Related articles   

  1012. MASTERS JC, Khandelwal A, di Pietro A, Dai H, et al
    Model-informed drug development supporting the approval of the avelumab flat-dose regimen in patients with advanced renal cell carcinoma.
    CPT Pharmacometrics Syst Pharmacol. 2022;11:458-468.
    Abstract     Related articles   

  1013. HE L, Wang X, Li C, Wan Y, et al
    Bibliometric analysis of the 100 top-cited articles on immunotherapy of urological cancer.
    Hum Vaccin Immunother. 2022;18:2035552.
    Abstract     Related articles   

  1014. CALDERON CORTEZ JF, Territo A, Fontana M, Gaya JM, et al
    Primary urethral carcinoma: Results from a single center experience.
    Actas Urol Esp (Engl Ed). 2022;46:70-77.
    Abstract     Related articles   

  1015. NISHIMORI T, Hanazono K, Matsuda K, Kawamura Y, et al
    Prognostic role of DeltaNp63 expression in canine transitional cell carcinoma of the urinary bladder.
    Open Vet J. 2021;11:700-706.
    Abstract     Related articles   

  1016. GOVONI VM, Pigoli C, Sueiro FAR, Zuliani F, et al
    Lymphatic invasion is a significant indicator of poor patient outcome in canine bladder urothelial carcinoma.
    Open Vet J. 2021;11:535-543.
    Abstract     Related articles   

  1017. CARRIL-AJURIA L, Martin-Soberon MC, de Velasco G, Agarwal N, et al
    Immunotherapy maintenance therapy for advanced urothelial carcinoma (aUC): a comprehensive review.
    J Cancer Res Clin Oncol. 2022;148:1097-1105.
    Abstract     Related articles   

  1018. RANTI D, Pfail J, Garcia M, Razdan S, et al
    Neobladder creation in patients with chronic kidney disease: A viable diversion strategy.
    Urol Oncol. 2022;40:168.
    Abstract     Related articles   

  1019. VENKAT S, Khan AI, Lewicki PJ, Borregales L, et al
    Novel nomograms to predict muscle invasion and lymph node metastasis in upper tract urothelial carcinoma.
    Urol Oncol. 2022;40:108.
    Abstract     Related articles   

  1020. LI Z, Zhang Z, Ma H, Yao K, et al
    Extraperitonealization of ileal conduit reduces parastomal hernia after cystectomy and ileal conduit diversion.
    Urol Oncol. 2022;40:162.
    Abstract     Related articles   

  1021. PIERCONTI F, Martini M, Cenci T, Fiorentino V, et al
    The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma.
    Urol Oncol. 2022;40:108.
    Abstract     Related articles   

  1022. CLAIBORNE RT, Tsan GL
    Case Report: Erdafitinib-induced Central Serous Chorioretinopathy.
    Optom Vis Sci. 2022;99:88-92.
    Abstract     Related articles   

  1023. WOO S, Ghafoor S, Das JP, Gangai N, et al
    Plasmacytoid urothelial carcinoma of the bladder: MRI features and their association with survival.
    Urol Oncol. 2022;40:108.
    Abstract     Related articles   

  1024. YANG CH, Weng WC, Ou YC, Lin YS, et al
    Diffusive Ki67 and vimentin are associated with worse recurrence-free survival of upper tract urothelial carcinoma: A retrospective cohort study from bench to bedside.
    Urol Oncol. 2022;40:109.
    Abstract     Related articles   

  1025. BUBE SH, Kingo PS, Madsen MG, Vasquez JL, et al
    Validation of a Novel Assessment Tool Identifying Proficiency in Transurethral Bladder Tumor Resection: The OSATURBS Assessment Tool.
    J Endourol. 2022;36:572-579.
    Abstract     Related articles   

  1026. CHEN X, Ou Z, Wang L, Zhang Z, et al
    Association of tumor mutational burden with genomic alterations in Chinese urothelial carcinoma.
    Mol Carcinog. 2022;61:311-321.
    Abstract     Related articles   

  1027. LYON TD, Faraj KS, Brennan E, Tyson MD 2nd, et al
    Defining radical cystectomy using the ICD-10 procedure coding system.
    Urol Oncol. 2022;40:165.
    Abstract     Related articles   

  1028. SARI MOTLAGH R, Rajwa P, Mori K, Laukhtina E, et al
    Comparison of Clinicopathologic and Oncological Outcomes Between Transurethral En Bloc Resection and Conventional Transurethral Resection of Bladder Tumor: A Systematic Review, Meta-Analysis, and Network Meta-Analysis with Focus on Different Energy So
    J Endourol. 2022;36:535-547.
    Abstract     Related articles   

  1029. FLAMMIA RS, Chierigo F, Wurnschimmel C, Horlemann B, et al
    Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma.
    Urol Oncol. 2022;40:165.
    Abstract     Related articles   

  1030. PARK CK, Cho NH
    Differences in genomic profile of high-grade urothelial carcinoma according to tumor location.
    Urol Oncol. 2022;40:109.
    Abstract     Related articles   

  1031. KEENAN RA, Haroon U, Ryan P, Harrington B, et al
    Management of Urological Malignancy in Heart and Lung Transplant Recipients: An Irish National Cohort Study.
    Exp Clin Transplant. 2021;19:1069-1075.
    Abstract     Related articles   

  1032. AYDIN AM, Reich RR, Cao B, Cheriyan SK, et al
    Clinical indications for necessary and discretionary hospital readmissions after radical cystectomy.
    Urol Oncol. 2022;40:164.
    Abstract     Related articles   

  1033. YU A, Wang Y, Mossanen M, Preston M, et al
    Robotic-assisted radical cystectomy is associated with lower perioperative mortality in octogenarians.
    Urol Oncol. 2022;40:163.
    Abstract     Related articles   

  1034. ALBISINNI S, Diamand R, Mjaess G, Assenmacher G, et al
    Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohort.
    Urol Oncol. 2022;40:163.
    Abstract     Related articles   

  1035. IAKYMENKO OA, Briski LM, Delma KS, Jorda M, et al
    Utility of D2-40, Cytokeratin 5/6, and High-Molecular-weight Cytokeratin (Clone 34betaE12) in Distinguishing Intraductal Spread of Urothelial Carcinoma From Prostatic Stromal Invasion.
    Am J Surg Pathol. 2022;46:454-463.
    Abstract     Related articles   

  1036. ALKAN S, Evlice O, Agin A
    The Evaluation of Cases with Ocular Complications due to Bacillus Calmette-Guerin (BCG) Treatment using the Pool Analysis Method.
    Semin Ophthalmol. 2022;37:373-378.
    Abstract     Related articles   

  1037. TAOKA R, Kobayashi T, Hidaka Y, Abe H, et al
    Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinoma.
    Urol Oncol. 2022;40:107.
    Abstract     Related articles   

  1038. SHIGETA K, Matsumoto K, Ogihara K, Murakami T, et al
    Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study.
    Urol Oncol. 2022;40:105.
    Abstract     Related articles   

  1039. CHAKIRYAN NH, Jiang DD, Gillis KA, Green E, et al
    Comparative effectiveness analysis of first-line immunotherapy versus chemotherapy in metastatic urothelial carcinoma of the bladder.
    Urol Oncol. 2022;40:107.
    Abstract     Related articles   

  1040. BHAMIDIPATY M, Rickard MJFX
    An ileal conduit retroperitoneal-pexy: An novel operative technique to treat the rare colonic internal hernia.
    ANZ J Surg. 2022;92:586-587.
    Abstract     Related articles   

  1041. NOJIMA S, Terayama K, Shimoura S, Hijiki S, et al
    A deep learning system to diagnose the malignant potential of urothelial carcinoma cells in cytology specimens.
    Cancer Cytopathol. 2021;129:984-995.
    Abstract     Related articles   

  1042. COLLA RUVOLO C, Wurnschimmel C, Wenzel M, Nocera L, et al
    Comparison between 1973 and 2004/2016 WHO grading systems in patients with Ta urothelial carcinoma of urinary bladder.
    J Clin Pathol. 2022;75:333-337.
    Abstract     Related articles   

  1043. GUO B, Liu M
    The role of chemotherapy in patients with pure squamous cell bladder carcinoma.
    World J Urol. 2022;40:865-866.
    Abstract     Related articles   

  1044. MITCHELL KA, Williams H
    Emerging genomic biomarkers for improving kidney, prostate, and bladder cancer health disparities outcomes.
    Urol Oncol. 2022;40:126-132.
    Abstract     Related articles   

  1045. LI Q, Cao B, Liu K, Sun H, et al
    Detecting the muscle invasiveness of bladder cancer: An application of diffusion kurtosis imaging and tumor contact length.
    Eur J Radiol. 2022;151:110329.
    Abstract     Related articles   

  1046. FLEGAR L, Kraywinkel K, Zacharis A, Aksoy C, et al
    Treatment trends for muscle-invasive bladder cancer in Germany from 2006 to 2019.
    World J Urol. 2022 Apr 29. pii: 10.1007/s00345-022-04017.
    Abstract     Related articles   


  1047. Addition of Nintedanib to Neoadjuvant Chemotherapy Is Safe in Bladder Cancer.
    Cancer Discov. 2022 Apr 29:OF1. doi: 10.1158/2159-8290.CD-RW2022.
    Abstract     Related articles   

  1048. GARCZYK S, Degener S, Bischoff F, Schnitzler T, et al
    Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer.
    Virchows Arch. 2022 Apr 28. pii: 10.1007/s00428-022-03328.
    Abstract     Related articles   

  1049. MORTEZAVI A, Crippa A, Kotopouli MI, Akre O, et al
    Association of Open vs Robot-Assisted Radical Cystectomy With Mortality and Perioperative Outcomes Among Patients With Bladder Cancer in Sweden.
    JAMA Netw Open. 2022;5:e228959.
    Abstract     Related articles   

  1050. DE ROJAS LEAL C, Lage-Sanchez JM, Pinel-Rios J, Leon Plaza O, et al
    Paraneoplastic autoimmune autonomic ganglionopathy as the first symptom of bladder cancer: a case report and review of literature.
    Neurol Sci. 2022 Apr 28. pii: 10.1007/s10072-022-06075.
    Abstract     Related articles   

  1051. CIOCAN C, Godono A, Franco N, La Vecchia C, et al
    Mortality from bladder cancer in dyestuff workers exposed to aromatic amines: A 73-year follow-up.
    Med Lav. 2022;113:e2022017.
    Abstract     Related articles   

  1052. SUN X, Zhang Y, Chen Y, Xin S, et al
    In Silico Establishment and Validation of Novel Lipid Metabolism-Related Gene Signature in Bladder Cancer.
    Oxid Med Cell Longev. 2022;2022:3170950.
    Abstract     Related articles   

  1053. ZUPPONE S, Assalini C, Minici C, Botrugno OA, et al
    A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer.
    Front Oncol. 2022;12:846958.
    Abstract     Related articles   

  1054. ZHANG Q, Tan Y, Zhang J, Shi Y, et al
    Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in Muscle-Invasive Bladder Cancer.
    Front Immunol. 2022;13:782982.
    Abstract     Related articles   

  1055. ZLOWOCKA-PERLOWSKA E, van de Wetering T, Toloczko-Grabarek A, Scott RJ, et al
    Bladder cancer survival in patients with NOD2 or CDKN2A variants.
    Oncotarget. 2022;13:628-640.
    Abstract     Related articles   

  1056. NIE S, Huili Y, He Y, Hu J, et al
    Identification of Bladder Cancer Subtypes Based on Necroptosis-Related Genes, Construction of a Prognostic Model.
    Front Surg. 2022;9:860857.
    Abstract     Related articles   

  1057. EVANS H, O'Sullivan B, Hughes F, Charles K, et al
    PD-L1 Testing in Urothelial Carcinoma: Analysis of a Series of 1401 Cases Using Both the 22C3 and SP142 Assays.
    Pathol Oncol Res. 2022;28:1610260.
    Abstract     Related articles   

  1058. FU Y, Zhao Z, Shi Y, Xu K, et al
    Hybridization chain reaction-mediated Fe2MoO4 bimetallic nanozyme for colorimetric risk prediction of bladder cancer.
    Biosens Bioelectron. 2022;210:114272.
    Abstract     Related articles   

  1059. GU Q, Hou W, Shi L, Zhu Z, et al
    CircMCTP2 (has-circ-0000658) facilitates the proliferation and metastasis of bladder carcinoma through modulating the miR-498/murine double minute-2 axis.
    Bioengineered. 2022;13:10734-10748.
    Abstract     Related articles   

  1060. RUSSELL B, Haggstrom C, Holmberg L, Liedberg F, et al
    Systematic review of the association between socioeconomic status and bladder cancer survival with hospital type, comorbidities, and treatment delay as mediators.
    BJUI Compass. 2021;2:140-158.
    Abstract     Related articles   

  1061. GROVER S, Raj S, Russell B, Mensah E, et al
    Long-term outcomes of outpatient laser ablation for recurrent non-muscle invasive bladder cancer: A retrospective cohort study.
    BJUI Compass. 2021;3:124-129.
    Abstract     Related articles   

  1062. RODRIGUEZ-HOMS M, Baack Kukreja J
    Bladder cancer biomarkers: Past and future directions.
    BJUI Compass. 2021;2:7-8.
    Abstract     Related articles   

  1063. AL KHADER A, Fararjeh AFS, Kaddumi EG, Al-Saghbini M, et al
    Significance of fibulin-3 expression in bladder cancer: a tissue microarray-based immunohistochemical study.
    World J Surg Oncol. 2022;20:133.
    Abstract     Related articles   

  1064. GUO Q, Zhang T, Gong Y, Tao Y, et al
    Aldehyde dehydrogenase 6 family member A1 negatively regulates cell growth and to cisplatin sensitivity in bladder cancer.
    Mol Carcinog. 2022 Apr 26. doi: 10.1002/mc.23411.
    Abstract     Related articles   

  1065. ERASLAN A, Ekenci BY, Dogan AE, Kaymak S, et al
    Parastomal skin metastasis in a patient with history of urinary bladder cancer.
    Urol Case Rep. 2022;43:102088.
    Abstract     Related articles   

  1066. KUROKAWA G, Sasaki H, Shimada H, Kasai K, et al
    [Laparoscopic Radical Cystectomy with Ileal Neobladder for Metachronous Bladder Cancer Following Laparoscopic Radical Prostatectomy : A Case Report].
    Hinyokika Kiyo. 2022;68:87-90.
    Abstract     Related articles   

  1067. SYMEONIDIS EN, Baniotis P, Langas G, Stefanidis P, et al
    En bloc resection, is this the future of non-muscle invasive bladder cancer management? Presentation of our technique and brief review of the literature.
    Urologia. 2022 Apr 25:3915603221093739. doi: 10.1177/03915603221093739.
    Abstract     Related articles   

  1068. FADALLAH M, Zahran MH, El-Assmy AM, Barakat NM, et al
    Omega-3 polyunsaturated fatty acids: a modified approach for chemo-prevention of bladder cancer in a rat model and molecular studies of antineoplastic mechanisms.
    Mol Biol Rep. 2022 Apr 25. pii: 10.1007/s11033-022-07445.
    Abstract     Related articles   

  1069. MERTENS LS, Claps F, Mayr R, Hodgson A, et al
    The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis.
    Int J Surg Pathol. 2022 Apr 24:10668969221095173. doi: 10.1177/10668969221095173
    Abstract     Related articles   

  1070. PAN X, Chen G, Hu W
    Piperlongumine increases the sensitivity of bladder cancer to cisplatin by mitochondrial ROS.
    J Clin Lab Anal. 2022 Apr 25:e24452. doi: 10.1002/jcla.24452.
    Abstract     Related articles   

  1071. LI J, Liu M, Sun P, Zhao W, et al
    Three-Dimensional Conformal Radiotherapy Combined with Gemcitabine and Docetaxel in the Treatment of Advanced Bladder Cancer and Its Effects on Inflammatory Factors and Immune Function.
    J Oncol. 2022;2022:9347218.
    Abstract     Related articles   

  1072. EL-KARAMANY TM, Al-Adl AM, Hosny MM, A Eldeep H, et al
    Clinical utility of vesical imaging-reporting and data system (VI-RADS) in non-muscle invasive bladder cancer (NMIBC) patients candidate for en-bloc transurethral resection: A prospective study.
    Urol Oncol. 2022 Apr 21. pii: S1078-1439(22)00099.
    Abstract     Related articles   

  1073. BURGESS EF, Livasy C, Trufan S, Zhu J, et al
    Clinical outcomes associated with expression of aurora kinase and p53 family members in muscle-invasive bladder cancer.
    Mol Clin Oncol. 2022;16:102.
    Abstract     Related articles   

  1074. TIAN YH, He YF, Tan JS, Jiang Y, et al
    The DeltaN p63 Promotes EMT and Metastasis in Bladder Cancer by the PTEN/AKT Signalling Pathway.
    Evid Based Complement Alternat Med. 2022;2022:9566055.
    Abstract     Related articles   

  1075. LIU CQ, Sun JX, Xu JZ, Qian XY, et al
    Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients With T2DM: An Updated Meta-Analysis.
    Front Pharmacol. 2022;13:865988.
    Abstract     Related articles   

  1076. CHEN Q, Cai L, Liang J
    Construction of prognosis model of bladder cancer based on transcriptome.
    Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021;50:1-9.
    Abstract     Related articles   

  1077. MATSUSHITA Y, Kawakami A, Sato R, Watanabe K, et al
    Significant impact of a history of prior or concomitant upper urinary tract cancer on the recurrence and progression of non-muscle invasive bladder cancer.
    Jpn J Clin Oncol. 2022 Apr 23. pii: 6573315. doi: 10.1093.
    Abstract     Related articles   

  1078. OZAWA Y, Yagi Y, Nakamura K, Hattori S, et al
    Secondary bladder cancer during long-term follow-up after iodine-125 permanent seed implantation for localized prostate cancer.
    Brachytherapy. 2022 Apr 20. pii: S1538-4721(22)00037.
    Abstract     Related articles   

  1079. RODLER S, Solyanik O, Ingenerf M, Fabritius M, et al
    Accuracy and prognostic value of radiological lymph node features in variant histologies of bladder cancer.
    World J Urol. 2022 Apr 23. pii: 10.1007/s00345-022-04010.
    Abstract     Related articles   

  1080. ZHANG Y, Zhou H, Tuo ZT, Wang J, et al
    Extraperitoneal laparoscopic radical cystectomy with intracorporeal neobladder: a comparison with transperitoneal approach.
    World J Surg Oncol. 2022;20:130.
    Abstract     Related articles   

  1081. DI MEO NA, Loizzo D, Pandolfo SD, Autorino R, et al
    Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer.
    Int J Mol Sci. 2022;23.
    Abstract     Related articles   

  1082. DUAN L, Liu X, Luo Z, Zhang C, et al
    G-Protein Subunit Gamma 4 as a Potential Biomarker for Predicting the Response of Chemotherapy and Immunotherapy in Bladder Cancer.
    Genes (Basel). 2022;13.
    Abstract     Related articles   

  1083. QIN C, Chen ZH, Cao R, Shi MJ, et al
    Differential Expression Profiles and Bioinformatics Analysis of tRNA-Derived Small RNAs in Muscle-Invasive Bladder Cancer in a Chinese Population.
    Genes (Basel). 2022;13.
    Abstract     Related articles   

  1084. MAJ M, Kazmierski L, Balik K, Kowalska K, et al
    Bladder Cancer Cells Exert Pleiotropic Effects on Human Adipose-Derived Stem Cells.
    Life (Basel). 2022;12.
    Abstract     Related articles   

  1085. LEWANDOWSKA K, Lewandowska A, Baranska I, Klatt M, et al
    Severe Respiratory Failure Due to Pulmonary BCGosis in a Patient Treated for Superficial Bladder Cancer.
    Diagnostics (Basel). 2022;12.
    Abstract     Related articles   

  1086. GONTERO P, Babjuk M
    Swedish national guidelines on urothelial cancer echo the EAU guidelines but with some regional dialect.
    Scand J Urol. 2022;56:147-148.
    Abstract     Related articles   

  1087. METZEN M, Kowar M, Solleder G, Wilhelm K, et al
    [BCG-therapy as a rare reason for postrenal failure].
    Dtsch Med Wochenschr. 2022;147:403-406.
    Abstract     Related articles   

  1088. GAKIS G, Perner S, Stenzl A, Renninger M, et al
    The role of single-nucleotide polymorphisms of the 8q24 chromosome region in patients with concomitant bladder and prostate cancer.
    Scand J Urol. 2022;56:126-130.
    Abstract     Related articles   

  1089. YERUKALA SATHIPATI S, Tsai MJ, Shukla SK, Ho SY, et al
    MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma.
    Sci Rep. 2022;12:4141.
    Abstract     Related articles   

  1090. GUNNARSSON U
    Anorectal side-effects of radical cystectomy.
    Scand J Urol. 2022;56:162-163.
    Abstract     Related articles   

  1091. CHENG M, Wang Q, Chen L, Zhao D, et al
    LncRNA UCA1/miR-182-5p/MGMT axis modulates glioma cell sensitivity to temozolomide through MGMT-related DNA damage pathways.
    Hum Pathol. 2022;123:59-73.
    Abstract     Related articles   

  1092. SUBBIAH V, Iannotti NO, Gutierrez M, Smith DC, et al
    FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies.
    Ann Oncol. 2022;33:522-533.
    Abstract     Related articles   

  1093. ALEVIZAKOS M, Bellmunt J
    Adjuvant immunotherapy for muscle-invasive urothelial carcinoma of the bladder.
    Expert Rev Anticancer Ther. 2022;22:259-267.
    Abstract     Related articles   

  1094. LOPEZ-BELTRAN A, Blanca A, Cimadamore A, Montironi R, et al
    T1 bladder carcinoma with variant histology: pathological features and clinical significance.
    Virchows Arch. 2022;480:989-998.
    Abstract     Related articles   

  1095. NELSON D, Kodsi M, Cockrell D, Morgan J, et al
    Thrombotic Thrombocytopenic Purpura associated with Pembrolizumab.
    J Oncol Pharm Pract. 2022;28:979-982.
    Abstract     Related articles   

  1096. JACKSON-SPENCE F, Szabados B, Toms C, Yang YH, et al
    Avelumab in locally advanced or metastatic urothelial carcinoma.
    Expert Rev Anticancer Ther. 2022;22:135-140.
    Abstract     Related articles   

  1097. PI J, Xiong Y, Liu C, Liao J, et al
    A Nomogram Model to Predict Recurrence of Non-Muscle Invasive Bladder Urothelial Carcinoma After Resection Based on Clinical Parameters and Immunohistochemical Markers.
    J Invest Surg. 2022;35:1186-1194.
    Abstract     Related articles   

  1098. PATEL SH, Wang S, Metcalf MR, Gupta N, et al
    Safety and Efficacy of Reproductive Organ-Sparing Radical Cystectomy in Women With Variant Histology and Advanced Stage.
    Clin Genitourin Cancer. 2022;20:60-68.
    Abstract     Related articles   

  1099. ITO Y, Yamamoto T, Miyai K, Take J, et al
    Ascorbic acid-2 glucoside mitigates intestinal damage during pelvic radiotherapy in a rat bladder tumor model.
    Int J Radiat Biol. 2022;98:942-957.
    Abstract     Related articles   

  1100. LYOU Y, Rosenberg JE, Hoffman-Censits J, Quinn DI, et al
    Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma.
    Clin Genitourin Cancer. 2022;20:35-42.
    Abstract     Related articles   

  1101. MORI K, Katayama S, Laukhtina E, Schuettfort VM, et al
    Discordance Between Clinical and Pathological Staging and Grading in Upper Tract Urothelial Carcinoma.
    Clin Genitourin Cancer. 2022;20:95.
    Abstract     Related articles   

  1102. LAUKHTINA E, Mori K, Mostafaei H, Merseburger AS, et al
    Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized controlled trials.
    Semin Oncol. 2021;48:181-192.
    Abstract     Related articles   

  1103. CURRAN C, Adib E, Kazakova V, Grivas P, et al
    Outcomes of metastatic urothelial carcinoma following discontinuation of enfortumab-vedotin.
    Clin Genitourin Cancer. 2022;20:11-16.
    Abstract     Related articles   

  1104. LEITE KRM, Borges LL, Filho LR, Chade D, et al
    Histological Variants of Urothelial Carcinoma Predict No Response to Neoadjuvant Chemotherapy.
    Clin Genitourin Cancer. 2022;20:e1-e6.
    Abstract     Related articles   

  1105. ALHALABI O, Hahn AW, Msaouel P, Meric-Bernstam F, et al
    Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials.
    Clin Genitourin Cancer. 2022;20:e16-e24.
    Abstract     Related articles   

  1106. THYAVIHALLY YB, Dev P, Waigankar S, Pednekar A, et al
    Intravesical bacillus Calmette-Guerin (BCG) in treating non-muscle invasive bladder cancer-analysis of adverse effects and effectiveness of two strains of BCG (Danish 1331 and Moscow-I).
    Asian J Urol. 2022;9:157-164.
    Abstract     Related articles   

  1107. CHEN J, Liao Y, Li R, Luo M, et al
    Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer.
    Technol Cancer Res Treat. 2022;21:15330338221090093.
    Abstract     Related articles   

  1108. HAMADE A, Li D, Tyryshkin K, Xu M, et al
    Sex differences in the aging murine urinary bladder and influence on the tumor immune microenvironment of a carcinogen-induced model of bladder cancer.
    Biol Sex Differ. 2022;13:19.
    Abstract     Related articles   

  1109. BRICIO TGM, Gouvea GL, Barros RV, Chahud F, et al
    What is the impact of dynamic contrast-enhancement sequence in the Vesical Imaging, Reporting and Data System (VI-RADS)? A subgroup analysis.
    Cancer Imaging. 2022;22:20.
    Abstract     Related articles   

  1110. LU Q, Yin H, Deng Y, Chen W, et al
    circDHTKD1 promotes lymphatic metastasis of bladder cancer by upregulating CXCL5.
    Cell Death Discov. 2022;8:243.
    Abstract     Related articles   

  1111. YANG HJ, Liu T, Xiong Y
    Anti-cancer effect of LINC00478 in bladder cancer correlates with KDM1A-dependent MMP9 demethylation.
    Cell Death Discov. 2022;8:242.
    Abstract     Related articles   

  1112. SPEK A
    [Intravesical gemcitabine for non-muscle invasive bladder cancer].
    Urologe A. 2022 May 4. pii: 10.1007/s00120-022-01840.
    Abstract     Related articles   

  1113. MOLLER CT, Fossa SD, Tafjord G, Babigumira R, et al
    Primary versus secondary muscle-invasive bladder cancer: survival after curative treatment.
    Scand J Urol. 2022 May 4:1-7. doi: 10.1080/21681805.2022.2056633.
    Abstract     Related articles   

  1114. MARTINEZ MAICAS H, Torregrosa Andres A
    Granulomatous renal affectation post-BCG treatment of bladder tumor.
    Radiologia (Engl Ed). 2022;64:179-181.
    Abstract     Related articles   

  1115. ROUANNE M, Adam J, Radulescu C, Letourneur D, et al
    BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer.
    J Clin Invest. 2022 May 3. pii: 145666. doi: 10.1172/JCI145666.
    Abstract     Related articles   

  1116. LIU J, Chou Z, Li C, Huang K, et al
    ZBTB7A, a miR-144-3p targeted gene, accelerates bladder cancer progression via downregulating HIC1 expression.
    Cancer Cell Int. 2022;22:179.
    Abstract     Related articles   

  1117. OBAIDULISLAM M, Bacchetti T, Berrougui H, AbdelouahedKhalil, et al
    Effect of glycated HDL on oxidative stress and cholesterol homeostasis in a human bladder cancer cell line, J82.
    Exp Mol Pathol. 2022 Apr 29:104777. doi: 10.1016/j.yexmp.2022.104777.
    Abstract     Related articles   

  1118. TAN Z, Fu S, Feng R, Huang Y, et al
    Identification of Potential Biomarkers for Progression and Prognosis of Bladder Cancer by Comprehensive Bioinformatics Analysis.
    J Oncol. 2022;2022:1802706.
    Abstract     Related articles   

  1119. LI T, Xu Q, Wei Y, Lin R, et al
    Overexpression of miRNA-93-5p Promotes Proliferation and Migration of Bladder Urothelial Carcinoma via Inhibition of KLF9.
    Comput Math Methods Med. 2022;2022:8911343.
    Abstract     Related articles   

  1120. TEOH JY, Castellani D
    Editorial: Recent Advances in Bladder Cancer Diagnosis and Treatment.
    Front Surg. 2022;9:890172.
    Abstract     Related articles   

  1121. GORDON NS, Humayun-Zakaria N, Goel A, Abbotts B, et al
    STAG2 Protein Expression in Non-muscle-invasive Bladder Cancer: Associations with Sex, Genomic and Transcriptomic Changes, and Clinical Outcomes.
    Eur Urol Open Sci. 2022;38:88-95.
    Abstract     Related articles   

  1122. WU J, Xie RY, Cao CZ, Shang BQ, et al
    Disease Management of Clinical Complete Responders to Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer: A Review of Literature.
    Front Oncol. 2022;12:816444.
    Abstract     Related articles   

  1123. KUNIMITSU Y, Morio K, Hirata S, Yamamoto K, et al
    Effects of Proton Pump Inhibitors on Survival Outcomes in Patients with Metastatic or Unresectable Urothelial Carcinoma Treated with Pembrolizumab.
    Biol Pharm Bull. 2022;45:590-595.
    Abstract     Related articles   

  1124. TAIEB A, Berkovic G, Haifler M, Cheshnovsky O, et al
    Classification of tissue biopsies by Raman spectroscopy guided by quantitative phase imaging and its application to bladder cancer.
    J Biophotonics. 2022 Apr 30:e202200009. doi: 10.1002/jbio.202200009.
    Abstract     Related articles   

  1125. VAN HATTUM JW, Scutigliani EM, Helderman RFCPA, Zweije R, et al
    A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer.
    Sci Rep. 2022;12:7017.
    Abstract     Related articles   

  1126. HOU J, Lu Z, Liu X, Luo B, et al
    Increased NUSAP1 expression is associated with lymph node metastasis and survival prognosis in bladder urothelial carcinoma.
    Sci Rep. 2022;12:7003.
    Abstract     Related articles   

  1127. AMER S, Ibrahim H, Elkordy M
    The Immunohistochemical Expression of SOX-10 in Urothelial Carcinoma and the Non Neoplastic Urothelium; and a Correlation with the Tumor Features.
    Asian Pac J Cancer Prev. 2022;23:1425-1432.
    Abstract     Related articles   

  1128. CHUNG YH, Cheng YT, Kao YH, Tsai WC, et al
    MiR-26a-5p as a useful therapeutic target for upper tract urothelial carcinoma by regulating WNT5A/beta-catenin signaling.
    Sci Rep. 2022;12:6955.
    Abstract     Related articles   

  1129. ALNAJAR H, Ravichandran H, Figueiredo Rendeiro A, Ohara K, et al
    Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab.
    Cold Spring Harb Mol Case Stud. 2022;8.
    Abstract     Related articles   

  1130. ULLDEMOLINS AZNAR P, Munoz Vicente E, Rosello-Sastre E
    [How has the Paris System contributed to urine cytology? Evaluating the contribution of the Paris System to urine cytology. A comparative study of the Paris System and the Papanicolaou method in a tertiary centre].
    Rev Esp Patol. 2022;55:125-134.
    Abstract     Related articles   

  1131. CHOU CT, Yu SW, Lin TC
    Systematic Review and Meta-Analysis of Inguinal Versus Classic Obturator Nerve Block.
    Asian J Anesthesiol. 2022;60:1-10.
    Abstract     Related articles   

  1132. MAMMONE RM, Havis B, Royal A, Donnelly LL, et al
    Urothelial carcinoma with tonsillar metastasis in a dog.
    J Vet Diagn Invest. 2022;34:564-567.
    Abstract     Related articles   

  1133. JESSEN NH, Jensen H, Falborg AZ, Glerup H, et al
    Contacts to general practice in the 12 months preceding a diagnosis of an abdominal cancer: a national register-based cohort study.
    Scand J Prim Health Care. 2022;40:148-156.
    Abstract     Related articles   

  1134. LI Z, Feng N, Pu H, Dong Q, et al
    PIxel-Level Segmentation of Bladder Tumors on MR Images Using a Random Forest Classifier.
    Technol Cancer Res Treat. 2022;21:15330338221086395.
    Abstract     Related articles   

  1135. TUNA R, Karaman S, Oktar T, Anak S, et al
    Bladder granulocytic sarcoma in a child: case report and literature review.
    Turk J Pediatr. 2022;64:152-159.
    Abstract     Related articles   

  1136. IZAWA N, Shiokawa H, Onuki R, Hamaji K, et al
    The clinical utility of comprehensive measurement of autoimmune disease-related antibodies in patients with advanced solid tumors receiving immune checkpoint inhibitors: a retrospective study.
    ESMO Open. 2022;7:100415.
    Abstract     Related articles   

  1137. SUNG HH, Kim H, Kim R, Kim CK, et al
    Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder.
    Investig Clin Urol. 2022;63:168-174.
    Abstract     Related articles   

  1138. KELSEY K
    Epigenetics, environment and epidemiology: an interview with Karl Kelsey.
    Epigenomics. 2022;14:323-326.
    Abstract     Related articles   

  1139. GUIMARAES-TEIXEIRA C, Lobo J, Miranda-Goncalves V, Barros-Silva D, et al
    Downregulation of m(6) A writer complex member METTL14 in bladder urothelial carcinoma suppresses tumor aggressiveness.
    Mol Oncol. 2022;16:1841-1856.
    Abstract     Related articles   

  1140. GROBET-JEANDIN E, Pinar U, Roupret M
    Upper Urinary Tract Urothelial Carcinoma in Lynch Syndrome Patients: The Urologist Still Has a Role in Genetic Screening.
    Eur Urol Oncol. 2022;5:42-43.
    Abstract     Related articles   

  1141. CHECCUCCI E, Manfredi M, Sica M, Amparore D, et al
    Robot-assisted-radical-cystectomy with total intracorporeal Y neobladder: Analysis of postoperative complications and functional outcomes with urodynamics findings.
    Eur J Surg Oncol. 2022;48:694-702.
    Abstract     Related articles   

  1142. KUMAR S, Kaundal P, Parmar K, Akif S, et al
    Bilateral obstructive megaureter with right lower ureteric urothelial carcinoma: a very rare coalition.
    Ann R Coll Surg Engl. 2022;104:e153-e155.
    Abstract     Related articles   

  1143. LONATI C, Necchi A, Gomez Rivas J, Afferi L, et al
    Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors.
    Eur Urol Oncol. 2022;5:30-41.
    Abstract     Related articles   

  1144. SAMEH R, Mostafa N, Ramadan M, AbdelRaouf S, et al
    Prognostic significance of EZH2 and ARID1A expression in urothelial carcinoma: an immunohistochemical study.
    J Histotechnol. 2022;45:21-28.
    Abstract     Related articles   

  1145. PARIHAR AS, Schmidt LR, Dehdashti F, Wahl RL, et al
    Detection of additional primary neoplasms on (18)F-Fluciclovine PET/CT in patients with primary prostate cancer.
    J Nucl Med. 2021 Aug 19. pii: jnumed.121.262647. doi: 10.2967/jnumed.121.262647.
    Abstract     Related articles   

  1146. LIU Y, Wei T
    Micturition-triggered severe headache associated with bladder paraganglioma: A case report.
    Cephalalgia. 2022;42:166-169.
    Abstract     Related articles   

  1147. ABDELZAHER AHMED E, Abdel Bary Abdel-Latif A, Fahmy AM, Elzarrouk Mania I, et al
    Differential lysophosphatidylcholine acyltransferase 1 (LPCAT1) expression confers aggressiveness and independently predicts recurrence in bladder urothelial carcinomas.
    J Histotechnol. 2021;44:196-205.
    Abstract     Related articles   

  1148. ZHONG M, Jiang F, Song L, Nie M, et al
    MiR-133b regulates the proliferation, colony formation, and invasion of bladder cancer cells via inhibiting SOX4.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022;47:407-415.
    Abstract     Related articles   

  1149. WOOD LS, Conway D, Lapuente M, Salvador G, et al
    Avelumab First-Line Maintenance Treatment in Advanced Bladder Cancer: Practical Implementation Steps for Infusion Nurses.
    J Infus Nurs. 2022;45:142-153.
    Abstract     Related articles   

  1150. BEANE FREEMAN LE, Kogevinas M, Cantor KP, Villanueva CM, et al
    Disinfection By-Products in Drinking Water and Bladder Cancer: Evaluation of Risk Modification by Common Genetic Polymorphisms in Two Case-Control Studies.
    Environ Health Perspect. 2022;130:57006.
    Abstract     Related articles   

  1151. LV M, Zhong Z, Huang M, Tian Q, et al
    Corrigendum to "lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA" [Biochim. Biophys. Acta Mol. Cell Res. 1864 (2017) 1887-1899/BBAMCR-17-151R2].
    Biochim Biophys Acta Mol Cell Res. 2022;1869:119281.
    Abstract     Related articles   

  1152. GRUBA N, Stachurski L, Lesner A
    Chemical tools to monitor bladder cancer progression.
    Biomarkers. 2022 May 9:1-41. doi: 10.1080/1354750X.2022.2076153.
    Abstract     Related articles   

  1153. SCHULZ A, Loloi J, Pina Martina L, Sankin A, et al
    The Development of Non-Invasive Diagnostic Tools in Bladder Cancer.
    Onco Targets Ther. 2022;15:497-507.
    Abstract     Related articles   

  1154. DE RUITER BM, van de Kamp MW, van Steenbergen JPZ, Franckena M, et al
    A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice.
    Eur Urol Open Sci. 2022;39:7-13.
    Abstract     Related articles   

  1155. GROSSMANN NC, Rajwa P, Quhal F, Konig F, et al
    Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study.
    Eur Urol Open Sci. 2022;39:14-21.
    Abstract     Related articles   

  1156. YAMAMOTO Y, Takahara T, Ohashi A, Taniguchi N, et al
    Cytokeratin 5/6 expression in pT1 bladder cancer predicts intravesical recurrence in patients treated with bacillus Calmette-Guerin instillation.
    Pathology. 2022 May 5. pii: S0031-3025(22)00124.
    Abstract     Related articles   

  1157. REN W, Ren J, Zhang N, Liu X, et al
    CBX7 represses the POU2F2 to inhibit the PD-L1 expression and regulate the immune response in bladder cancer.
    Biochem Biophys Res Commun. 2022;613:12-18.
    Abstract     Related articles   

  1158. YONEYAMA MS, Yoneyama T, Tobisawa Y, Yamamoto H, et al
    TMEM2 expression is downregulated as bladder cancer invades the muscle layer.
    Biochem Biophys Res Commun. 2022;613:1-6.
    Abstract     Related articles   

  1159. YAN S, Zeng H, Jin K, Shao F, et al
    NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer.
    J Immunother Cancer. 2022;10.
    Abstract     Related articles   

  1160. YANG J, Qi F, Tan B, Dai G, et al
    circSPECC1 promotes bladder cancer progression via regulating miR-136-5p/GNAS axis.
    Pathol Res Pract. 2022;234:153914.
    Abstract     Related articles   

  1161. WANG G, Zhang M, Zhang Y, Xie Y, et al
    NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression.
    Clin Transl Med. 2022;12:e738.
    Abstract     Related articles   

  1162. INCE O, Yildiz H, Kisbet T, Erturk SM, et al
    Classification of retinoblastoma-1 gene mutation with machine learning-based models in bladder cancer.
    Heliyon. 2022;8:e09311.
    Abstract     Related articles   

  1163. CHO H, Tong F, You S, Jung S, et al
    Prediction of the Immune Phenotypes of Bladder Cancer Patients for Precision Oncology.
    IEEE Open J Eng Med Biol. 2022;3:47-57.
    Abstract     Related articles   

  1164. KRISTOFFERSEN HL, Roge R, Nielsen S
    Comparison of Antibodies to Detect Uroplakin in Urothelial Carcinomas.
    Appl Immunohistochem Mol Morphol. 2022;30:326-332.
    Abstract     Related articles   

  1165. JAVIER-DESLOGES J, Nelson TJ, Murphy JD, McKay RR, et al
    An evaluation of trends in the representation of patients by age, sex, and diverse race/ethnic groups in bladder and kidney cancer clinical trials.
    Urol Oncol. 2022;40:199.
    Abstract     Related articles   

  1166. SCHNEIDEWIND L, Kiss B
    [Extended vs. standard lymphadenectomy for the treatment of urothelial carcinoma of the bladder in patients undergoing radical cystectomy].
    Urologe A. 2022;61:530-533.
    Abstract     Related articles   

  1167. RAVI P, Ravi A, Riaz IB, Freeman D, et al
    Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial Carcinoma.
    Oncologist. 2022;27:e406-e409.
    Abstract     Related articles   

  1168. SHARMA G, Krishna M, Pareek T, Bora GS, et al
    Current practice patterns in the perioperative management of patients undergoing radical cystectomy: Results from a global survey.
    Urol Oncol. 2022;40:196.
    Abstract     Related articles   

  1169. MOULAVASILIS N, Stravodimos K, Meletis E, Levis P, et al
    The Paris system classification for urinary cytology in patients under bacillus Calmette-Guerin treatment.
    Diagn Cytopathol. 2022;50:289-294.
    Abstract     Related articles   

  1170. SONG Y, Du Y, Qin C, Xu T, et al
    Comment on "Durability of response to primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel: OLYMPUS trial final report".
    World J Urol. 2022;40:1251-1252.
    Abstract     Related articles   

  1171. MCINTIRE PJ, Aragao A, Burns BL, Pambuccian SE, et al
    Digital image analysis of high-grade urothelial carcinoma in urine cytology confirms chromasia heterogeneity and reveals a subset with hypochromatic nuclei and another with extremely dark or "India ink" nuclei.
    Cancer Cytopathol. 2022;130:363-369.
    Abstract     Related articles   

  1172. O'SULLIVAN S, Janssen M, Holzinger A, Nevejans N, et al
    Explainable artificial intelligence (XAI): closing the gap between image analysis and navigation in complex invasive diagnostic procedures.
    World J Urol. 2022;40:1125-1134.
    Abstract     Related articles   

  1173. LI H, Ni M, Xue C, Li L, et al
    Optimal first-line treatment for platinum-eligible metastatic urothelial carcinoma: Comparison of chemo-immunotherapy, immunotherapy, and chemotherapy- A systematic review and meta-analysis.
    Clin Immunol. 2022;236:108927.
    Abstract     Related articles   

  1174. GEYNISMAN DM, Broughton E, Hao Y, Zhang Y, et al
    Real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United States.
    Urol Oncol. 2022;40:195.
    Abstract     Related articles   

  1175. YAMAMOTO S, Kato M, Takeyama Y, Yukimatsu N, et al
    A retrospective study on optimal number of cycles of the first-line platinum-based chemotherapy for metastatic urothelial carcinoma.
    Urol Oncol. 2022;40:194.
    Abstract     Related articles   

  1176. BADIANI S, MacDermid E, Rutland T, Turner C, et al
    Metastatic urothelial carcinoma to the colon presenting with pelvic abscess tracking to the right hip joint.
    ANZ J Surg. 2022;92:1229-1231.
    Abstract     Related articles   

  1177. XIA QD, Hu J, Liu Z, Li C, et al
    Can artificial intelligence help reduce unnecessary bladder biopsies? Comment on "Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary".
    World J Urol. 2022;40:1241-1242.
    Abstract     Related articles   

  1178. SHAH HD, Saranath D, Murthy V
    A molecular dynamics and docking study to screen anti-cancer compounds targeting mutated p53.
    J Biomol Struct Dyn. 2022;40:2407-2416.
    Abstract     Related articles   

  1179. KONALA VM, Adapa S, Aronow WS
    Immunotherapy in Bladder Cancer.
    Am J Ther. 2022;29:e334-e337.
    Abstract     Related articles   

  1180. FAVORITO LA
    Vesical imaging reporting and data system (VI-RADS) in bladder cancer diagnosis in review in this number of International Brazilian Journal of Urology.
    Int Braz J Urol. 2022;48:607-608.
    Abstract     Related articles   

  1181. SINGH R, Singh UP, Agrawal V, Garg M, et al
    Epithelial-to-mesenchymal transition based diagnostic and prognostic signature markers in non-muscle invasive and muscle invasive bladder cancer patients.
    Mol Biol Rep. 2022 May 20. pii: 10.1007/s11033-022-07563.
    Abstract     Related articles   

  1182. SUDOL D, Widz D, Mitura P, Plaza P, et al
    Neutrophil-to-lymphocyte ratio as a predictor of overall survival and cancer advancement in patients undergoing radical cystectomy for bladder cancer.
    Cent European J Urol. 2022;75:41-46.
    Abstract     Related articles   

  1183. JEONG SH, Ku JH
    Urinary Markers for Bladder Cancer Diagnosis and Monitoring.
    Front Cell Dev Biol. 2022;10:892067.
    Abstract     Related articles   

  1184. HAGIMOTO H, Sano T, Kashima S, Yoshino T, et al
    Rapidly Progressive Bladder Cancer Diagnosed because of Spontaneous Bladder Rupture.
    Case Rep Urol. 2022;2022:4586199.
    Abstract     Related articles   

  1185. LUO Z, Jiao B, Huang T, Zhao H, et al
    What is the Role of the Preoperative Blood-Based Inflammation Biomarkers in the Prognosis of Upper Tract Urothelial Carcinoma With Radical Nephroureterectomy? A Single-Centre Retrospective Study.
    Technol Cancer Res Treat. 2022;21:15330338221095667.
    Abstract     Related articles   

  1186. SARIER M
    Association between human papillomavirus and urothelial carcinoma of the bladder.
    Rev Assoc Med Bras (1992). 2022;68:551-552.
    Abstract     Related articles   

  1187. LIU J, Song W, Li Y, Wang Y, et al
    Burden of Coronary Heart Disease and Cancer from Dietary Exposure to Inorganic Arsenic in Adults in China, 2016.
    Ann Glob Health. 2022;88:28.
    Abstract     Related articles   

  1188. RAJENDRAN G, Taylor JA 3rd, Woolbright BL
    Natural products as a means of overcoming cisplatin chemoresistance in bladder cancer.
    Cancer Drug Resist. 2021;4:69-84.
    Abstract     Related articles   

  1189. FUU T, Iijima K, Kusama Y, Otsuki T, et al
    Complete response to combination therapy using nivolumab and ipilimumab for metastatic, sarcomatoid collecting duct carcinoma presenting with high expression of programmed death-ligand 1: a case report.
    J Med Case Rep. 2022;16:193.
    Abstract     Related articles   

  1190. CHI M, Liu J, Mei C, Shi Y, et al
    TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    J Exp Clin Cancer Res. 2022;41:175.
    Abstract     Related articles   

  1191. SHAFI S, Aung TN, Xirou V, Gavrielatou N, et al
    Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer.
    Lab Invest. 2022 May 17. pii: 10.1038/s41374-022-00796.
    Abstract     Related articles   

  1192. HENSLEY PJ, Panebianco V, Pietzak E, Kutikov A, et al
    Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and Limitations.
    Eur Urol Oncol. 2022 May 14. pii: S2588-9311(22)00066.
    Abstract     Related articles   

  1193. RANTI D, Bieber C, Wang YS, Sfakianos JP, et al
    Natural killer cells: unlocking new treatments for bladder cancer.
    Trends Cancer. 2022 May 14. pii: S2405-8033(22)00073.
    Abstract     Related articles   

  1194. GARAS SN, McAlpine K, Ross J, Carrier M, et al
    Venous thromboembolism risk in patients receiving neoadjuvant chemotherapy for bladder cancer.
    Urol Oncol. 2022 May 14. pii: S1078-1439(22)00116.
    Abstract     Related articles   

  1195. HIETALA A, Joutsen J, Vaarala S, Saily M, et al
    A rare and complete response to combination therapy with radiation and nivolumab in a patient with metastatic urothelial cancer.
    BMJ Case Rep. 2022;15.
    Abstract     Related articles   

  1196. LI Y, Youssef SF, Buanz AB
    Intravesical combination therapies for non-muscle invasive bladder cancer: Recent advances and future directions.
    Eur J Pharmacol. 2022 May 14:175024. doi: 10.1016/j.ejphar.2022.175024.
    Abstract     Related articles   

  1197. MARKOVITZ GH
    Two cases of Bacillus Calmette-Guerin cystitis treated with hyperbaric oxygen.
    Undersea Hyperb Med. 2022;49:191-195.
    Abstract     Related articles   

  1198. LONGJUN C, Jianjun Z, Kun P, Lin H, et al
    NF-kappaB-Activated lncRNACASC9 Promotes Bladder Cancer Progression by Regulating the TK1 Expression.
    J Oncol. 2022;2022:9905776.
    Abstract     Related articles   

  1199. TONRY CL, Evans RM, Ruddock MW, Duggan B, et al
    Clinical features and predictive biomarkers for bladder cancer in patients with Type 2 Diabetes presenting with haematuria.
    Diabetes Metab Res Rev. 2022 May 16:e3546. doi: 10.1002/dmrr.3546.
    Abstract     Related articles   

  1200. BEIJERT IJ, Hentschel AE, Brundl J, Comperat EM, et al
    T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum.
    Eur Urol Focus. 2022 May 13. pii: S2405-4569(22)00110.
    Abstract     Related articles   

  1201. GOMEZ-ROCA C, Cassier P, Zamarin D, Machiels JP, et al
    Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naive or experienced for immune checkpoint blockade.
    J Immunother Cancer. 2022;10.
    Abstract     Related articles   

  1202. WANG EYH, Pihlstrom N, Malmstrom PU, Gardmark T, et al
    Improved long-term outcome of patients with non-muscle invasive, low and intermediate risk bladder cancer between 1997 and 2014; a Swedish population-based study.
    Scand J Urol. 2022 May 16:1-6. doi: 10.1080/21681805.2022.2062046.
    Abstract     Related articles   

  1203. LI J, Cao D, Huang Y, Xiong Q, et al
    The Prognostic and Clinicopathological Significance of Systemic Immune-Inflammation Index in Bladder Cancer.
    Front Immunol. 2022;13:865643.
    Abstract     Related articles   

  1204. KONIG F, Pradere B, Grossmann NC, Quhal F, et al
    Quality indicators for the management of muscle-invasive bladder cancer in the perioperative setting of radical cystectomy: a narrative review.
    Transl Cancer Res. 2022;11:908-917.
    Abstract     Related articles   

  1205. MITCHELL A, Ingle M, Smith G, Chick J, et al
    Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac.
    Clin Transl Radiat Oncol. 2022;35:27-32.
    Abstract     Related articles   

  1206. GAO X, Cai J
    Genome-wide Exploration of a Pyroptosis-Related Long Non-Coding RNA Signature Associated With the Prognosis and Immune Response in Patients With Bladder Cancer.
    Front Genet. 2022;13:865204.
    Abstract     Related articles   

  1207. XIE Q, Zheng H, Chen Y, Peng X, et al
    Cost-Effectiveness of Avelumab Maintenance Therapy Plus Best Supportive Care vs. Best Supportive Care Alone for Advanced or Metastatic Urothelial Carcinoma.
    Front Public Health. 2022;10:837854.
    Abstract     Related articles   

  1208. VILARES AT, Nunes Silva C, Correia da Silva M, Sousa J, et al
    Multisystemic BCGitis: A rare complication of intravesical BCG immunotherapy for bladder cancer.
    Radiol Case Rep. 2022;17:2383-2387.
    Abstract     Related articles   

  1209. CATTO JWF, Khetrapal P, Ricciardi F, Ambler G, et al
    Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial.
    JAMA. 2022 May 15. pii: 2792543. doi: 10.1001/jama.2022.7393.
    Abstract     Related articles   

  1210. MAGANTY A, Herrel LA, Hollenbeck BK
    Robotic Surgery for Bladder Cancer.
    JAMA. 2022 May 15. pii: 2792544. doi: 10.1001/jama.2022.6417.
    Abstract     Related articles   

  1211. FENG D, Lv J, Li K, Cao Q, et al
    CircZNF609 promotes bladder cancer progression and inhibits cisplatin sensitivity via miR-1200/CDC25B pathway.
    Cell Biol Toxicol. 2022 May 14. pii: 10.1007/s10565-022-09715.
    Abstract     Related articles   

  1212. MEDLE B, Sjodahl G, Eriksson P, Liedberg F, et al
    Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing: A Systematic Review.
    Cancers (Basel). 2022;14.
    Abstract     Related articles   

  1213. KOLAT D, Kaluzinska Z, Bednarek AK, Pluciennik E, et al
    Determination of WWOX Function in Modulating Cellular Pathways Activated by AP-2alpha and AP-2gamma Transcription Factors in Bladder Cancer.
    Cells. 2022;11.
    Abstract     Related articles   

  1214. LAI CR, Wang HH, Chang HH, Tsai YL, et al
    Enhancement of Farnesoid X Receptor Inhibits Migration, Adhesion and Angiogenesis through Proteasome Degradation and VEGF Reduction in Bladder Cancers.
    Int J Mol Sci. 2022;23.
    Abstract     Related articles   

  1215. SHIGETA K, Matsumoto K, Tanaka N, Mikami S, et al
    Profiling the Biological Characteristics and Transitions through Upper Tract Tumor Origin, Bladder Recurrence, and Muscle-Invasive Bladder Progression in Upper Tract Urothelial Carcinoma.
    Int J Mol Sci. 2022;23.
    Abstract     Related articles   

  1216. HARLAND N, Maurer FB, Abruzzese T, Bock C, et al
    Elevated Expression of the Immune Checkpoint Ligand CD276 (B7-H3) in Urothelial Carcinoma Cell Lines Correlates Negatively with the Cell Proliferation.
    Int J Mol Sci. 2022;23.
    Abstract     Related articles   

  1217. MICHAELI JC, Boch T, Albers S, Michaeli T, et al
    Socio-economic burden of disease: Survivorship costs for bladder cancer.
    J Cancer Policy. 2022;32:100326.
    Abstract     Related articles   

  1218. WU J, Li T, Ji H, Chen Z, et al
    VRK1 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis In Vitro and In Vivo.
    Front Pharmacol. 2022;13:874235.
    Abstract     Related articles   

  1219. YAN Y, Cao X, Wang Z, Huang Z, et al
    Pyroptosis-Related Patterns Predict Tumor Immune Landscape and Immunotherapy Response in Bladder Cancer.
    Front Mol Biosci. 2022;9:815290.
    Abstract     Related articles   

  1220. ZENG S, Zhang Z, Xu C
    Large population-based study of upper tract urothelial carcinoma in China may provide further insight into the impact of bladder cancer on upper tract urothelial carcinoma's prognosis in Chinese population.
    Transl Androl Urol. 2022;11:573-574.
    Abstract     Related articles   

  1221. ZHANG W, Zhang J, Hu Z, Sun W, et al
    LncRNA ARAP1-AS1 Promotes Bladder Cancer Development by Regulating the miR-3918/KIF20A Axis.
    Mol Biotechnol. 2022 May 13. pii: 10.1007/s12033-022-00489.
    Abstract     Related articles   

  1222. LU K, Chiu KY, Cheng CL
    Immunotherapy in Genitourinary Malignancy: Evolution in Revolution or Revolution in Evolution.
    Cancer Treat Res. 2022;183:201-223.
    Abstract     Related articles   

  1223. LAFORGUE L, Fertin A, Usson Y, Verdier C, et al
    Efficient deformation mechanisms enable invasive cancer cells to migrate faster in 3D collagen networks.
    Sci Rep. 2022;12:7867.
    Abstract     Related articles   

  1224. JONES TD, Cheng L
    Noninvasive papillary urothelial neoplasia (NIPUN): Renaming cancer.
    Urol Oncol. 2021;39:286-290.
    Abstract     Related articles   

  1225. KOGUCHI D, Matsumoto K, Ikeda M, Taoka Y, et al
    Impact of salvage cytotoxic chemotherapy on prognosis in patients with recurrence after radical cystectomy: a multi-institutional retrospective study.
    BMC Urol. 2022;22:75.
    Abstract     Related articles   

  1226. GAITEIRO C, Soares J, Relvas-Santos M, Peixoto A, et al
    Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion.
    Theranostics. 2022;12:3150-3177.
    Abstract     Related articles   

  1227. WANG C, Liu S, Zhang X, Wang Y, et al
    SKA3 is a prognostic biomarker and associated with immune infiltration in bladder cancer.
    Hereditas. 2022;159:20.
    Abstract     Related articles   

  1228. TAKATA M, Kumagai M, Tsubata Y, Okanemasa Y, et al
    A surgical case of high-grade urothelial carcinoma of the renal pelvis complicated with giant hydronephrosis, giving rise to diagnostic difficulties on a cytological examination.
    Diagn Pathol. 2022;17:47.
    Abstract     Related articles   

  1229. QU YY, Sun Z, Han W, Zou Q, et al
    Camrelizumab plus famitinib for advanced or metastatic urothelial carcinoma after platinum-based therapy: data from a multicohort phase 2 study.
    J Immunother Cancer. 2022;10.
    Abstract     Related articles   

  1230. RAZDAN S, Eilender B, Pfail JP, Garcia M, et al
    Higher preoperative eGFR is a predictor of worse renal function decline after robotic assisted radical cystectomy: Implications for postoperative management.
    Urol Oncol. 2022;40:275.
    Abstract     Related articles   

  1231. MAR N, Uchio E, Kalebasty AR
    Use of immunotherapy in clinical management of genitourinary cancers - a review.
    Cancer Treat Res Commun. 2022;31:100564.
    Abstract     Related articles   

  1232. GHORBANI H, Soltani S, Zakavi SR, Masoudifard A, et al
    Bone scan with technetium 99m-methyl diphosphonate, the missing link in the initial staging of muscle-invasive bladder carcinoma.
    Nucl Med Commun. 2022 Apr 12. pii: 00006231-990000000-00007.
    Abstract     Related articles   

  1233. MING J, Wang Y, Su Z, Wang C, et al
    Annular-shaped stenosis in the ureter: Caution should be taken.
    Urol Oncol. 2022;40:274.
    Abstract     Related articles   

  1234. MOHAMMADINEJAD P, Khandelwal A, Inoue A, Takahashi H, et al
    Utility of an automatic adaptive iterative metal artifact reduction AiMAR algorithm in improving CT imaging of patients with hip prostheses evaluated for suspected bladder malignancy.
    Abdom Radiol (NY). 2022;47:2158-2167.
    Abstract     Related articles   

  1235. BHARADWAJ M, Kaul S, Fleishman A, Korets R, et al
    Adjuvant chemotherapy versus observation following radical cystectomy for locally advanced urothelial carcinoma of the bladder.
    Urol Oncol. 2022;40:274.
    Abstract     Related articles   

  1236. HSU HT, Lee HL, Cheng HH, Chang CH, et al
    Relationships of multiple metals exposure, global DNA methylation, and urothelial carcinoma in central Taiwan.
    Arch Toxicol. 2022;96:1893-1903.
    Abstract     Related articles   

  1237. FISCHER-VALUCK BW, Patel SA, Brenneman RJ, Christodouleas J, et al
    Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy.
    Eur Urol Oncol. 2022;5:246-250.
    Abstract     Related articles   

  1238. STANGL-KREMSER J, Muto G, Grosso AA, Briganti A, et al
    The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis.
    Urol Oncol. 2022;40:243-261.
    Abstract     Related articles   

  1239. TANG X, Xiao X, Sun H, Zheng S, et al
    96DRA-Urine: A high throughput sample preparation method for urinary proteome analysis.
    J Proteomics. 2022;257:104529.
    Abstract     Related articles   

  1240. STENMAN J, Wickart-Johansson G, Sundquist F, Nilsson J, et al
    Five-Year Follow-up After Multimodal Treatment Incorporating HDR Brachytherapy for Bladder Prostate Rhabdomyosarcoma in Children.
    Int J Radiat Oncol Biol Phys. 2022;113:355-359.
    Abstract     Related articles   

  1241. PIAZZA P, Bravi CA, Puliatti S, Cacciamani GE, et al
    Assessing pentafecta achievement after robot-assisted radical cystectomy and its association with surgical experience: Results from a high-volume institution.
    Urol Oncol. 2022;40:272.
    Abstract     Related articles   

  1242. SOFTNESS K, Kaul S, Fleishman A, Efstathiou J, et al
    Radical cystectomy versus trimodality therapy for muscle-invasive urothelial carcinoma of the bladder.
    Urol Oncol. 2022;40:272.
    Abstract     Related articles   

  1243. SHBAIR AT, Yasin AI, Topcu A, Coban G, et al
    Metastatic Breast Carcinoma Mimicking Urothelial Carcinoma.
    Int J Surg Pathol. 2022;30:466-469.
    Abstract     Related articles   

  1244. MERMIER M, Baron P, Roumiguie M, Bajeot AS, et al
    Predictive Factors of Early Postoperative Complications After Robot-Assisted Radical Cystectomy for Urothelial Bladder Carcinoma.
    J Endourol. 2022;36:634-640.
    Abstract     Related articles   

  1245. GEDON J, Kehl A, Aupperle-Lellbach H, von Bomhard W, et al
    BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006-2019).
    Vet Comp Oncol. 2022;20:449-457.
    Abstract     Related articles   

  1246. GOMEZ-VEIGA F, Alcaraz-Asensio A, Burgos-Revilla JM, Cozar-Olmo FJ, et al
    Advances in urologic oncology "OncoUrology Forum Special Edition": The best of 2020.
    Actas Urol Esp (Engl Ed). 2022;46:214-222.
    Abstract     Related articles   

  1247. M SERAG EL-DIEN M, Fathy Mahmoud S, Alhanafy AM, Mohamed Zanaty F, et al
    Prognostic significance of LRIG2 and LRIG3 proteins in urothelial bladder carcinoma.
    J Immunoassay Immunochem. 2022;43:308-332.
    Abstract     Related articles   

  1248. PINARD CJ, Stegelmeier AA, Bridle BW, Mutsaers AJ, et al
    Evaluation of lymphocyte-specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients.
    Vet Comp Oncol. 2022;20:427-436.
    Abstract     Related articles   

  1249. YU CC, Chen CH, Hong JH, Ke HL, et al
    Comparison of oncological outcomes for hand-assisted and pure laparoscopic radical nephroureterectomy: results from the Taiwan Upper Tract Urothelial Cancer Collaboration Group.
    Surg Endosc. 2022;36:4342-4348.
    Abstract     Related articles   

  1250. LIMKIN EJ, Guerin F, Espenel S, Terlizzi M, et al
    Use of an intravaginal spacer in young girls treated with brachytherapy for bladder neck rhabdomyosarcoma: Dosimetric impact for organs at risk sparing and acute tolerance.
    Cancer Radiother. 2022;26:486-490.
    Abstract     Related articles   

  1251. THIRUNAVUKKARASU B, Singh S, Sharma AP, Bal A, et al
    Atrophic Kidney-Like Lesion - Case Report of A Provisional Entity with Brief Review of Literature.
    Turk Patoloji Derg. 2022;38:148-152.
    Abstract     Related articles   

  1252. GU Y, Zeng J, Zou Y, Liu C, et al
    Folate Intake and Risk of Urothelial Carcinoma: A Systematic Review and Meta-Analysis of Epidemiological Studies.
    Nutr Cancer. 2022;74:1593-1605.
    Abstract     Related articles   

  1253. KACZOROWSKI M, Matysiak J, Kielb P, Malkiewicz B, et al
    Nuclear Factor IA Is Down-regulated in Muscle-invasive and High-grade Bladder Cancers.
    Anticancer Res. 2022;42:493-500.
    Abstract     Related articles   

  1254. KURASHINA R, Ando K, Inoue M, Izumi K, et al
    Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma.
    Anticancer Res. 2022;42:1131-1136.
    Abstract     Related articles   

  1255. TOMISAKI I, Harada M, Minato A, Nagata Y, et al
    Impact of the Use of Proton Pump Inhibitors on Pembrolizumab Effectiveness for Advanced Urothelial Carcinoma.
    Anticancer Res. 2022;42:1629-1634.
    Abstract     Related articles   

  1256. FURUBAYASHI N, Morokuma F, Tomoda T, Hori Y, et al
    Optimal Timing of Switching from Platinum-based Chemotherapy to Pembrolizumab for Advanced Urothelial Carcinoma Based on Real-world Data: A Multi-institutional Retrospective Study.
    Anticancer Res. 2022;42:1571-1577.
    Abstract     Related articles   

  1257. SALKINI MW, Yang X, Hashmi FH, Kandzari SJ, et al
    First American Cancer Patient to Receive Dicycloplatin (DCP) Chemotherapy Achieves Remission After Seven Weeks of DCP Capsules - A Case Report.
    Anticancer Res. 2022;42:1339-1344.
    Abstract     Related articles   

  1258. HENSLEY PJ, Bree KK, Brooks N, Matulay J, et al
    Time interval from transurethral resection of bladder tumour to bacille Calmette-Guerin induction does not impact therapeutic response.
    BJU Int. 2021;128:634-641.
    Abstract     Related articles   

  1259. ABOZAID M, Tan WS, Khetrapal P, Baker H, et al
    Recovery of health-related quality of life in patients undergoing robot-assisted radical cystectomy with intracorporeal diversion.
    BJU Int. 2022;129:72-79.
    Abstract     Related articles   

  1260. VAN HOOGSTRATEN LMC, Witjes JA, Meijer RP, Ripping TM, et al
    Non-metastatic muscle-invasive bladder cancer: the role of age in receiving treatment with curative intent.
    BJU Int. 2022 Jan 22. doi: 10.1111/bju.15697.
    Abstract     Related articles   

  1261. MAISCH P, Koziarz A, Vajgrt J, Narayan V, et al
    Blue versus white light for transurethral resection of non-muscle invasive bladder cancer.
    BJU Int. 2022 Mar 2. doi: 10.1111/bju.15723.
    Abstract     Related articles   

  1262. ALMASSI N, Vertosick EA, Sjoberg DD, Wong NC, et al
    Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy.
    BJU Int. 2022;129:463-469.
    Abstract     Related articles   

  1263. SCHUETTFORT VM, D'Andrea D, Quhal F, Mostafaei H, et al
    A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma.
    BJU Int. 2022;129:182-193.
    Abstract     Related articles   

  1264. LEUNBACH TL, Stilling C, Tabor MB, Bjerggaard Jensen J, et al
    Caveats in the diagnosis of suspected non-endemic verrucous carcinoma in the urinary bladder.
    BJU Int. 2022;129:457-459.
    Abstract     Related articles   

  1265. SUBIELA JD, Rodriguez Faba O, Aumatell J, Calderon J, et al
    Contemporary outcomes of bladder carcinoma in situ treated with an adequate bacille Calmette-Guerin immunotherapy.
    BJU Int. 2022;129:542-550.
    Abstract     Related articles   

  1266. HASHEM A, Abdellutif MM, Laymon M, Abdullateef M, et al
    Clinical efficacy of mebeverine for persistent nocturnal enuresis after orthotopic W-neobladder.
    BJU Int. 2022;129:387-393.
    Abstract     Related articles   

  1267. LEBRET T, Pignot G, Colombel M, Guy L, et al
    Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt test.
    BJU Int. 2022;129:356-363.
    Abstract     Related articles   

  1268. YANAGISAWA T, Sato S, Hayashida Y, Okada Y, et al
    Do we need repeat TUR after en bloc resection for pT1 bladder cancer?
    BJU Int. 2022 Apr 29. doi: 10.1111/bju.15760.
    Abstract     Related articles   

  1269. LIU Z, Zeng H, Jin K, Yu Y, et al
    TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer.
    Br J Cancer. 2022 Jan 17. pii: 10.1038/s41416-022-01703.
    Abstract     Related articles   

  1270. CHEN J, Rodopoulou S, Strak M, de Hoogh K, et al
    Long-term exposure to ambient air pollution and bladder cancer incidence in a pooled European cohort: the ELAPSE project.
    Br J Cancer. 2022 Feb 16. pii: 10.1038/s41416-022-01735.
    Abstract     Related articles   

  1271. JIN K, Yu Y, Zeng H, Liu Z, et al
    CD103(+)CD8(+) tissue-resident memory T cell infiltration predicts clinical outcome and adjuvant therapeutic benefit in muscle-invasive bladder cancer.
    Br J Cancer. 2022 Feb 14. pii: 10.1038/s41416-022-01725.
    Abstract     Related articles   

  1272. SHOHDY KS, Villamar DM, Cao Y, Trieu J, et al
    Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma.
    Br J Cancer. 2022;126:430-439.
    Abstract     Related articles   

  1273. NARII N, Sobue T, Zha L, Kitamura T, et al
    Vegetable and fruit intake and the risk of bladder cancer: Japan Public Health Center-based prospective study.
    Br J Cancer. 2022 Mar 3. pii: 10.1038/s41416-022-01739.
    Abstract     Related articles   

  1274. LETT L, George M, Slater R, De Lacy Costello B, et al
    Investigation of urinary volatile organic compounds as novel diagnostic and surveillance biomarkers of bladder cancer.
    Br J Cancer. 2022 Mar 29. pii: 10.1038/s41416-022-01785.
    Abstract     Related articles   

  1275. DE JONG JJ, Valderrama BP, Perera J, Juanpere N, et al
    Non-muscle-invasive micropapillary bladder cancer has a distinct lncRNA profile associated with unfavorable prognosis.
    Br J Cancer. 2022 Apr 21. pii: 10.1038/s41416-022-01799.
    Abstract     Related articles   

  1276. ZHOU Z, Zhang Z, Chen H, Bao W, et al
    SBSN drives bladder cancer metastasis via EGFR/SRC/STAT3 signalling.
    Br J Cancer. 2022 Apr 28. pii: 10.1038/s41416-022-01794.
    Abstract     Related articles   

  1277. KOSHKIN VS, Henderson N, James M, Natesan D, et al
    Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
    Cancer. 2022;128:1194-1205.
    Abstract     Related articles   

  1278. BELLAT V, Michel AO, Thomas C, Stokol T, et al
    A urinary drug-disposing approach as an alternative to intravesical chemotherapy for treating non-muscle invasive bladder cancer.
    Cancer Res. 2022 Jan 17. pii: 0008-5472.CAN-21-2897.
    Abstract     Related articles   

  1279. WANG Y, Zhang Y, Li PC, Guo J, et al
    Development of novel aptamer-based targeted chemotherapy for bladder cancer.
    Cancer Res. 2022 Jan 21. pii: 0008-5472.CAN-21-2691.
    Abstract     Related articles   

  1280. AN M, Zheng H, Huang J, Lin Y, et al
    Aberrant Nuclear Export of circNCOR1 Underlies SMAD7-Mediated Lymph Node Metastasis of Bladder Cancer.
    Cancer Res. 2022 Apr 8. pii: 694333. doi: 10.1158/0008-5472.CAN-21-4349.
    Abstract     Related articles   

  1281. NI Z, Sun P, Zheng J, Wu M, et al
    JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
    Cancer Res. 2022;82:1789-1802.
    Abstract     Related articles   

  1282. QIAN J, Huang C, Zhu Z, He Y, et al
    NFE2L3 promotes tumor progression and predicts a poor prognosis of bladder cancer.
    Carcinogenesis. 2022 Jan 12. pii: 6505217. doi: 10.1093.
    Abstract     Related articles   

  1283. SHENG X, Yan X, Wang L, Shi Y, et al
    Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody-Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma.
    Clin Cancer Res. 2021;27:43-51.
    Abstract     Related articles   

  1284. CHANG E, Weinstock C, Zhang L, Charlab R, et al
    FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma.
    Clin Cancer Res. 2021;27:922-927.
    Abstract     Related articles   

  1285. CRABB SJ, Danson S, Catto JWF, Hussain S, et al
    Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE).
    Clin Cancer Res. 2021;27:1882-1892.
    Abstract     Related articles   

  1286. SHENG X, Chen H, Hu B, Yao X, et al
    Safety, Efficacy, and Biomarker Analysis of Toripalimab in Patients with Previously Treated Advanced Urothelial Carcinoma: Results from a Multicenter Phase II Trial POLARIS-03.
    Clin Cancer Res. 2022;28:489-497.
    Abstract     Related articles   

  1287. CHU CE, Sjostrom M, Egusa EA, Gibb EA, et al
    Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin.
    Clin Cancer Res. 2021;27:5123-5130.
    Abstract     Related articles   

  1288. KOUTROS S, Rao N, Moore LE, Nickerson ML, et al
    Targeted Deep Sequencing of Bladder Tumors Reveals Novel Associations between Cancer Gene Mutations and Mutational Signatures with Major Risk Factors.
    Clin Cancer Res. 2021;27:3725-3733.
    Abstract     Related articles   

  1289. WANG L, Sfakianos JP, Beaumont KG, Akturk G, et al
    Myeloid Cell-associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing.
    Clin Cancer Res. 2021;27:4287-4300.
    Abstract     Related articles   

  1290. GIRARDI DM, Niglio SA, Mortazavi A, Nadal R, et al
    Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy.
    Clin Cancer Res. 2022;28:1353-1362.
    Abstract     Related articles   

  1291. BELLMUNT J, de Wit R, Fradet Y, Climent MA, et al
    Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials.
    Clin Cancer Res. 2022;28:2050-2060.
    Abstract     Related articles   

  1292. ENIKEEV D, Babjuk M, Shpikina A, Shariat S, et al
    En bloc resection for nonmuscle-invasive bladder cancer: selecting a proper laser.
    Curr Opin Urol. 2021 Dec 24. pii: 00042307-900000000-98808.
    Abstract     Related articles   

  1293. HUSSEIN AA, Li Q, Guru KA
    Robot-assisted radical cystectomy: surgical technique, perioperative and oncologic outcomes.
    Curr Opin Urol. 2022;32:116-122.
    Abstract     Related articles   

  1294. BERNDL F, Hassler MR
    Molecular intricacies of upper tract urothelial carcinoma and their relevance for therapy considerations.
    Curr Opin Urol. 2022;32:48-53.
    Abstract     Related articles   

  1295. LONATI C, Moschini M, Simeone C, Spiess PE, et al
    Lynch syndrome in urological practice: diagnosis, therapeutic strategies, and screening for upper tract urothelial carcinoma.
    Curr Opin Urol. 2022;32:40-47.
    Abstract     Related articles   

  1296. SONPAVDE GP, Sternberg CN, Loriot Y, Marabelle A, et al
    Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma.
    Eur J Cancer. 2022;163:55-65.
    Abstract     Related articles   

  1297. KLUMPER N, Sikic D, Saal J, Buttner T, et al
    C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma.
    Eur J Cancer. 2022;167:13-22.
    Abstract     Related articles   

  1298. ROUMIGUIE M, Kamat AM, Bivalacqua TJ, Lerner SP, et al
    International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guerin-exposed High-risk Non-muscle-invasive Bladder Cancer.
    Eur Urol. 2021 Dec 23. pii: S0302-2838(21)02213.
    Abstract     Related articles   

  1299. MOSSANEN M, Carvalho FLF, Muralidhar V, Preston MA, et al
    Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy.
    Eur Urol. 2021 Dec 22. pii: S0302-2838(21)02212.
    Abstract     Related articles   

  1300. GROBET-JEANDIN E, Pinar U, Roupret M
    Re: Trey Durdin, Alvin Goh, Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer? Eur Urol 2021;80:16-7: Transurethral Resection of Bladder Tumor in Diagnosis of Muscle-invasive Bladder Cancer:
    Eur Urol. 2022 Jan 11. pii: S0302-2838(21)02282.
    Abstract     Related articles   

  1301. SJODAHL G, Abrahamsson J, Holmsten K, Bernardo C, et al
    Reply to Joep J. de Jong and Ewan A. Gibb's Letter to the Editor re: Gottfrid Sjodahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. In press. https://do
    Eur Urol. 2022 Jan 13. pii: S0302-2838(21)02284.
    Abstract     Related articles   

  1302. DE JONG JJ, Gibb EA
    Re: Gottfrid Sjodahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.10.035: Neoadjuvant Chemotherapy Resp
    Eur Urol. 2022 Jan 13. pii: S0302-2838(21)02281.
    Abstract     Related articles   

  1303. RENTSCH CA, Hayoz S, Cathomas RL
    Re: Pembrolizumab Monotherapy for the Treatment of High-risk Non-muscle-invasive Bladder Cancer Unresponsive to BCG (KEYNOTE-057): An Open-label, Single-arm, Multicenter, Phase 2 Study.
    Eur Urol. 2022 Jan 24. pii: S0302-2838(22)00022.
    Abstract     Related articles   

  1304. BRAUN A, Abbosh PH
    Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy: A Rare Entity with Unique Genomic Features.
    Eur Urol. 2022 Jan 30. pii: S0302-2838(22)00067.
    Abstract     Related articles   

  1305. BABJUK M
    Re: Long-term Experience with Radiofrequency-induced Hyperthermia Combined with Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer.
    Eur Urol. 2022 Jan 29. pii: S0302-2838(22)00023.
    Abstract     Related articles   

  1306. GROBET-JEANDIN E, Pinar U, Roupret M
    Re: Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study.
    Eur Urol. 2022 Jan 27. pii: S0302-2838(22)00012.
    Abstract     Related articles   

  1307. PARIKH DA, Khaki AR, Williams SB
    Re: Pembrolizumab Monotherapy for the Treatment of High-risk Non-muscle-invasive Bladder Cancer Unresponsive to BCG (KEYNOTE-057): An Open-label, Single-arm, Multicentre, Phase 2 Study.
    Eur Urol. 2022 Feb 4. pii: S0302-2838(22)00017.
    Abstract     Related articles   

  1308. HE P, Zhou X, Chen Z
    Reply to Shun-Fa Hung, Shyi-Chun Yii, and Shiu-Dong Chung's Letter to the Editor re: Zhiwen Chen, Peng He, Xiaozhou Zhou, et al. Preliminary Functional Outcome Following Robotic Intracorporeal Orthotopic Ileal Neobladder Suspension with Round Ligament
    Eur Urol. 2022 Feb 3. pii: S0302-2838(22)00081.
    Abstract     Related articles   

  1309. LEOW JJ, Chong YL, Chang SL, Valderrama BP, et al
    Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.
    Eur Urol. 2021;79:635-654.
    Abstract     Related articles   

  1310. HUNG SF, Yii SC, Chung SD
    Re: Zhiwen Chen, Peng He, Xiaozhou Zhou, et al. Preliminary Functional Outcome Following Robotic Intracorporeal Orthotopic Ileal Neobladder Suspension with Round Ligaments in Women with Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eur
    Eur Urol. 2022 Feb 9. pii: S0302-2838(22)00077.
    Abstract     Related articles   

  1311. VAN DER HEIJDEN MS, Loriot Y, Duran I, Ravaud A, et al
    Atezolizumab Versus Chemotherapy in Patients with Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: A Long-term Overall Survival and Safety Update from the Phase 3 IMvigor211 Clinical Trial.
    Eur Urol. 2021;80:7-11.
    Abstract     Related articles   

  1312. LI R, Gilbert SM, Kamat AM
    Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guerin.
    Eur Urol. 2021;80:1-3.
    Abstract     Related articles   

  1313. SATISH P, Kuusk T, Campain N, Abu-Ghanem Y, et al
    The European Association of Urology COVID Intermediate-priority Group is Poorly Predictive of Pathological High Risk Among Patients with Renal Tumours.
    Eur Urol. 2021;80:265-267.
    Abstract     Related articles   

  1314. DELL'OGLIO P, Andras I, Ortega D, Galfano A, et al
    Impact of the Implementation of the EAU Guidelines Recommendation on Reporting and Grading of Complications in Patients Undergoing Robot-assisted Radical Cystectomy: A Systematic Review.
    Eur Urol. 2021;80:129-133.
    Abstract     Related articles   

  1315. XU P, Chen B, Xu A, Yuan D, et al
    Initial Experience with Intracorporeal Laparoscopic Radical Cystectomy and Detaenial Sigmoid Neobladder Reconstruction.
    Eur Urol. 2021;79:545-551.
    Abstract     Related articles   

  1316. FOERSTER B, Abufaraj M, Matin SF, Azizi M, et al
    Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study.
    Eur Urol. 2021;80:507-515.
    Abstract     Related articles   

  1317. PIAZZA P, Rosiello G, Chacon VT, Puliatti S, et al
    Robot-assisted Cystectomy with Intracorporeal Urinary Diversion After Pelvic Irradiation for Prostate Cancer: Technique and Results from a Single High-volume Center.
    Eur Urol. 2021 Apr 7. pii: S0302-2838(21)00229.
    Abstract     Related articles   

  1318. WEINSTOCK C, Agrawal S, Chang E
    Optimizing Clinical Trial Design for Patients with Non-muscle-invasive Bladder Cancer.
    Eur Urol. 2022 Mar 15. pii: S0302-2838(22)01655.
    Abstract     Related articles   

  1319. MAYR R, Eckstein M, Wirtz RM, Santiago-Walker A, et al
    Prognostic and Predictive Value of Fibroblast Growth Factor Receptor Alterations in High-grade Non-muscle-invasive Bladder Cancer Treated with and Without Bacillus Calmette-Guerin Immunotherapy.
    Eur Urol. 2022 Mar 26. pii: S0302-2838(22)01670.
    Abstract     Related articles   

  1320. ALFRED WITJES J
    Re: Oncological Benefit of Re-resection for T1 Bladder Cancer: A Comparative Effectiveness Study.
    Eur Urol. 2022 Mar 25. pii: S0302-2838(22)01786.
    Abstract     Related articles   

  1321. ERTL IE, Lemberger U, Ilijazi D, Hassler MR, et al
    Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active Compound.
    Eur Urol. 2022 Apr 4. pii: S0302-2838(22)01678.
    Abstract     Related articles   

  1322. MCGREGOR B, O'Donnell PH, Balar A, Petrylak D, et al
    Health-related Quality of Life of Patients with Locally Advanced or Metastatic Urothelial Cancer Treated with Enfortumab Vedotin after Platinum and PD-1/PD-L1 Inhibitor Therapy: Results from Cohort 1 of the Phase 2 EV-201 Clinical Trial.
    Eur Urol. 2022;81:515-522.
    Abstract     Related articles   

  1323. GALLIOLI A, Breda A, Palou J
    Re: Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study.
    Eur Urol. 2022;81:428-429.
    Abstract     Related articles   

  1324. GEAVLETE P, Multescu R, Geavlete B
    Re: How to Manage Patients with Suspected Upper Tract Urothelial Carcinoma in the Pandemic of COVID-19?
    Eur Urol. 2022;81:543.
    Abstract     Related articles   

  1325. NAKAUMA-GONZALEZ JA, Rijnders M, van Riet J, van der Heijden MS, et al
    Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma.
    Eur Urol. 2022;81:331-336.
    Abstract     Related articles   

  1326. HENSLEY PJ, Kamat AM
    Re: Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes.
    Eur Urol. 2022;81:316-317.
    Abstract     Related articles   

  1327. RUTKA JT, Fleshner N, Nathens AB
    Re: Jeremy Yuen-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Euro Urol 2021;80:442-9.
    Eur Urol. 2022;81:e51.
    Abstract     Related articles   

  1328. SJODAHL G, Abrahamsson J, Holmsten K, Bernardo C, et al
    Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes.
    Eur Urol. 2022;81:523-532.
    Abstract     Related articles   

  1329. CARMEN MIR M, Greenwell T, O'Kelly F, Proietti S, et al
    Reply to Laurence Klotz's Letter to the Editor re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9. Eur Urol 2021;80
    Eur Urol. 2022;81:e26-e27.
    Abstract     Related articles   

  1330. CATHOMAS R, Lorch A, Bruins HM, Comperat EM, et al
    The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma.
    Eur Urol. 2022;81:95-103.
    Abstract     Related articles   

  1331. SAAD S, Osman NI, Chapple CR
    Reply to Sanjay B. Kulkarni, Pankaj M. Joshi, Marco Bandini, et al.'s Letter to the Editor re: Sanad Saad, Nadir I. Osman, Christopher R. Chapple. Female Urethra: Is Ventral the True Dorsal? Eur Urol 2020;78:e218-9.
    Eur Urol. 2022;81:e16-e17.
    Abstract     Related articles   

  1332. LIEDBERG F, Abrahamsson J, Bobjer J
    Re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy Have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/
    Eur Urol. 2022;81:e18-e19.
    Abstract     Related articles   

  1333. SHIGETA K, Matsumoto K, Oya M
    Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer's Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial
    Eur Urol. 2022;81:e20-e21.
    Abstract     Related articles   

  1334. DEV S
    Reply to Laurence Klotz's Letter to the Editor re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9. Eur Urol 2021;80
    Eur Urol. 2022;81:e25.
    Abstract     Related articles   

  1335. CLEMENTS MB, Atkinson TM, Dalbagni GM, Li Y, et al
    Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort.
    Eur Urol. 2022;81:294-304.
    Abstract     Related articles   

  1336. LAUKHTINA E, Shariat SF
    Re: Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer.
    Eur Urol. 2022 Apr 30. pii: S0302-2838(22)01816.
    Abstract     Related articles   

  1337. CONROY S, Nguyen AHT
    Compound to Clinic? A Preclinical High-throughput Screening Pathway To Expedite Drug Discovery in Bladder Cancer.
    Eur Urol. 2022 May 5. pii: S0302-2838(22)01811.
    Abstract     Related articles   

  1338. HALL E, Hussain SA, Porta N, Lewis R, et al
    Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 Trial.
    Eur Urol. 2022 May 13. pii: S0302-2838(22)02265.
    Abstract     Related articles   

  1339. DIANATINASAB M, Wesselius A, Salehi-Abargouei A, Yu EYW, et al
    Dietary fats and their sources in association with the risk of bladder cancer: A pooled analysis of 11 prospective cohort studies.
    Int J Cancer. 2022 Feb 19. doi: 10.1002/ijc.33970.
    Abstract     Related articles   

  1340. HAYAKAWA N, Kikuchi E
    Editorial Comment to Incidence and location of perioperative deep vein thrombosis in patients with bladder cancer undergoing radical cystectomy.
    Int J Urol. 2021 Dec 28. doi: 10.1111/iju.14777.
    Abstract     Related articles   

  1341. SHINDO T
    Editorial Comment from Dr Shindo to Prognostication in Japanese patients with Bacillus Calmette-Guerin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomy.
    Int J Urol. 2022 Jan 4. doi: 10.1111/iju.14783.
    Abstract     Related articles   

  1342. GRAVESTOCK P, Coulthard N, Veeratterapillay R, Heer R, et al
    Response to Re: Systematic review and meta-analysis of narrow band imaging for non-muscle-invasive bladder cancer.
    Int J Urol. 2022 Jan 1. doi: 10.1111/iju.14780.
    Abstract     Related articles   

  1343. CHEN CS, Li JR, Yang CK, Cheng CL, et al
    Significant predictors of contralateral upper tract recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
    Int J Urol. 2022;29:69-75.
    Abstract     Related articles   

  1344. KIJIMA T
    Editorial Comment to Programmed cell death-ligand 1 expression in different molecular subtypes of upper tract urothelial carcinoma.
    Int J Urol. 2022;29:91.
    Abstract     Related articles   

  1345. TOMIYAMA E, Fujita K, Hashimoto M, Miyamoto H, et al
    Programmed cell death-ligand 1 expression in different molecular subtypes of upper tract urothelial carcinoma.
    Int J Urol. 2022;29:89-90.
    Abstract     Related articles   

  1346. LEOW JJ, Yong DZ, Chia PL
    Editorial Comment to Impact of neoadjuvant chemotherapy on survival and recurrence patterns after robot-assisted radical cystectomy for muscle-invasive bladder cancer: Results from the International Robotic Cystectomy Consortium.
    Int J Urol. 2022 Feb 10. doi: 10.1111/iju.14818.
    Abstract     Related articles   

  1347. YANG T, Liang H, Pei X, Zhang N, et al
    Substratification of patients with highest-risk non-muscle invasive bladder cancer helps to identify the candidates for immediate radical cystectomy: A two-center study.
    Int J Urol. 2022 Feb 5. doi: 10.1111/iju.14808.
    Abstract     Related articles   

  1348. TAOKA R, Sugimoto M
    Editorial Comment to Substratification of patients with highest-risk non-muscle invasive bladder cancer helps to identify the candidates for immediate radical cystectomy: A two-center study.
    Int J Urol. 2022 Feb 15. doi: 10.1111/iju.14828.
    Abstract     Related articles   

  1349. IQBAL U, Houenstein HA, Elsayed AS, Jing Z, et al
    Ileal conduit versus neobladder: A propensity score-matched analysis of the effect on renal function.
    Int J Urol. 2022;29:158-163.
    Abstract     Related articles   

  1350. LIN MY, Niu SW, Li WM, Lee HL, et al
    Incidence and survival variations of upper tract urothelial cancer in Taiwan (2001-2010).
    Int J Urol. 2022;29:121-127.
    Abstract     Related articles   

  1351. IDE H
    Editorial Comment from Dr Ide to Substratification of patients with highest-risk non-muscle invasive bladder cancer helps to identify the candidates for immediate radical cystectomy: A two-center study.
    Int J Urol. 2022 Feb 25. doi: 10.1111/iju.14837.
    Abstract     Related articles   

  1352. KOBAYASHI K, Matsuyama H, Kawai T, Ikeda A, et al
    Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
    Int J Urol. 2022 Mar 15. doi: 10.1111/iju.14854.
    Abstract     Related articles   

  1353. URABE F, Matsuzaki J, Ito K, Takamori H, et al
    Serum microRNA as liquid biopsy biomarker for the prediction of oncological outcomes in patients with bladder cancer.
    Int J Urol. 2022 Mar 14. doi: 10.1111/iju.14858.
    Abstract     Related articles   

  1354. NASELLI A, Pirola GM
    Editorial Comment from Dr Naselli and Dr Pirola to Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
    Int J Urol. 2022 Mar 31. doi: 10.1111/iju.14883.
    Abstract     Related articles   

  1355. TELLINI R, Mari A, Minervini A
    Editorial Comment from Dr Tellini et al. to Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
    Int J Urol. 2022 Apr 5. doi: 10.1111/iju.14895.
    Abstract     Related articles   

  1356. HAYAKAWA N, Kikuchi E
    Editorial Comment from Dr Hayakawa and Dr Kikuchi to Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
    Int J Urol. 2022 Apr 2. doi: 10.1111/iju.14888.
    Abstract     Related articles   

  1357. MIYAKE M
    Editorial Comment to Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinoma.
    Int J Urol. 2022;29:364-365.
    Abstract     Related articles   

  1358. OZAKI K, Hatakeyama S, Hamaya T, Okita K, et al
    Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinoma.
    Int J Urol. 2022;29:362-364.
    Abstract     Related articles   

  1359. KANNO T, Kobori G, Ito K, Nakagawa H, et al
    Complications and their management following retroperitoneal lymph node dissection in conjunction with retroperitoneal laparoscopic radical nephroureterectomy.
    Int J Urol. 2022;29:455-461.
    Abstract     Related articles   

  1360. FUJITA N, Hatakeyama S, Momota M, Narita T, et al
    Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer who receive adjuvant induction bacillus Calmette-Guerin therapy.
    Int J Urol. 2022 May 16. doi: 10.1111/iju.14926.
    Abstract     Related articles   

  1361. GHOREIFI A, Basin MF, Ghodoussipour S, Bazargani ST, et al
    Perioperative outcomes of goal-directed versus conventional fluid therapy in radical cystectomy with enhanced recovery protocol.
    Int Urol Nephrol. 2021;53:1827-1833.
    Abstract     Related articles   

  1362. PARAJULI P, Luitel BR, Pradhan MM, Chapagain S, et al
    Clinicopathological patterns of bladder carcinoma over 1 year: experience from University Hospital of Nepal.
    Int Urol Nephrol. 2021;53:2289-2294.
    Abstract     Related articles   

  1363. YORULMAZ EM, Yilmaz Y, Kose O, Akin Y, et al
    Investigation of the causes of BCG refractory in patients treated with intracavitary BCG as secondary treatment in superficial bladder tumors with transurethral resection.
    Int Urol Nephrol. 2022;54:533-540.
    Abstract     Related articles   

  1364. REHME C, Fritsch B, Thomas L, Istin S, et al
    Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor: a retrospective analysis of 143 patients.
    Int Urol Nephrol. 2022;54:71-79.
    Abstract     Related articles   

  1365. ZHAO X, Wang Y, Liang C
    Cigarette smoking and risk of bladder cancer: a dose-response meta-analysis.
    Int Urol Nephrol. 2022 Mar 25. pii: 10.1007/s11255-022-03173.
    Abstract     Related articles   

  1366. KAWADA T
    Serum irisin concentration in patients with bladder cancer.
    Int Urol Nephrol. 2022 Apr 1. pii: 10.1007/s11255-022-03199.
    Abstract     Related articles   

  1367. CHIERIGO F, Borghesi M, Wurnschimmel C, Flammia RS, et al
    Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity.
    Int Urol Nephrol. 2022 May 4. pii: 10.1007/s11255-022-03221.
    Abstract     Related articles   

  1368. TAKEN K, Aslan R, Eryilmaz R, Alp HH, et al
    Response to Letter to the Editor 'Serum irisin concentration in patients with bladder cancer'.
    Int Urol Nephrol. 2022;54:1247-1248.
    Abstract     Related articles   

  1369. FUNT SA, Lattanzi M, Whiting K, Al-Ahmadie H, et al
    Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.
    J Clin Oncol. 2022 Jan 28:JCO2101485. doi: 10.1200/JCO.21.01485.
    Abstract     Related articles   

  1370. PFISTER C, Gravis G, Flechon A, Chevreau C, et al
    Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial.
    J Clin Oncol. 2022 Mar 7:JCO2102051. doi: 10.1200/JCO.21.02051.
    Abstract     Related articles   

  1371. SONPAVDE GP, Mouw KW, Mossanen M
    Therapy for Muscle-Invasive Urothelial Carcinoma: Controversies and Dilemmas.
    J Clin Oncol. 2022;40:1275-1280.
    Abstract     Related articles   

  1372. OWENS-WALTON J, Williams C, Rompre-Brodeur A, Pinto PA, et al
    Minority Enrollment in Phase II and III Clinical Trials in Urologic Oncology.
    J Clin Oncol. 2022;40:1583-1589.
    Abstract     Related articles   

  1373. KHALEEL S, Regmi S, Hannah P, Watarai B, et al
    Impact of Preoperative Immunonutrition on Perioperative Outcomes Following Cystectomy. Reply.
    J Urol. 2021;206:1531-1532.
    Abstract     Related articles   

  1374. ALSYOUF M, Djaladat H
    Impact of Preoperative Immunonutrition on Perioperative Outcomes following Cystectomy. Letter.
    J Urol. 2021;206:1530-1531.
    Abstract     Related articles   

  1375. MONAGHAN TF, Wagg AS, Rahman SN, Winer AG, et al
    Electronic Rapid Fitness Assessment Identifies Factors Associated with Adverse Early Postoperative Outcomes following Radical Cystectomy. Letter.
    J Urol. 2022;207:237-238.
    Abstract     Related articles   

  1376. CHESNUT GT, Goh AC
    Electronic Rapid Fitness Assessment Identifies Factors Associated with Adverse Early Postoperative Outcomes following Radical Cystectomy. Reply.
    J Urol. 2022;207:238-239.
    Abstract     Related articles   

  1377. GOLD SA, Kenigsberg AP, Lotan Y
    Diagnostic and Cost Implications of the 2020 AUA Microhematuria Guidelines: Modeling Impact in a Large Public Health Care System.
    J Urol. 2022;207:52-60.
    Abstract     Related articles   

  1378. RAMAN JD, Kavalieris L, Konety B, Porten S, et al
    The Diagnostic Performance of Cxbladder Resolve, Alone and in Combination with Other Cxbladder Tests, in the Identification and Priority Evaluation of Patients at Risk for Urothelial Carcinoma.
    J Urol. 2021;206:1380-1389.
    Abstract     Related articles   

  1379. YANKELEVICH GR, Dreher PC, Taylor Z, Kim D, et al
    Socio-Environmental Conditions Associated with Geospatial Clusters of Urothelial Carcinoma: A Multi-Institutional Analysis.
    J Urol. 2021;206:1390-1402.
    Abstract     Related articles   

  1380. FURBERG H, Petruzella S, Whiting K, Stein E, et al
    Association of Biochemically Verified Post-diagnosis Smoking and Non-muscle Invasive Bladder Cancer Recurrence Risk.
    J Urol. 2022 Jan 27:101097JU0000000000002449. doi: 10.1097/JU.0000000000002449.
    Abstract     Related articles   

  1381. MITRA AP, Cai J, Miranda G, Bhanvadia S, et al
    Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 Cases.
    J Urol. 2022;207:302-313.
    Abstract     Related articles   

  1382. MIEST T, Khanna A, Sharma V, Hensley PJ, et al
    Development and Validation of a Risk-Adapted Scoring Model for Metachronous Upper Tract Urothelial Carcinoma following Radical Cystectomy.
    J Urol. 2022;207:284-292.
    Abstract     Related articles   

  1383. SONG Y, Du Y, Qin C, Xu T, et al
    The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis. Letter.
    J Urol. 2022;207:937.
    Abstract     Related articles   

  1384. GESSNER KH, Siemens DR, Bjurlin MA
    Does Smoking Cessation Reduce Bladder Cancer Recurrence?
    J Urol. 2022 Mar 15:101097JU0000000000002649. doi: 10.1097/JU.0000000000002649.
    Abstract     Related articles   

  1385. YANAGISAWA T, Mori K, Motlagh RS, Kawada T, et al
    En Bloc Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and Histopathology.
    J Urol. 2022;207:754-768.
    Abstract     Related articles   

  1386. MATIN SF, Pierorazio PM, Kleinmann N, Gore JL, et al
    Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report.
    J Urol. 2022;207:779-788.
    Abstract     Related articles   

  1387. RICHTER LA, Osazuwa-Peters OL, Routh JC, Handa VL, et al
    Vaginal Complications after Cystectomy: Results from a Medicare Sample.
    J Urol. 2022;207:789-796.
    Abstract     Related articles   


  1388. Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer.
    J Urol. 2022;207:1166.
    Abstract     Related articles   

  1389. MASTROIANNI R, Ferriero M, Tuderti G, Anceschi U, et al
    Open Radical Cystectomy versus Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Early Outcomes of a Single-Center Randomized Controlled Trial.
    J Urol. 2022;207:982-992.
    Abstract     Related articles   

  1390. ROSEN GH, Nallani A, Muzzey C, Murray KS, et al
    Antegrade Instillation of UGN-101 (Mitomycin for Pyelocalyceal Solution) for Low-Grade Upper Tract Urothelial Carcinoma: Initial Clinical Experience.
    J Urol. 2022;207:1302-1311.
    Abstract     Related articles   

  1391. KATES M, Mansour AM, Lamm DL, Shore N, et al
    Phase 1/2 Trial Results of a Large Surface Area Microparticle Docetaxel for the Treatment of High-Risk Non-muscle Invasive Bladder Cancer.
    J Urol. 2022 May 16:101097JU0000000000002778. doi: 10.1097/JU.0000000000002778.
    Abstract     Related articles   

  1392. HUELSTER HL, Sexton WJ
    Real-World Outcomes Driving the Needle toward Simplification of Nonmuscle Invasive Bladder Cancer Risk Stratification.
    J Urol. 2022 May 2:101097JU0000000000002731. doi: 10.1097/JU.0000000000002731.
    Abstract     Related articles   

  1393. KOMURA K, Inamoto T, Tsujino T, Matsui Y, et al
    Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents.
    Oncogene. 2021;40:6210-6222.
    Abstract     Related articles   

  1394. BAKER SC, Mason AS, Slip RG, Skinner KT, et al
    Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer.
    Oncogene. 2022 Feb 22. pii: 10.1038/s41388-022-02235.
    Abstract     Related articles   

  1395. MESSAOUD M, Vercherin P, Chaneliere AF, Mottet N, et al
    [Geriatric assessment and treatment of nonmetastatic muscle-invasive bladder cancer in patients over 75 years of age. Retrospective and multicentric study of 121 cases].
    Prog Urol. 2022 Jan 5. pii: S1166-7087(21)00582.
    Abstract     Related articles   

  1396. SOOROJEBALLY Y, Surlemont L, Neuzillet Y, Lebret T, et al
    Impact of carcinoma in situ on survival of patients treated by adjuvant chemotherapy after cystectomy.
    Prog Urol. 2022;32:53-60.
    Abstract     Related articles   

  1397. LEON P, Saint F, Audenet F, Roumiguie M, et al
    [Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer].
    Prog Urol. 2022 Feb 9. pii: S1166-7087(22)00011.
    Abstract     Related articles   

  1398. AUDENET F, Sotto A, Roumiguie M, Allory Y, et al
    [Guidelines from the cancer (CC-AFU) and infection disease (CI-AFU) committees of the French Association of Urology for the management of adverse events and complications of BCG].
    Prog Urol. 2022;32:165-176.
    Abstract     Related articles   

  1399. ROLLIN P, Xylinas E, Lanz C, Audenet F, et al
    [Intravesical adjuvant regimen of epitubicin for intermediate risk NMIBC: Feasability study from CC-AFU vessie].
    Prog Urol. 2022;32:326-331.
    Abstract     Related articles   

  1400. WEINHOLD P, Jokisch F, Schulz GB, Buchner A, et al
    Clinical Implication of Borderline CT-Morphological Metastatic Spread in Bladder Cancer: What You See Is Not Always What You Got.
    Urol Int. 2022 Feb 3:1-10. doi: 10.1159/000521857.
    Abstract     Related articles   

  1401. VOLZ Y, Pfitzinger PL, Eismann L, Ebner B, et al
    Prognostic Value of Pretreatment Inflammatory Markers in Patients Receiving Radical Cystectomy for Urothelial Bladder Cancer: Does Age Matter?
    Urol Int. 2022 Feb 8:1-8. doi: 10.1159/000521829.
    Abstract     Related articles   

  1402. KAMECKI H, Debowska M, Nyk L, Przewor A, et al
    The Clinical Features of Incidentally Diagnosed Urothelial Bladder Cancer: A Retrospective Data Analysis.
    Urol Int. 2022 Feb 11:1-8. doi: 10.1159/000521684.
    Abstract     Related articles   

  1403. LANNES F, Walz J, Maubon T, Rybikowski S, et al
    Enhanced Recovery after Surgery for Radical Cystectomy Decreases Postoperative Complications at Different Times.
    Urol Int. 2022;106:171-179.
    Abstract     Related articles   

  1404. SHAO G, Xu C, Liu J, Li X, et al
    Clinical, Pathological, and Prognostic Analysis of Urachal Carcinoma.
    Urol Int. 2022;106:199-208.
    Abstract     Related articles   

  1405. LIU Z, Zhang P, Wang H, Zheng B, et al
    Raman Spectrum-Based Diagnosis Strategy for Bladder Tumor.
    Urol Int. 2022;106:109-115.
    Abstract     Related articles   

  1406. CHEN H, Wang M, Weng T, Wei Y, et al
    Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma.
    Urol Int. 2022;106:186-194.
    Abstract     Related articles   

  1407. ADAMCZYK P, Poblocki P, Kadlubowski M, Ostrowski A, et al
    Complication Rate after Radical Cystectomy Depends on the Surgical Technique and Patient's Clinical Status.
    Urol Int. 2022;106:163-170.
    Abstract     Related articles   

  1408. LEE J, Suh J, Jeong CW, Kwak C, et al
    Efficacy of the Treatment of Intraperitoneal Bladder Perforation during Transurethral Resection of Bladder Tumor with the Urethral Catheter Alone: Retrospective Analysis of over 15 Years Using the Clinical Data Warehouse System.
    Urol Int. 2022;106:138-146.
    Abstract     Related articles   

  1409. GROBET-JEANDIN E, Wirth GJ, Benamran D, Dupont A, et al
    Substaging of pT1 Urothelial Bladder Carcinoma Predicts Tumor Progression and Overall Survival.
    Urol Int. 2022;106:130-137.
    Abstract     Related articles   

  1410. GRAFFEILLE V, Verhoest G, Gryn A, Kammerer-Jacquet SF, et al
    Complete Transurethral Resection before Radical Cystectomy May Improve Oncological Outcomes.
    Urol Int. 2022;106:122-129.
    Abstract     Related articles   

  1411. LEE MS, Shen M, Williams A, Kendrick D, et al
    Retroureteral Small Bowel Herniation Resulting in Bowel Obstruction Following Robotic Cystectomy With Extracorporeal Ileal Conduit.
    Urology. 2021;147:3-6.
    Abstract     Related articles   

  1412. DALIMOV Z, Iqbal U, Jing Z, Wiklund P, et al
    Intracorporeal Versus Extracorporeal Neobladder After Robot-assisted Radical Cystectomy: Results From the International Robotic Cystectomy Consortium.
    Urology. 2022;159:127-132.
    Abstract     Related articles   

  1413. HINATA N, Hussein AA, Bando Y, Terakawa T, et al
    Histologic Investigation of the Female Vesicourethral Junction and Adjacent Tissues for Nerve-sparing Radical Cystectomy.
    Urology. 2021;149:161-167.
    Abstract     Related articles   

  1414. ELSAYED AS, Ozair S, Iqbal U, Mostowy M, et al
    Prevalence and Predictors of Venous Thromboembolism After Robot-Assisted Radical Cystectomy.
    Urology. 2021;149:146-153.
    Abstract     Related articles   

  1415. ALDHAAM NA, Elsayed AS, Hussein AA, Siam A, et al
    Impact of Perioperative Multidisciplinary Rehabilitation Pathway on Early Outcomes after Robot-assisted Radical Cystectomy: A Matched Analysis.
    Urology. 2021;147:155-161.
    Abstract     Related articles   

  1416. AVULOVA S, Wittmann D
    Optimizing Women's Sexual Function and Sexual Experience After Radical Cystectomy.
    Urology. 2021;151:138-144.
    Abstract     Related articles   

  1417. SMITH AL, Weissbart SJ
    Gynecologic Considerations for the Urologic Surgeon.
    Urology. 2021;150:116-124.
    Abstract     Related articles   

  1418. CRUZ AP, Chelluri R, Ramchandani P, Guzzo TJ, et al
    Post-cystectomy Enterocele: A Case Series and Review of the Literature.
    Urology. 2021;150:180-187.
    Abstract     Related articles   

  1419. KIM AH, Ruel NH, Yamzon J, Zhumkhawala AA, et al
    Novel Antibiotic-Irrigating Wound Protector Reduces Infectious Complications in Robot-Assisted Radical Cystectomy with Extracorporeal Urinary Diversion.
    Urology. 2022;159:160-166.
    Abstract     Related articles   

  1420. STANGL-KREMSER J, Ahmadi H, Derstine B, Wang SC, et al
    Psoas Muscle Mass can Predict Postsurgical Outcomes in Patients Who Undergo Radical Cystectomy and Urinary Diversion Reconstruction.
    Urology. 2021;158:142-149.
    Abstract     Related articles   

  1421. LOH-DOYLE JC, Bhanvadia SK, Han J, Ghodoussipour S, et al
    Patient Reported Sexual Function Outcomes in Male Patients Following Open Radical Cystoprostatectomy and Urinary Diversion.
    Urology. 2021;157:161-167.
    Abstract     Related articles   

  1422. WESTERMAN ME, Bree KK, Kokorovic A, Frank J, et al
    What Women Want: Radical Cystectomy and Perioperative Sexual Function Educational Needs.
    Urology. 2021;157:181-187.
    Abstract     Related articles   

  1423. MURTHY PB, Lone Z, Munoz Lopez C, Ericson JZK, et al
    Comparison of Oncologic Outcomes Following Open and Robotic-assisted Radical Cystectomy with both Extracorporeal and Intracorporeal Urinary Diversion.
    Urology. 2021;154:184-190.
    Abstract     Related articles   

  1424. KLEIN GT, Ajay D, Volk RJ, Leal V, et al
    Living With Urinary Diversions: Patient Insights to Improve the Perioperative Experience.
    Urology. 2021;152:190-194.
    Abstract     Related articles   

  1425. KERN SQ, Speir RW, Tong Y, Kaimakliotis H, et al
    Longitudinal Health Related Quality of Life After Open Radical Cystectomy: Comparison of Ileal Conduit, Indiana Pouch, and Orthotopic Neobladder.
    Urology. 2021;152:184-189.
    Abstract     Related articles   

  1426. KNORR JM, Ericson KJ, Zhang JH, Murthy P, et al
    Comparison of Major Complications at 30 and 90 Days Following Radical Cystectomy.
    Urology. 2021;148:192-197.
    Abstract     Related articles   

  1427. GUL ZG, Liaw CW, Mehrazin R
    Gender Differences in Incidence, Diagnosis, Treatments, and Outcomes in Clinically Localized Bladder and Renal Cancer.
    Urology. 2021;151:176-181.
    Abstract     Related articles   

  1428. YANG H, Zhang Z, Zhao K, Zhang Y, et al
    Extraperitoneal Laparoscopic Radical Cystectomy With Preservation of Fertility for the Treatment of Ewing Sarcoma: The First Report of a Reliable Surgical Method.
    Urology. 2022;159:241-246.
    Abstract     Related articles   

  1429. VASSANTACHART A, Daneshmand S, Cai J, Miranda G, et al
    Feasibility and Outcomes of Orthotopic Ileal Neobladder Reconstruction Following Pelvic Irradiation.
    Urology. 2021;148:198-202.
    Abstract     Related articles   

  1430. GHOREIFI A, Djaladat H
    Re: Vejlgaard M, Maibom SL, Stroomberg HV, et al. Long-term Renal Function following Radical Cystectomy for Bladder Cancer. Urology. 2021;S0090-4295(21)01083-9. doi:10.1016/j.urology.2021.11.015.
    Urology. 2022 Feb 25. pii: S0090-4295(22)00146.
    Abstract     Related articles   

  1431. CROGHAN SM, Daniels AE, Kelly C, Fitzgibbon L, et al
    The Pull-through Anastomosis of Ureter to Enteric Conduit (PAUTEC): A Novel Technique for Urinary Diversion.
    Urology. 2021;157:263-268.
    Abstract     Related articles   

  1432. PACCHETTI A, Pignot G, Le Quellec A, Rybikowski S, et al
    Sexual-Sparing Robot Assisted Radical Cystectomy in Female: A Step-By-Step Guide.
    Urology. 2021;156:322-323.
    Abstract     Related articles   

  1433. CHANDORA A, Lovin JM, Smith EA
    Inflammatory Myofibroblastic Tumor Presenting as Gross Hematuria in a Pediatric Patient With VACTERL Syndrome Following Bladder Augmentation.
    Urology. 2021;154:268-270.
    Abstract     Related articles   

  1434. TRAN THT, Melamed J, Deng FM
    Gastric Adenocarcinoma Arising in Gastrocystoplasty.
    Urology. 2021;148:270-273.
    Abstract     Related articles   

  1435. VEJLGAARD M, Andreas Roder M
    Reply to Djaladat H and Ghoreifi A's Letter-to-the-Editor Re: Vejlgaard M, Maibom SL, Stroomberg HV, et al. Long-term Renal Function Following Radical Cystectomy for Bladder Cancer. Urology. 2021;S0090-4295(21)01083-9. doi:10.1016/j.urology.2021.11.01
    Urology. 2022 Mar 6. pii: S0090-4295(22)00147.
    Abstract     Related articles   

  1436. DOUGLAWI A, Ghoreifi A, Lee R, Yip W, et al
    Bladder Recurrence Following Diagnostic Ureteroscopy in Patients Undergoing Nephroureterectomy for Upper Tract Urothelial Cancer: Is Ureteral Access Sheath Protective?
    Urology. 2022;160:142-146.
    Abstract     Related articles   

  1437. KUMARASEGARAM V, Drejer D, Jensen JB
    Detection Rate of Carcinoma In Situ During TURBT Following Shift from Photodynamic Diagnosis to Narrow Band Imaging in a Single University Hospital.
    Urology. 2022;161:83-86.
    Abstract     Related articles   

  1438. IPLIKCI A, Cakici MC, Simsek BC, Yildirim A, et al
    Lip Metastasis After Radical Cystectomy.
    Urology. 2022;161:17-18.
    Abstract     Related articles   

  1439. SCHLOMER BJ, Norris N, Gurram B, Carpinito G, et al
    Bladder Necrosis at Time of Presentation with Ulcerative Colitis in an 8-year-old Female: A Case Report.
    Urology. 2022;160:195-198.
    Abstract     Related articles   

  1440. ZHANG Y, Zhu B, Cai Y, Zhu S, et al
    Alteration in glycolytic/cholesterogenic gene expression is associated with bladder cancer prognosis and immune cell infiltration.
    BMC Cancer. 2022;22:2.
    Abstract     Related articles   

  1441. HUANG T, Li J, Wang SM
    Core promoter mutation contributes to abnormal gene expression in bladder cancer.
    BMC Cancer. 2022;22:68.
    Abstract     Related articles   

  1442. WAHLIN S, Boman K, Moran B, Nodin B, et al
    Pre-clinical and clinical studies on the role of RBM3 in muscle-invasive bladder cancer: longitudinal expression, transcriptome-level effects and modulation of chemosensitivity.
    BMC Cancer. 2022;22:131.
    Abstract     Related articles   

  1443. KIM KS, Kim SH, Cho HJ, Sur HJ, et al
    Holmium laser-assisted laparoscopic partial cystectomy for bladder cancer: a single-institutional pilot study with technical feasibility and short-term oncological outcome.
    BMC Cancer. 2022;22:195.
    Abstract     Related articles   

  1444. FANG Q, Zhang X, Nie Q, Hu J, et al
    Improved urine DNA methylation panel for early bladder cancer detection.
    BMC Cancer. 2022;22:237.
    Abstract     Related articles   

  1445. WANG R, Kang H, Zhang X, Nie Q, et al
    Urinary metabolomics for discovering metabolic biomarkers of bladder cancer by UPLC-MS.
    BMC Cancer. 2022;22:214.
    Abstract     Related articles   

  1446. GUAN Z, Sun Y, Mu L, Jiang Y, et al
    Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-kappaB signaling activation.
    BMC Cancer. 2022;22:240.
    Abstract     Related articles   

  1447. BHATTACHARJEE S, Sullivan MJ, Wynn RR, Demagall A, et al
    PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth.
    BMC Cancer. 2022;22:312.
    Abstract     Related articles   

  1448. SUN M, Liu X, Zhao W, Zhang B, et al
    Circ_0058063 contributes to cisplatin-resistance of bladder cancer cells by upregulating B2M through acting as RNA sponges for miR-335-5p.
    BMC Cancer. 2022;22:313.
    Abstract     Related articles   

  1449. WU Z, Xia C, Zhang C, Yang D, et al
    Prognostic significance of SNCA and its methylation in bladder cancer.
    BMC Cancer. 2022;22:330.
    Abstract     Related articles   

  1450. FANG C, Huang X, Dai J, He W, et al
    The circular RNA circFARSA sponges microRNA-330-5p in tumor cells with bladder cancer phenotype.
    BMC Cancer. 2022;22:373.
    Abstract     Related articles   

  1451. YANG Z, Zhang X, Zhang J, Gao J, et al
    Rationale and design of a prospective, multicenter, phase II clinical trial of safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer (NCRT
    BMC Cancer. 2022;22:462.
    Abstract     Related articles   

  1452. WEICKHARDT AJ, Lau DK, Hodgson-Garms M, Lavis A, et al
    Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer.
    BMC Cancer. 2022;22:478.
    Abstract     Related articles   

  1453. DENG L, Chao H, Deng H, Yu Z, et al
    A novel and sensitive DNA methylation marker for the urine-based liquid biopsies to detect bladder cancer.
    BMC Cancer. 2022;22:510.
    Abstract     Related articles   

  1454. HAO N, Yang D, Liu T, Liu S, et al
    Laminin-integrin a6b4 interaction activates notch signaling to facilitate bladder cancer development.
    BMC Cancer. 2022;22:558.
    Abstract     Related articles   

  1455. ZHU L, Liu X, Zhang W, Hu H, et al
    MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder.
    BMC Cancer. 2022;22:556.
    Abstract     Related articles   

  1456. ODA S, Fujisawa M, Chunning L, Ito T, et al
    Expression of Spred2 in the urothelial tumorigenesis of the urinary bladder.
    PLoS One. 2021;16:e0254289.
    Abstract     Related articles   

  1457. AL-EZZI EM, Veitch ZW, Salah SH, Van der Kwast TH, et al
    Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study.
    PLoS One. 2021;16:e0259272.
    Abstract     Related articles   

  1458. LEMINSKI A, Kaczmarek K, Byrski T, Slojewski M, et al
    Neoadjuvant chemotherapy with dose dense MVAC is associated with improved survival after radical cystectomy compared to other cytotoxic regimens: A tertiary center experience.
    PLoS One. 2021;16:e0259526.
    Abstract     Related articles   

  1459. SANGSTER AG, Gooding RJ, Garven A, Ghaedi H, et al
    Mutually exclusive mutation profiles define functionally related genes in muscle invasive bladder cancer.
    PLoS One. 2022;17:e0259992.
    Abstract     Related articles   

  1460. HEMMINKI K, Forsti A, Hemminki A, Ljungberg B, et al
    Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years.
    PLoS One. 2022;17:e0261124.
    Abstract     Related articles   

  1461. FU Y, Sun S, Bi J, Kong C, et al
    An HDAC9-associated immune-related signature predicts bladder cancer prognosis.
    PLoS One. 2022;17:e0264527.
    Abstract     Related articles   

  1462. ISONO M, Okubo K, Asano T, Sato A, et al
    Ataxia telangiectasia and Rad3-related inhibition by AZD6738 enhances gemcitabine-induced cytotoxic effects in bladder cancer cells.
    PLoS One. 2022;17:e0266476.
    Abstract     Related articles   

  1463. KANG DH, Cho KS, Moon YJ, Chung DY, et al
    Effect of neoadjuvant chemotherapy on overall survival of patients with T2-4aN0M0 bladder cancer: A systematic review and meta-analysis according to EAU COVID-19 recommendation.
    PLoS One. 2022;17:e0267410.
    Abstract     Related articles   

  1464. AGHAMIR SMK, Khatami F, Farrokhpour H, Oliveira Reis L, et al
    Oncologic outcomes of Bacillus Calmette-Guerin therapy in elderly patients with non-muscle-invasive bladder cancer: A meta-analysis.
    PLoS One. 2022;17:e0267934.
    Abstract     Related articles   

  1465. OKORIE CL, Gatsby E, Schroeck FR, Ould Ismail AA, et al
    Using electronic health records to streamline provider recruitment for implementation science studies.
    PLoS One. 2022;17:e0267915.
    Abstract     Related articles   

  1466. KONG N, Zhang R, Wu G, Sui X, et al
    Intravesical delivery of KDM6A-mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer.
    Proc Natl Acad Sci U S A. 2022;119.
    Abstract     Related articles   

  1467. SUN X, Xie L, Qiu S, Li H, et al
    Elucidation of CKAP4-remodeled cell mechanics in driving metastasis of bladder cancer through aptamer-based target discovery.
    Proc Natl Acad Sci U S A. 2022;119:e2110500119.
    Abstract     Related articles   


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;